
<html lang="en"     class="pb-page"  data-request-id="a2707b91-0951-4035-a0d3-c1763a2dc362"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2016.59.issue-19;article:article:10.1021/acs.jmedchem.6b01066"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="β-Sulfonamido Functionalized Aspartate Analogues as Excitatory Amino Acid Transporter Inhibitors: Distinct Subtype Selectivity Profiles Arising from Subtle Structural Differences" /></meta><meta name="dc.Creator" content="Jacob C.  Hansen" /></meta><meta name="dc.Creator" content="Walden E.  Bjørn-Yoshimoto" /></meta><meta name="dc.Creator" content="Niels  Bisballe" /></meta><meta name="dc.Creator" content="Birgitte  Nielsen" /></meta><meta name="dc.Creator" content="Anders A.  Jensen" /></meta><meta name="dc.Creator" content="Lennart  Bunch" /></meta><meta name="dc.Description" content="In this study inspired by previous work on 3-substituted Asp analogues, we designed and synthesized a total of 32 β-sulfonamide Asp analogues and characterized their pharmacological properties at t..." /></meta><meta name="Description" content="In this study inspired by previous work on 3-substituted Asp analogues, we designed and synthesized a total of 32 β-sulfonamide Asp analogues and characterized their pharmacological properties at t..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 16, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01066" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01066" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01066" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01066" /></link>
        
    
    

<title>β-Sulfonamido Functionalized Aspartate Analogues as Excitatory Amino Acid Transporter Inhibitors: Distinct Subtype Selectivity Profiles Arising from Subtle Structural Differences | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01066" /></meta><meta property="og:title" content="β-Sulfonamido Functionalized Aspartate Analogues as Excitatory Amino Acid Transporter Inhibitors: Distinct Subtype Selectivity Profiles Arising from Subtle Structural Differences" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0011.jpeg" /></meta><meta property="og:description" content="In this study inspired by previous work on 3-substituted Asp analogues, we designed and synthesized a total of 32 β-sulfonamide Asp analogues and characterized their pharmacological properties at the excitatory amino acid transporter subtypes EAAT1, EAAT2, and EAAT3. In addition to several potent EAAT inhibitors displaying IC50 values ∼1 μM at all three subtypes, this elaborate structure–activity relationship also identified analogues exhibiting distinct preferences or selectivities for specific transporter subtypes. Introduction of two fluorine atoms on the phenyl ring yielded analogue 4y that displayed an IC50 of 0.8 μM at EAAT1 with a 14- and 9-fold preference over EAAT2 and EAAT3, respectively. Conversely, the m-CF3-phenyl analogue 4r was a potent selective EAAT2-inhibitor (IC50 = 2.8 μM) exhibiting 30- and 50-fold selectivity over EAAT1 and EAAT3, respectively. In conclusion, even small structural differences in these β-sulfonamide Asp analogues provide analogues with diverse EAAT subtype selectivity profiles." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01066"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01066">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01066&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01066&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01066&amp;href=/doi/10.1021/acs.jmedchem.6b01066" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 8771-8786</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01058" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00355" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">β-Sulfonamido Functionalized Aspartate Analogues as Excitatory Amino Acid Transporter Inhibitors: Distinct Subtype Selectivity Profiles Arising from Subtle Structural Differences</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacob+C.++Hansen">Jacob C. Hansen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Walden+E.++Bj%C3%B8rn-Yoshimoto">Walden E. Bjørn-Yoshimoto</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Niels++Bisballe">Niels Bisballe</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Birgitte++Nielsen">Birgitte Nielsen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anders+A.++Jensen">Anders A. Jensen</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lennart++Bunch">Lennart Bunch</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen Ø 2100, Denmark</span></div><div class="corresp-info"><strong>*</strong>Phone: +45 35 33 62 44. E-mail: <a href="/cdn-cgi/l/email-protection#026e6760774271776c662c69772c6669"><span class="__cf_email__" data-cfemail="214d4443546152544f450f4a540f454a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01066&amp;href=/doi/10.1021%2Facs.jmedchem.6b01066" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 8771–8786</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 16, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 July 2016</li><li><span class="item_label"><b>Published</b> online</span>16 September 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 October 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01066" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01066</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8771%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJacob%2BC.%2BHansen%252C%2BWalden%2BE.%2BBj%25C3%25B8rn-Yoshimoto%252C%2BNiels%2BBisballe%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D19%26contentID%3Dacs.jmedchem.6b01066%26title%3D%25CE%25B2-Sulfonamido%2BFunctionalized%2BAspartate%2BAnalogues%2Bas%2BExcitatory%2BAmino%2BAcid%2BTransporter%2BInhibitors%253A%2BDistinct%2BSubtype%2BSelectivity%2BProfiles%2BArising%2Bfrom%2BSubtle%2BStructural%2BDifferences%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8786%26publicationDate%3DOctober%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01066"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">974</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01066" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;β-Sulfonamido Functionalized Aspartate Analogues as Excitatory Amino Acid Transporter Inhibitors: Distinct Subtype Selectivity Profiles Arising from Subtle Structural Differences&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jacob&quot;,&quot;last_name&quot;:&quot;C. Hansen&quot;},{&quot;first_name&quot;:&quot;Walden&quot;,&quot;last_name&quot;:&quot;E. Bjørn-Yoshimoto&quot;},{&quot;first_name&quot;:&quot;Niels&quot;,&quot;last_name&quot;:&quot;Bisballe&quot;},{&quot;first_name&quot;:&quot;Birgitte&quot;,&quot;last_name&quot;:&quot;Nielsen&quot;},{&quot;first_name&quot;:&quot;Anders&quot;,&quot;last_name&quot;:&quot;A. Jensen&quot;},{&quot;first_name&quot;:&quot;Lennart&quot;,&quot;last_name&quot;:&quot;Bunch&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;8771-8786&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01066&quot;},&quot;abstract&quot;:&quot;In this study inspired by previous work on 3-substituted Asp analogues, we designed and synthesized a total of 32 β-sulfonamide Asp analogues and characterized their pharmacological properties at the excitatory amino acid transporter subtypes EAAT1, EAAT2, and EAAT3. In addition to several potent EAAT inhibitors displaying IC50 values ∼1 μM at all three subtypes, this elaborate structure–activity relationship also identified analogues exhibiting distinct preferences or selectivities for specific transporter subtypes. Introduction of two fluorine atoms on the phenyl ring yielded analogue 4y that displayed an IC50 of 0.8 μM at EAAT1 with a 14- and 9-fold preference over EAAT2 and EAAT3, respectively. Conversely, the m-CF3-phenyl analogue 4r was a potent selective EAAT2-inhibitor (IC50 = 2.8 μM) exhibiting 30- and 50-fold selectivity over EAAT1 and EAAT3, respectively. In conclusion, even small structural differences in these β-sulfonamide Asp analogues provide analogues with diverse EAAT subtype selectivity pro&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01066&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01066" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01066&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01066" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01066&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01066" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01066&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01066&amp;href=/doi/10.1021/acs.jmedchem.6b01066" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01066" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01066" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01066%26sid%3Dliteratum%253Aachs%26pmid%3D27636002%26genre%3Darticle%26aulast%3DHansen%26date%3D2016%26atitle%3D%25CE%25B2-Sulfonamido%2BFunctionalized%2BAspartate%2BAnalogues%2Bas%2BExcitatory%2BAmino%2BAcid%2BTransporter%2BInhibitors%253A%2BDistinct%2BSubtype%2BSelectivity%2BProfiles%2BArising%2Bfrom%2BSubtle%2BStructural%2BDifferences%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D19%26spage%3D8771%26epage%3D8786%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/jmcmar.2016.59.issue-19/20161013/jmcmar.2016.59.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In this study inspired by previous work on 3-substituted Asp analogues, we designed and synthesized a total of 32 β-sulfonamide Asp analogues and characterized their pharmacological properties at the excitatory amino acid transporter subtypes EAAT1, EAAT2, and EAAT3. In addition to several potent EAAT inhibitors displaying IC<sub>50</sub> values ∼1 μM at all three subtypes, this elaborate structure–activity relationship also identified analogues exhibiting distinct preferences or selectivities for specific transporter subtypes. Introduction of two fluorine atoms on the phenyl ring yielded analogue <b>4y</b> that displayed an IC<sub>50</sub> of 0.8 μM at EAAT1 with a 14- and 9-fold preference over EAAT2 and EAAT3, respectively. Conversely, the <i>m</i>-CF<sub>3</sub>-phenyl analogue <b>4r</b> was a potent selective EAAT2-inhibitor (IC<sub>50</sub> = 2.8 μM) exhibiting 30- and 50-fold selectivity over EAAT1 and EAAT3, respectively. In conclusion, even small structural differences in these β-sulfonamide Asp analogues provide analogues with diverse EAAT subtype selectivity profiles.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">(<i>S</i>)-Glutamate (Glu, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A) is the major excitatory neurotransmitter in the central nervous system (CNS), where it controls and regulates an immense number of different processes. Because of this abundance and the importance of glutamatergic neurotransmission for virtually all central functions, hyperactivity or hypoactivity in these systems are believed to be at the core of numerous cognitive, psychiatric, neurotoxic, and neurodegenerative disorders. Thus, the considerable therapeutic interest in glutamatergic targets is rooted in the possibility that these disorders as well as others not based in glutamatergic dysfunction potentially could be treated through this neurotransmitter system.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of: (A) Endogenous EAAT substrates Glu and Asp. (B) Competitive EAAT inhibitors TBOA,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a><b>18</b>,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><b>14</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> DHK,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> and <b>13</b>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (C) Noncompetitive EAAT1 inhibitors <b>15</b>,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a><b>16</b>,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and <b>17</b>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synaptic uptake of Glu following its release into the synaptic cleft is mediated by the five members of the excitatory amino acid transporter (EAAT) family, EAAT1–5.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9 ref10">(5-10)</a> These high-affinity Glu transporters are expressed in the plasma membranes of glia cells (predominantly EAAT1,2) and neurons (predominantly EAAT3–5). EAAT2 is the major EAAT subtype estimated to be responsible for >90% of total Glu uptake in the brain, with EAAT1 and EAAT3 also being abundantly distributed throughout the CNS. In contrast, EAAT4 and EAAT5 are almost exclusively expressed in cerebellar Purkinje cells and in the retina, respectively, and these subtypes also exhibit distinct transporter/channel properties compared to the other three EAATs and thus are believed to act predominantly as Cl<sup>–</sup> channels.<a onclick="showRef(event, 'ref5 ref6 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref8">(5, 6, 8)</a> The distinct regional and cellular distribution of the five EAAT subtypes in the CNS is likely to be important for their regulation of glutamatergic neurotransmission, just as selective modulation of the Glu uptake through different transporter subtypes may have different impact on glutamatergic neurotransmission, both when it comes to the characteristics and levels of the induced effects but also in terms of the CNS regions affected.</div><div class="NLM_p">The potential in EAATs as therapeutic targets has so far not been explored to the extent as is the case in the Glu receptor fields,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and the limited selection of potent and truly subtype-selective EAAT modulators identified to date constitutes an obstacle to the delineation of the physiological roles and the therapeutic potential of each of the five transporters. Medicinal chemistry development in the EAAT field has mainly been based on the endogenous transporter substrates Glu and (<i>S</i>/<i>R</i>)-aspartate (Asp).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Several nonselective substrates and competitive nonsubstrate inhibitors of the transporters have emerged from these efforts, <span class="smallcaps smallerCapital">dl</span>-<i>threo</i>-β-benxyloxyaspartate (TBOA)<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> being the prototypic nonselective EAAT inhibitor. Interestingly, EAAT2-selectivity has emerged from quite different modifications to the Glu and Asp structures, as EAAT2-selective inhibitors include the conformationally restricted Glu analogue dihydrokainic acid (DHK),<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> the 4-substituted Glu analogue (2<i>S</i>,4<i>R</i>)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid (<b>13</b>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and the functionalized asparagine analogue <i>N</i>-[4-(2-bromo-4,5-difluorophenoxy)phenyl]-<span class="smallcaps smallerCapital">l</span>-asparagine (<b>14</b>, WAY-213613)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B). Although 4-methyl-Glu is a substrate of EAAT1 and a nonsubstrate inhibitor of EAAT2,3 and thus exhibits functional EAAT1-selectivity,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> the only truly selective EAAT1 inhibitors reported to date are the noncompetitive inhibitors 2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4<i>H</i>-chromene-3-carbonitrile (<b>15</b>, UCPH-101),<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> 2-amino-4-(4-methyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4<i>H</i>-chromene-3-carbonitrile (<b>16</b>, UCPH-102),<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> and most recently (<i>Z</i>)-4-chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid (<b>17</b>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C). Truly subtype-selective modulators of EAAT3–5 have yet to be discovered, but interestingly the β-substituted Asp analogue <span class="smallcaps smallerCapital">l</span>-<i>threo</i>-β-benzylaspartate (<b>18</b>, <span class="smallcaps smallerCapital">l</span>-β-BA)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> has been reported to display a 10-fold preference as an inhibitor of EAAT3 over EAAT1,2.</div><div class="NLM_p last">Over the past decade, we have applied various approaches in our efforts to discover subtype-selective EAAT ligands.<a onclick="showRef(event, 'ref6 ref16 ref19 ref21 ref26'); return false;" href="javascript:void(0);" class="ref ref6 ref16 ref19 ref21 ref26">(6, 16, 19, 21, 26)</a> In the present study, we were inspired by the previously reported work on 3-substituted Asp analogues as EAAT inhibitors, where the initial discovery of the nonselective EAAT substrate <span class="smallcaps smallerCapital">l</span>-<i>threo</i>-β-hydroxyaspartic acid<a onclick="showRef(event, 'ref15 ref27'); return false;" href="javascript:void(0);" class="ref ref15 ref27">(15, 27)</a> has led to subsequent development of the nonselective EAAT inhibitor TBOA<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> and the more potent and EAAT1,2-preferring inhibitor TFB-TBOA<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> as well as to the EAAT3-preferring inhibitor <b>18</b>.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> To explore the potential in the 3-substituted Asp analogue as a scaffold for EAAT ligands further, we have designed and synthesized a series of β-amino-Asp analogues and characterized their pharmacological properties at EAAT1–3. On the basis of this elaborate structure–activity relationship (SAR) study, we report that even small structural differences in the 3-substituents of these analogues give rise to dramatically different functional profiles at EAAT1–3.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In view of the stereochemical match (<i>threo</i>)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and structural similarity of Asp analogues TBOA and <b>18</b>, we hypothesized that the functionality in the β-position of Asp plays a decisive role for the observed EAAT-selectivity profile and that this difference in pharmacology is likely to arise from differential spatial orientation of the aryl group in the substrate binding pocket of the EAAT. We therefore designed new series of β-amino-Asp analogues <b>1</b>–<b>4a</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) to explore the orientation of the aryl group as well as its distance from the Asp scaffold on inhibitory activity.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of rationally designed β-functionalized Asp analogues <b>1</b>, <b>2</b>, <b>3</b>-<b>A</b>/<b>B</b>, and <b>4a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of <b>1</b>, <b>2</b>, <b>3</b>-<b>A</b>/<b>B</b>, and <b>4a</b></h3><div class="NLM_p">The apparently important orientation of the phenyl ring in the Asp analogues <b>18</b> and TBOA urged us to reduce the degree of rotational freedom between the Asp backbone and the aromatic ring. To install this structural restriction, we opted for the incorporation of an sp<sup>2</sup> hybridized nitrogen atom in the β-position of Asp. Furthermore, insertion of an amino group would provide a versatile scaffold, allowing for the synthesis of a variety of derivatives. We therefore nominated β-azido Asp <b>8</b> to be a key intermediate in the synthesis of the new β-functionalized Asp analogues.</div><div class="NLM_p">It has been reported, that differentiation of the <i>Re</i> and <i>Si</i> face of the in situ formed enolate of <i>N</i>-trityl protected Asp ensures diastereoselective insertion of an electrophile at the 3-postion of Asp.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> A key feature in this stereoselectivity is countercation chelation and temperature. Using LHMDS, the diastereomeric ratio of 1:11 (<i>S</i>,<i>S</i>:<i>S</i>,<i>R</i>) is obtained, whereas for KHMDS, a 99:1 (<i>S</i>,<i>S</i>:<i>S</i>,<i>R</i>) ratio is achieved. Because the <i>threo</i>-diastereomer (TBOA) is the pharmacologically active diastereomer of this class, we planned a <i>direct</i> insertion of nitrogen functionality at the β-position using KHMDS. Conversely, <i>indirect</i> insertion of nitrogen could be pursued, i.e., suitable S<sub>N</sub>2 substitution reaction on the <i>erythro</i> intermediate prepared with the use of lithium hexamethyldisilazide (LHMDS).</div><div class="NLM_p">Initial attempts to functionalize the β-position of Asp were aimed at azidation of dimethyl (2<i>S</i>)-<i>N</i>-(triphenylmethyl)aspartate <b>6</b> using potassium hexamethyldisilazide (KHMDS) (2.1 equiv) and trisyl-N<sub>3</sub> (2.5 equiv) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Applying low temperature chelation (−78 °C) failed to produce any conversion. Likewise, elevation of the temperature after addition of electrophilic azidation reagent to 7 °C did not offer any of the desired azide <b>8</b>. Increasing the amount of added electrophile and base, for both KHMDS and LHMDS, similarly failed. Confident that the enolate was successfully formed (by quenching with D<sub>2</sub>O), we attempted the reaction with less sterically hindered tosyl-N<sub>3</sub>, however, this was also unsuccessful.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of β-Functionalized Asp Analogues <b>1</b>, <b>2</b>, <b>3</b>-<b>A</b>/<b>B</b>, and <b>4a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeOH, H<sub>2</sub>SO<sub>4</sub>, reflux, quant; (b) TrCl, TEA, DCM, 75% (2 steps); (c) <b>6</b>, LHMDS, THF, 30 min, −30 °C, then NBS 100 min, −30 to −5 °C; (d) NaN<sub>3</sub>, DMF, 56% (2 steps); (e) PPh<sub>3</sub>, THF, 79%; (f) phenylacetylene, sodium ascorbate, CuSO<sub>4</sub>·5H<sub>2</sub>O, H<sub>2</sub>O/<i>t</i>-BuOH; (g) PhCOCl, TEA, DCM; (h) PhOCOCl, TEA, DCM; (i) PhSO<sub>2</sub>Cl, TEA, DCM; (j) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF; (k) 6 M HCl, reflux, 1 h, preparative HPLC.</p></p></figure><div class="NLM_p last">Because of the apparent lack of reactivity of the azidation reagents toward the enolate, the direct azidation strategy was abandoned. Instead, we turned to the more reactive bromination reagent that could afford the desired 3-bromo Asp <b>7</b>, which could then undergo nucleophilic substitution with the sterically less demanding N<sub>3</sub><sup>–</sup>. Reaction of NBS with the lithium enolate of <b>6</b> (generated with LHMDS) was unreactive at −78 °C but gave full conversion with dr 1:0.3 when warming to rt. Repeating these conditions with Br<sub>2</sub> as the electrophile produced a complex mixture of products, even at −78 °C. We therefore examined the temperature range of reactivity for NBS and found it to be −48 °C to −30 °C under these reaction conditions. Realizing that we could not obtain full diastereoselective control in this reaction step, we decided to aim for a 1:1 mixture of diastereomers. Gratifyingly, full conversion was achieved at −30 to −5 °C to give bromide <b>7</b> in diastereomeric ratio 2:3, which was used without further purification. Conversion of crude bromide <b>7</b> to azide <b>8</b> proceeded smoothly with NaN<sub>3</sub> in anhyd DMF in quantitative yield. To access triazole <b>1</b>, azide <b>8</b> cleanly underwent copper catalyzed Huisgen cycloaddition, followed by hydrolysis and purification by preparative HPLC to give target compound <b>1</b> in 14% yield with dr 0.5:1. Amide <b>2</b>, carbamates <b>3A</b>-<b>A</b>/<b>B</b>, and sulfonamide <b>4a</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) were synthesized by first reducing azide <b>8</b> to amine <b>9</b> under Staudinger conditions followed by reaction with benzoyl chloride, phenyl chloroformate, and phenylsulfonyl chloride, respectively (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Pharmacological Characterization of <b>1</b>, <b>2</b>, <b>3</b>-<b>A</b>/<b>B</b>, and <b>4a</b> at EAAT1–3</h3><div class="NLM_p">The pharmacological properties of the four Asp analogues <b>1</b>, <b>2</b>, <b>3</b>-<b>A</b>/<b>B</b>, and <b>4a</b> were characterized at stable EAAT1-, EAAT2-, and EAAT3-HEK293 cells in a conventional [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp uptake assay,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and the results are given in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. While the 4′-phenyl triazole analogue <b>1</b> was inactive as inhibitor at EAAT1–3, the amide <b>2</b> displayed weak inhibitory activity at EAAT2 (IC<sub>50</sub> ∼ 70 μM) while being inactive at EAAT1,3 at concentrations up to 300 μM. As for the two diastereomeric carbamate analogues, <b>3</b>-<b>A</b> displayed negligible inhibitory activity at EAAT1–3, whereas the other diastereomer <b>3</b>-<b>B</b> showed weak inhibitory activity at EAAT1 (IC<sub>50</sub> ∼ 70 μM) and even weaker activity at EAAT2,3. Interestingly, the sulfonamide analogue <b>4a</b> displayed significant inhibitory activity at the three transporter subtypes, with IC<sub>50</sub> values ranging from 2.0 to 6.8 μM.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pharmacological Properties of Previously Reported Asp Analogues and β-Sulfonamide Asp Analogues at Stable EAAT1-, EAAT2-, and EAAT3-HEK293 Cell Lines in the [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp Uptake Assay (IC<sub>50</sub> Values are Given in μM with pIC<sub>50</sub> ± SEM in Brackets (<i>n</i> = 3–5))</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0007.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Because the concentration–inhibition curves for the compound were not completed within the concentration range tested, the IC<sub>50</sub> value was estimated based on the fitted curve.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Stereochemistry of <b>4a</b></h3><div class="NLM_p">To address stereochemical reference to <b>18</b> and TBOA, the diastereomeric mixture <b>4a</b> was separated by preparative HPLC to afford the single diastereomers <b>4a</b>-<b>A</b> and <b>4a</b>-<b>B</b>. When characterized functionally at EAAT1–3 in the [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp uptake assay, distinct pharmacological profiles were disclosed for the respective diastereomers. Diastereomer <b>4a</b>-<b>A</b> displayed negligible inhibitory activity at EAAT1–3, whereas <b>4a</b>-<b>B</b> exhibited inhibitory potencies in the high nanomolar/low micromolar range across the three subtypes (IC<sub>50</sub> values of 0.80–2.4 μM, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). To assign the absolute stereochemistry at the β-position of diastereomers <b>4a</b>-<b>A</b> and <b>4a</b>-<b>B</b>, they were functionalized with PhSO<sub>2</sub>Cl at the α-amino group to form the corresponding disulfonamido derivatives (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Hereby, only the <i>erythro</i>-diastereomer would acquire a plane of symmetry (<i>meso</i> compound) and thus not be optically active. The disulfonamido derivative of the pharmacologically inactive diastereomer <b>4a</b>-<b>A</b> was without optical rotatory power and hence assigned the <i>erythro</i> configuration, while the disulfonamido derivative of the pharmacologically active diastereomer <b>4a</b>-<b>B</b> was optically active and hence unambiguously assigned the <span class="smallcaps smallerCapital">l</span>-<i>threo</i> isomer (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Concentration–inhibition curves for TBOA and β-sulfonamide Asp analogues <b>4a</b>-<b>B</b>, <b>4d</b>-<b>B</b>, <b>4r</b>, and <b>4ac</b> at stable EAAT1-, EAAT2-, and EAAT3-HEK293 cell lines in the [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp uptake assay. Data are given as mean ± SEM (<i>n</i> = 3–5).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Assignment of Absolute Configurations of the Diastereomers Phenylsulfonamides <b>4a</b>-<b>A</b> and <b>4a</b>-<b>B</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) PhSO<sub>2</sub>Cl, NaOH, DIPEA, acetone</p></p></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Design, Synthesis, and Pharmacological Characterization of Analogues of <b>4a</b></h3><div class="NLM_p">Given the interesting pharmacological properties of the sulfonamide analogue <b>4a</b>-<b>B</b>, this series was expanded to investigate the influence of substitution on the aryl ring (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The synthesis of all 28 new analogues followed the strategy outline in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> for the synthesis of <b>4a</b>, and the pharmacological characterization was performed at the EAAT1-, EAAT2-, and EAAT3-HEK293 cell lines in the [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp uptake assay.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">In comparison with lead structure <b>4a</b>, the 1-napthyl (<b>4b</b>) and the 2-naphtyl (<b>4c</b>) analogues both displayed reduced inhibitory activities at EAAT1–3 (IC<sub>50</sub> values of 6.5–65 μM). Interestingly though, expansion of the aromatic system in 1-naphthyl Asp derivative <b>4b</b> induced a 5-fold preference for EAAT2 over EAAT1,3. Increasing the distance between the Asp backbone and the aromatic group in the benzyl derivative <b>4aa</b> also failed to increase the inhibitory potency (IC<sub>50</sub> values of 49–76 μM), and as with the lead <b>4a</b>, no subtype selectivity was observed for this analogue.</div><div class="NLM_p">Extending the study of the aromatic group to include heteroaromatic analogues <b>4ab</b> and <b>4ac</b> gave further insight into the biologically active space for this ligand series. The two analogues were essentially nonselective inhibitors of EAAT1–3, with the 2-thiophene analogue <b>4ac</b> being roughly equipotent with <b>4a</b>-<b>B</b> at the transporters. Interestingly, however, <b>4ac</b> displayed a slightly lower (∼3-fold) IC<sub>50</sub> value at EAAT3 than at EAAT1,2 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Although this difference is too small to classify the analogue as an EAAT3-preferring inhibitor, the fairly high inhibitory potency and EAAT1–3 profile of <b>4ac</b> suggests that it could be a potential lead structure for the future development of EAAT3-preferring or -selective inhibitors.</div><div class="NLM_p">The synthesis and pharmacological characterization of the <i>N</i>-methylated analogue <b>4ad</b> again demonstrated that subtle chemical changes to a ligand may completely eliminate pharmacological activity. The analogue <b>4ad</b> was without inhibitory activity at all three EAATs (IC<sub>50</sub> values >300 μM). Rotational restriction of the phenyl ring by introduction of two <i>ortho</i>-chloro atoms, compound <b>4x</b>, also decreased the inhibitory EAAT potency significantly (IC<sub>50</sub> values of 50–300 μM) in comparison to the lead structure <b>4a</b>.</div><div class="NLM_p">We were intrigued to investigate the possibility of a π–cation interaction between the phenyl ring in the lead structure <b>4a</b> and the substrate binding pocket in the EAAT. Hence, the pentafluorophenyl derivative <b>4d</b> was synthesized.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> As for lead structure <b>4a</b>, the diastereomers of <b>4d</b> were easily separated into diastereomer <b>4d</b>-<b>A</b> and diastereomer <b>4d</b>-<b>B</b>. In agreement with lead structure <b>4a</b>, the inhibitory activity resided only in the single diastereomer <b>4d</b>-<b>B</b>, which was shown to be an EAAT1-preferring inhibitor, exhibiting an IC<sub>50</sub> value of 16 μM at EAAT1 and 6-fold and 10-fold lower inhibitory potencies at EAAT2 and EAAT3, respectively (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Considering the differences in inhibitory potencies across EAAT1–3, the putative π–cation is either manifested differently between EAAT subtypes, or alternatively the difference in the pharmacological profiles of <b>4d</b>-<b>B</b> and <b>4a</b>-<b>B</b> is a direct effect of the fluorine substitution.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacological Properties of β-sulfonamide Asp Analogues at Stable EAAT1-, EAAT2-, and EAAT3-HEK293 Cell Lines in the [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp Uptake Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0008.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0009.gif" alt="" id="GRAPHIC-d39e1186-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0010.gif" alt="" id="GRAPHIC-d39e1187-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Because the concentration–inhibition curves for the compound were not completed within the concentration range tested, the IC<sub>50</sub> value was estimated based on the fitted curve.</p></div></div><div></div></div><div class="NLM_p">To gain further insight into the impact that pentafluorination of the phenyl ring had on EAAT potency and subtype selectivity, the mono-, di-, and trifluoro analogues <b>4e</b>, <b>4y</b>, and <b>4z</b> were synthesized. Analogously to pentafluorinated analogue <b>4d</b>-<b>B</b>, the 2,4,5-trifluorinated analogue <b>4z</b> displayed preference for EAAT1 over EAAT2 and EAAT3 (9- and 4-fold, respectively), and moreover it exhibited a 6-fold increase in inhibitory potency for EAAT1 compared to <b>4d</b>-<b>B</b>. Interestingly, the 3,4-difluorinated analogue <b>4y</b> again incrementally increased inhibitory potency toward EAAT1 by 3-fold (IC<sub>50</sub> 0.80 μM), and furthermore this analogue exhibited an even more pronounced preference for EAAT1 over EAAT2 (14-fold) and EAAT3 (9-fold) (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The 4-fluoro analogue <b>4e</b> displayed similar inhibitory potency at EAAT1 (IC<sub>50</sub> 1.6 μM) as <b>4y</b>, but in contrast to <b>4y</b> it was essentially nonselective at the three EAAT subtypes (IC<sub>50</sub> values of 1.6–4.7 μM). Thus, the di-, tri-, and pentafluoro derivatives <b>4y</b>, <b>4z</b>, and <b>4d</b>-<b>B</b> all displayed similar degrees of selectivity for EAAT1 over EAAT2,3, whereas reducing the number of fluorine atoms increased the inhibitory potency of the analogues at all three transporter subtypes. However, because the EAAT1-preference of the 3,4-difluoro analogue <b>4y</b> was eliminated in the 4-fluoro analogue <b>4e</b>, we concluded that a fluoro atom in the 3-position could be essential for this preference. The study of the four fluorinated analogues did not disclose clear evidence for a π–cation interaction, as no correlation of reduced potency with reducing number of fluoro atoms was observed.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">To explore in greater details the effects of substituents on the aromatic ring, we then synthesized a number of <i>ortho</i>-, <i>meta</i>-, and <i>para</i>-substituted analogues (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The <i>ortho</i>-Cl analogue <b>4t</b> and <i>ortho</i>-Me analogue <b>4u</b> showed similar pharmacological characteristics as the lead <b>4a</b>, with low micromolar inhibitory potencies at all three transporters.</div><div class="NLM_p">The <i>para</i>-position was first probed with the <i>para</i>-CF<sub>3</sub> analogue <b>4l</b>, which interestingly displayed a significant loss of EAAT activity (IC<sub>50</sub> values of 30–100 μM). In view of the high inhibitory potencies exhibited by <i>para</i>-fluoro analogue <b>4e</b> (IC<sub>50</sub> values of 1.6–4.7 μM) and <i>para</i>-Cl analogue <b>4f</b> (IC<sub>50</sub> values of 0.32–3.1 μM), we synthesized the <i>para</i>-bromo analogue <b>4g</b>. This analogue, however, displayed a similar pharmacological profile (IC<sub>50</sub> values of 0.35–5.0 μM) to these smaller halide analogues. It was unclear why the <i>para</i>-CF<sub>3</sub> analogue <b>4l</b> showed weak inhibitory EAAT potency despite having an electronegativity between those of Cl and Br.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Thus, we synthesized derivatives <b>4o</b>, <b>4m</b>, and <b>4j</b> to characterize the effects of resonance electron withdrawing. The bulky sulfone analogue <b>4j</b> was essentially inactive at EAAT1–3, indicating a possible spatial restriction in the <i>para</i>-position. The conjugated ketone analogue <b>4o</b> displayed weak, nonselective EAAT inhibition (IC<sub>50</sub> values of 43–100 μM), while the <i>para</i>-NO<sub>2</sub> derivative <b>4m</b> exhibited moderate inhibitory activity at EAAT1 (IC<sub>50</sub> 13 μM) and a small preference for this subtype over EAAT2,3 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Thus, inhibitory potency seems not exclusively to be a result of electronic effects, and other factors may play a defining role as well. This lack of correlation is further exemplified when examining electron donating derivatives <b>4k</b> and <b>4n</b>. While both analogues display low micromolar inhibitory potencies at EAAT1 (IC<sub>50</sub> values of 4.0 and 2.3 μM, respectively), the aniline analogue <b>4n</b> exhibits equipotent inhibition at EAAT2 and EAAT3, whereas the anisole analogue <b>4k</b> loses inhibitory potency at these subtypes (IC<sub>50</sub> values of ∼30 μM). Finally, in an attempt to define the spatial limitations of the <i>para</i>-substituent, analogues <b>4h</b>, <b>4i</b>, and <b>4p</b> were synthesized. Here, the steric bulk of the <i>para</i>-<i>tert</i>-butyl substituent in <b>4i</b> almost completely eliminated EAAT activity, analogously to what was observed with the <i>para</i>-sulfone analogue <b>4j</b>. As with the sterically similar halides, the <i>para</i>-Me analogue <b>4h</b> displayed potent, albeit nonselective, EAAT inhibition. Highly interestingly, the sterically demanding <i>para</i>-biphenyl analogue <b>4p</b> displayed high inhibitory potency at EAAT1 and EAAT2 (IC<sub>50</sub> values of 2.3 and 0.50 μM, respectively) and 10–40-fold lower potency at EAAT3. This selectivity profile is somewhat similar to that exhibited by the 2-naphthyl analogue <b>4c</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), and it demonstrates that the EAAT protein is flexible when stressed by a <i>para</i>-substituent substantial in size.</div><div class="NLM_p last">In regard to the <i>meta</i>-position, the <i>meta</i>-CF<sub>3</sub> substituted analogue <b>4r</b> displayed a highly interesting selectivity profile at EAAT1–3, being a potent inhibitor of EAAT2 (IC<sub>50</sub> 2.8 μM) with 30- and 50-fold selectivity toward EAAT1 (IC<sub>50</sub> ∼ 100 μM) and EAAT3 (IC<sub>50</sub> ∼ 150 μM), respectively (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Interesting, the 3,5-dimethyl analogue <b>4v</b> exhibited 5–9-fold preference for EAAT2 over EAAT1,3, and thus the selectivity profiles of these two analogues strongly suggested that the <i>meta</i>-position in the phenyl ring is a hot spot for EAAT2-selectivity. Supplementing these findings was the complete loss of EAAT activity observed for the <i>meta</i>-COOH analogue <b>4s</b> and the fact that the <i>meta</i>-Cl analogue <b>4q</b> was a potent EAAT1,2-preferring inhibitor. Hence, the identity of the substituent introduced in the <i>meta</i>-position of the phenyl ring in the β-sulfonamide Asp analogue is clearly of key importance for its functional properties, both when it comes to its basic EAAT activity but also in terms of whether it exhibits EAAT2-selectivity or not.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Pharmacological Characterization of Selected β-Sulfonamide Asp Analogues at Ionotropic Glutamate Receptors</h3><div class="NLM_p last">The β-sulfonamide Asp analogues <b>4a</b>-<b>A</b>, <b>4a</b>-<b>B</b>, <b>4b</b>, <b>4c</b>, <b>4e</b>, <b>4h</b>, <b>4v</b>, <b>4r</b>, <b>4f</b>, <b>4q</b>, and <b>4t</b> were characterized in radioligand binding assays to native ionotropic glutamate receptors (rat synaptosomes).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> None of the 11 analogues exhibited significant binding affinity to AMPA receptors ([<sup>3</sup>H]AMPA displacement), kainic acid receptors ([<sup>3</sup>H]kainic acid displacement), or NMDA receptors ([<sup>3</sup>H]-(<i>R</i>,<i>Z</i>)-2-amino-4-(phosphonomethyl)hept-3-enoic acid ([<sup>3</sup>H]CGP39653) displacement) when tested at concentrations up to 100 μM.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Modeling</h3><div class="NLM_p">Homology models of EAAT1–3 were built from the crystal structure of Glt<sub>Ph</sub> crystallized with TBOA (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2nww">2nww</a>)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> based on an alignment of the amino acid sequences of the three human transporters and that of Glt<sub>Ph</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_001.pdf" class="ext-link">Supporting Information</a>). Subsequently, a docking study was performed of the selected ligands <b>4a</b>-<b>B</b> (nonselective), <b>4d</b>-<b>B</b> (EAAT1-preferring), <b>4r</b> (EAAT2-selective), <b>4p</b> (EAAT1,2-preferring), <b>4ac</b> (nonselective), and <b>4ad</b> (inactive). Unfortunately, this in silico study did not shed further light on the observed differences in pharmacological profiles of the analogues with respect to amino acid residues differing between the substrate binding pocket in EAAT1–3. However, two energetically similar binding modes of <b>4a</b>-<b>B</b> were disclosed (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). The one binding mode of <b>4a</b>-<b>B</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A,B, magenta) very much resembles the binding mode of TBOA in the Glt<sub>Ph</sub> crystal structure, showing occupancy of a large area in space. The other binding mode of <b>4a</b>-<b>B</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A,C, green) orients the phenyl ring into a different cavity of the substrate binding pocket. Future SAR studies of the β-sulfonamide Asp analogue scaffold may unequivocally conclude which of the two binding modes is the biologically active one or whether both binding modes are possible with preference depending on the specific analogue.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Superimposition of binding mode of TBOA (black) when crystallized in Glt<sub>Ph</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2nww">2nww</a>) with the two most favorable binding modes of <b>4a</b>-<b>B</b> (magenta and green) obtained by docking into a homology model of EAAT1 built from the Glt<sub>Ph</sub>/TBOA crystal structure.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> (B) Binding of magenta <b>4a</b>-<b>B</b> in EAAT1. (C) Binding of green <b>4a-B</b> in EAAT1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the present study, we have explored new β-functionalized Asp analogues (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) as inhibitors of the EAATs. An elaborate SAR study on the new and potent β-sulfonamide Asp scaffold <b>4a</b> was carried out by the synthesis of 28 analogues, and thereby new pharmacological tools for the EAATs were identified. Furthermore, we have highlighted the existence of an adjacent vestibule to the substrate binding site in the transporters that could be highly interesting for future ligand development.</div><div class="NLM_p">Several analogues of <b>4a</b>-<b>B</b> were potent nonselective inhibitors which displayed IC<sub>50</sub> values in the high-nanomolar/low-microlar range at all three transporters (<b>4f</b>, <b>4g</b>, and <b>4h</b>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). However, the main objective of this study was to discover subtype-selective or subtype-preferring EAAT inhibitors, and introduction of fluorine atoms on the phenyl ring did indeed yield analogues characterized by preference for EAAT1 over EAAT2,3 (<b>4d</b>-<b>B</b>, <b>4z</b>, and <b>4y</b>). The 3,4-difluoro analogue <b>4y</b>, a potent EAAT1 inhibitor (IC<sub>50</sub> 0.8 μM) displaying 14- and 9-fold preference for this subtype over EAAT2 and EAAT3, respectively, is particularly interesting, as it to the best of our knowledge is the most EAAT1-selective competitive nonsubstrate inhibitor to be published to date. Even though its EAAT1-preference admittedly pales in comparison with the >300-fold EAAT1-selectivity exhibited by the noncompetitive inhibitors <b>15</b><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and <b>16</b>,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> we nevertheless find <b>4y</b> a promising lead for future development of truly EAAT1-selective inhibitors acting through the substrate-binding site in the transporter.</div><div class="NLM_p">Another highly interesting analogue to come out of the SAR study was <b>4r</b>, obtained by installation of a trifluoromethyl group in the <i>meta</i>-position of the phenyl ring. <b>4r</b> is a potent EAAT2 inhibitor (IC<sub>50</sub> 2.8 μM) characterized by ≥30-fold selectivity toward EAAT1 and EAAT3. While this EAAT2-selectivity is substantially lower than that previously reported for WAY-213613, it is roughly comparable to those exhibited by DHK and <b>13</b>, and it should also be noted that <b>4r</b> is 10–30-fold more potent at EAAT2 than these two latter inhibitors.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17">(14-17)</a> Moreover, considering the relatively limited SAR work focused on the <i>meta</i>-position in the phenyl ring of the β-sulfonamide Asp analogue performed in the present study, it seems plausible that future medicinal chemistry development based on <b>4r</b> as lead could provide analogues with further increased inhibitory potencies and/or degrees of EAAT2-selectivity.</div><div class="NLM_p last">This SAR study also elucidates the existence of an adjacent vestibule to the substrate binding site in the EAAT that holds considerable promise for future development of transporter ligands. Collectively, the EAAT1-preferences and EAAT2-selectivities exhibited by analogues in this series, the EAAT3-preference reported for <b>18</b>,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and the completely nonselective EAAT inhibition mediated by TBOA<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> and other analogues from this series illustrate the apparently immense potential for functional diversity in Asp analogues with 3-substituents projecting into this adjacent vestibule. Although we were unable to rationalize the molecular basis for the different selectivity profiles displayed by the β-sulfonamide Asp analogues in our in silico study, we propose that Asp analogues comprising 3-substituents with even slightly different spatial orientations could exhibit very different selectivity profiles at the EAATs, and future studies applying this strategy could thus perhaps help to supplement the presently limited selection of pharmacological tools in the field.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry</h3><div class="NLM_p">All reactions involving dry solvents or sensitive agents were performed under an argon atmosphere, and glassware was flame-dried under vacuum prior to use. Commercially available chemicals were used without further purification with the exception of <i>N</i>-bromosuccinimide (NBS), which was recrystallized from water and lyophilized to produce a white flaky solid. DCM, THF, and DMF were dried using a SG WATER solvent purification system (commercialized by Pure Process Technology). MeOH was dried by standing over 4 Å molecular sieves for a minimum of 48 h. Triethylamine (TEA) was purified by fractional distillation, followed by standing over 4 Å molecular sieves. Reactions were monitored by analytical thin-layer chromatography (TLC, Merck silica gel 60 F<sub>254</sub> aluminum sheets) or by HPLC.</div><div class="NLM_p">Flash chromatography was carried out using Merck silica gel 60A (40–63 μm). For dry column vacuum chromatography (DCVC), Merck silica gel 60 (15–40 μm) and a standard setup was used.</div><div class="NLM_p"><sup>1</sup>H NMR spectra were recorded at 400 or 600 MHz and <sup>13</sup>C NMR spectra at 100 or 150 MHz on a Bruker Avance III or Bruker Avance III HD, respectively. Chemical shifts (δ) are reported in ppm relative to TMS. For <sup>13</sup>C NMR in D<sub>2</sub>O was added 1% MeOD as internal reference. <sup>19</sup>F NMR spectra were recorded using CFCl<sub>3</sub> as reference standard.</div><div class="NLM_p last">HPLC was performed using a Dionex UltiMate 3000 pump and photodiode array detector (210 and 254 nm, respectively) installed with an XTerra MS C 18 3.5 μ m, 4.6 mm × 150 mm column, using a 5 → 95% MeCN gradient in H<sub>2</sub>O containing 0.1% TFA. For HPLC control, data collection, and data handling, Chromeleon software v. 6.80 was used. Preparative HPLC was carried out on an Agilent Prep HPLC systems with Agilent 1100 series pump, Agilent 1200 series diode array, multiple wavelength detector (G1365B), and Agilent PrepHT High Performance Preparative Cartridge Column (Zorbax, 300 SB-C18 Prep HT, 21.2 mm × 250 mm, 7 μm). LC-MS spectra were recorded using either an Agilent 1200 series solvent delivery system equipped with an autoinjector coupled to an Agilent 6400 series triple quadrupole mass spectrometer equipped with an electrospray ionization source or Waters Aquity UPLC-MS with dual wavelength detection with electrospray ionization. Gradients of 5% aqueous MeCN + 0.1% HCO<sub>2</sub>H (solvent A) and 95% aqueous MeCN + 0.05% HCO<sub>2</sub>H (solvent B) were employed. IR spectra were recorded on a PerkinElmer 801 spectrophotometer. Optical rotation was measured using a PerkinElmer 241 spectrometer, with Na lamp (D line, 589 nm). Compounds were dried under high vacuum or freeze-dried using a Holm & Halby, Heto LyoPro 6000 freeze drier. The purity of compounds submitted for pharmacological characterization was determined by LCMS to be >95%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Procedure for Synthesis and Purification of Sulfonamide Aspartate Analogues (General Procedure A)</h3><div class="NLM_p">In a representative reaction, a dry, argon-filled 20 mL vial, fitted with screw-cap and PTFE/silicone septum and magnetic stirrer, for 18 h was charged with dimethyl (2<i>S</i>)-3-amino-<i>N</i>-(triphenylmethyl)aspartate <b>9</b> (200 mg, 478 μmol) and anhydrous DCM (6 mL). To the stirred solution was added TEA (100 μL, 717 μmol) and the desired arylsulfonyl chloride, respectively. The mixture was stirred at ambient temperature for 20 h and then diluted with DCM (2 mL). The reaction mixture was washed once with 1 M HCl and three times with saturated NaHCO<sub>3</sub> by addition of the aqueous solution to the vial, agitating, and removing the aqueous layer with a pipet. The organic phase was reduced under a stream of air, followed by evaporation in vacuo. The residue was used in the following step without further purification.</div><div class="NLM_p last">The crude, protected sulfonamide aspartate analogue was suspended in 6 M HCl (5 mL). The capped vial was stirred vigorously at 100 °C for 4.5 h and then allowed to cool to room temperature. The reaction mixture was then washed three times with Et<sub>2</sub>O and three times with DCM, and the aqueous phase was concentrated in vacuo. The residue was taken up in a minimum of H<sub>2</sub>O (0.1% TFA) and purified on a preparative HPLC. Fractions were analyzed by LC-MS or NMR (0.5 mL sample from tube + 0.05 mL D<sub>2</sub>O) and collected accordingly. The combined fractions were sequentially concentrated and then added 1 M HCl (5 mL), after which the compounds were lyophilized.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Alternative Procedure for the Synthesis and Purification of Sulfonamide Aspartate Analogues (General Procedure B)</h3><div class="NLM_p last">In cases of large amounts of arylsulfonate byproduct, an alternative procedure was used. The desired aspartate analogue was synthesized and hydrolyzed as described in general procedure A. Following the wash of the aqueous hydrolysate with Et<sub>2</sub>O and DCM, the solution was subjected to ion exchange chromatography. A filter with a sintered glass frit was filled with Amberlite IRA-420 (2 cm × 7 cm). The funnel was assembled with a separation funnel and an adapter with side arm, resembling a setup for dry column vacuum chromatography. The column was pre-equilibrated with 1 M HCl until the effluent was at pH = 1. The hydrolysate was charged to the resin and passed through the column with 1 M HCl (20 mL) by applying a very slight vacuum. The resulting effluent was collected in a 100 mL round-bottom flask, evaporated, and purified by preparative HPLC.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Symmetrization of <b>4a</b>-<b>A</b> and <b>4a</b>-<b>B</b> for Elucidation of Absolute Stereochemistry</h3><div class="NLM_p">Each of the purified and separated diastereomers, <b>4a</b>-<b>A</b> and <b>4a</b>-<b>B</b> (3.15 mg, 9.7 μmol), were dissolved in NaOH (29 μL, 1 M aq, 29 μmol) in separate Eppendorf tubes at 0 °C. Benzenesulfonyl chloride (1.4 μL, 10.7 μmol), <i>N</i>,<i>N</i>-diisopropylethylamine (1.9 μL, 10.7 μmol), and acetone (10 μL) were added, and the reaction mixture was allowed to warm to room temperature over 2 h and stirred for an additional 16 h. Each of the reaction mixtures were then diluted with 1 mL of H<sub>2</sub>O and purified by preparative HPLC to produce <b>11</b> (2.05 mg, 49%, from <b>4a</b>-<b>A</b>) and <b>12</b> (inseparable 2:3 ratio with benzenesulfonate, from <b>4a</b>-<b>B</b>). Optical rotation was measured in triplicate for each of the samples, and only <b>12</b> was able to perform rotation (in 1 mL of distilled MeOH, at 20 °C; cuvette, 10 cm, α = 0.03 for <b>12</b>). <b>11</b>: <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ: 7.86–7.82 (m, 4H), 7.61 (td, <i>J</i> = 7.3, 1.3 Hz, 2H), 7.55–7.51 (m, 4H), 4.24 (s, 2H). <b>12</b>: <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ: 7.84–7.79 (m, 4H), 7.59 (dd, <i>J</i> = 7.4, 1.2 Hz, 2H), 7.54–7.47 (m, 4H), 4.41 (s, 2H). <b>11</b>: <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD) δ: 170.6, 141.7, 133.8, 130.1, 128.4, 59.6. <b>12</b>: <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD) δ: 170.7, 141.8, 133.8, 130.0, 128.2, 59.3.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (2<i>S</i>)-3-(4-Phenyl-1<i>H</i>-1,2,3-triazol-1-yl)aspartic Acid (<b>1</b>)</h4><div class="NLM_p last">Dimethyl (2<i>S</i>)-3-azido-<i>N</i>-(triphenylmethyl)aspartate (<b>8</b>) (150 mg, 338 μmol) and phenylacetylene (78 μL, 709 μmol) were suspended in H<sub>2</sub>O/<i>t</i>-BuOH (1.35 mL 1:1 v/v) in a vial. Sodium ascorbate (33 μL, 1 M aq, 34 μmol) was added, followed by CuSO<sub>4</sub>·5H<sub>2</sub>O (114 μL, 0.3 M aq, 34 μmol), and the reaction mixture was stirred at ambient temperature for 16 h under argon. The reaction mixture was diluted with H<sub>2</sub>O and extracted three times with Et<sub>2</sub>O. The combined organic extracts were concentrated in vacuo and directly suspended in 6 M HCl (5 mL) and subsequently refluxed for 4 h. The cooled aqueous reaction mixture was washed twice with Et<sub>2</sub>O, concentrated in vacuo, and purified twice by preparative HPLC. The combined were evaporated, and 1 M HCl (5 mL) was added  and evaporated. This was repeated three times to give the HCl salt of <b>1</b> (13 mg, 14% from <b>8</b>, diastereomeric ratio 0.5:1). Diastereomer 1: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.80 (broad s, 3H), 8.65 (s, 1H), 7.83 (d, <i>J</i> = 7.6 Hz, 2H), 7.46 (t, <i>J</i> = 7.6 Hz, 2H), 7.40–7.30 (m, 1H), 6.21 (d, <i>J</i> = 4.4 Hz, 1H), 4.85 (d, <i>J</i> = 4.4 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.80 (s, 3H), 8.51 (s, 1H), 7.83 (d, <i>J</i> = 7.6 Hz, 2H), 7.46 (t, <i>J</i> = 7.6 Hz, 2H), 7.40–7.30 (m, 1H), 6.18 (d, <i>J</i> = 3.7 Hz, 1H), 4.91 (d, <i>J</i> = 3.7 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.5, 166.5, 146.4, 130.3, 129.1, 128.3, 125.4, 123.2, 61.3, 53.0. Diastereomer 2: <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.4, 166.4, 146.2, 130.4, 129.1, 128.2, 125.3, 123.6, 61.2, 52.8. LCMS (ES+) <i>m</i>/<i>z</i> 277.0 [M + H]<sup>+</sup>, C<sub>12</sub>H<sub>13</sub>N<sub>4</sub>O<sub>4</sub> requires 277.1.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (2<i>S</i>)-3-Benzamidoaspartic Acid (<b>2</b>)</h4><div class="NLM_p last">Dimethyl (2<i>S</i>)-3-amino-<i>N</i>-(triphenylmethyl)aspartate <b>9</b> (150 mg, 358 μmol) was dissolved in anhydrous DCM (4.5 mL) in a dry flask under argon. The solution was cooled to 0 °C followed by addition of TEA (75 μL, 537 μmol) and benzoyl chloride (50 μL, 430 μmol), and the solution was allowed to reach ambient temperature. The solution was stirred for 3 days, evaporated, and resuspended in 5 mL of 6 M HCl and refluxed for 4 h. The resulting mixture was concentrated in vacuum and purified by preparative HPLC (combined fractions were evaporated, 1 M HCl (5 mL) added, and concentrated). This was repeated three times to produce the HCl salt to give <b>2</b> as a colorless solid (26 mg, 29% from <b>9</b>, diastereomeric ratio 0.5:1). Diastereomer 1: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.73 (ddd, <i>J</i> = 8.3, 6.6, 1.3 Hz, 2H), 7.59–7.53 (m, 1H), 7.45 (td, <i>J</i> = 7.9, 1.4 Hz, 2H), 5.24 (d, <i>J</i> = 3.5 Hz, 1H), 4.66 (d, <i>J</i> = 3.5 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.73 (ddd, <i>J</i> = 8.3, 6.6, 1.3 Hz, 2H), 7.59–7.53 (m, 1H), 7.45 (td, <i>J</i> = 7.9, 1.4 Hz, 2H), 5.16 (d, <i>J</i> = 3.5 Hz, 1H), 4.57 (d, <i>J</i> = 3.5 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 172.60, 171.52, 169.88, 133.82, 133.10, 129.74, 128.48, 56.19, 53.79. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 172.25, 171.95, 170.50, 133.86, 132.97, 129.79, 128.38, 55.28, 53.58. LCMS (ES+) <i>m</i>/<i>z</i> 253.2 [M + H]<sup>+</sup>, C<sub>11</sub>H<sub>13</sub>N<sub>2</sub>O<sub>5</sub> requires 253.1.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (2<i>S</i>)-3-((Phenoxycarbonyl)amino)aspartic Acid (<b>3</b>-<b>A</b>)</h4><div class="NLM_p last">Dimethyl (2<i>S</i>)-3-amino-<i>N</i>-(triphenylmethyl)aspartate <b>9</b> (150 mg, 358 μmol) was dissolved in 4.5 mL of anhydrous DCM in a dry flask under argon followed by addition of TEA (75 μL, 537 μmol) and phenyl chloroformate (54 μL, 439 μmol). The reaction mixture was stirred at room temperature for 18 h and then concentrated in vacuo. The crude residue was suspended in 6 M HCl (5 mL) and refluxed for 4 h. The cooled mixture was washed twice with Et<sub>2</sub>O, concentrated, and purified by preparative HPLC to yield single diastereomer (22 mg, 23% from <b>9</b>) after sequential evaporation from 5 mL of 1 M HCl (three times). One single diastereomer: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.66 (s, 3H), 8.34 (d, <i>J</i> = 9.4 Hz, 1H), 7.45–7.36 (m, 2H), 7.28–7.20 (m, 1H), 7.20–7.12 (m, 2H), 4.85 (dd, <i>J</i> = 9.4, 3.4 Hz, 1H), 4.40 (d, <i>J</i> = 3.8 Hz, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 169.0, 167.6, 154.8, 150.8, 129.3, 125.3, 121.6, 53.9, 53.8. LCMS (ES+) <i>m</i>/<i>z</i> 269.2 [M + H]<sup>+</sup>, C<sub>11</sub>H<sub>12</sub>N<sub>2</sub>O<sub>6</sub> requires 269.1.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (2<i>S</i>)-3-((Phenoxycarbonyl)amino)aspartic Acid (<b>3</b>-<b>B</b>)</h4><div class="NLM_p last">Diastereomer <b>3</b>-<b>B</b> was isolated as impure fractions from preparative HPLC in <b>3</b>-<b>A</b>. These concentrated fractions were subsequently purified by a second preparative HPLC run to give <b>3</b>-<b>B</b> (15 mg, 16% from <b>9</b>) after three sequential evaporations from 1 M HCl (5 mL). One single diastereomer: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.75 (s, 3H), 8.31 (d, <i>J</i> = 9.3 Hz, 1H), 7.47–7.34 (m, 2H), 7.29–7.17 (m, 1H), 7.15–7.07 (m, 2H), 4.77 (dd, <i>J</i> = 9.3, 4.6 Hz, 1H), 4.37 (d, <i>J</i> = 4.6 Hz, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 169.3, 168.2, 154.4, 150.8, 129.4, 125.4, 121.6, 53.8, 53.1. LCMS (ES+) <i>m</i>/<i>z</i> 269.0 [M + H]<sup>+</sup>, C<sub>11</sub>H<sub>12</sub>N<sub>2</sub>O<sub>6</sub> requires 269.1.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (2<i>S</i>,3<i>R</i>)-3-(Phenylsulfonamido)aspartic Acid (<b>4a</b>-<b>A</b>)</h4><div class="NLM_p last">General procedure A. Yield 17 mg, 15%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.66 (br s, 3H), 8.54 (d, <i>J</i> = 9.2 Hz, 1H), 7.80–7.77 (m, 2H), 7.65–7.58 (m, 1H), 7.54 (m, 2H), 4.48 (dd, <i>J</i> = 9.0, 3.4 Hz, 1H), 4.15 (d, <i>J</i> = 3.9 Hz, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.7, 167.9, 140.6, 133.0, 129.2, 126.9, 55.5, 54.3. LCMS (ES+) <i>m</i>/<i>z</i> 289.0 [M + H]<sup>+</sup>, C<sub>10</sub>H<sub>13</sub>N<sub>2</sub>O<sub>6</sub>S requires 289.0.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (2<i>S,</i>3<i>S</i>)-3-(Phenylsulfonamido)aspartic Acid (<b>4a</b>-<b>B</b>)</h4><div class="NLM_p last">General procedure A. Yield 9 mg, 8%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.66 (br s, 3H), 8.31 (d, <i>J</i> = 9.4 Hz, 1H), 7.84–7.81 (m, 2H), 7.65–7.58 (m, 1H), 7.54 (m, 2H), 4.50 (dd, <i>J</i> = 9.0, 3.7 Hz, 1H), 4.09 (br s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.0, 167.3, 140.2, 133.1, 129.3, 127.1, 55.8, 54.9. LCMS (ES+) <i>m</i>/<i>z</i> 289.0 [M + H]<sup>+</sup>, C<sub>10</sub>H<sub>13</sub>N<sub>2</sub>O<sub>6</sub>S requires 289.0.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (2<i>S</i>)-3-(Naphthalene-1-sulfonamido)aspartic Acid (<b>4b</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b>: 47 mg, 29%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.74 (dd, <i>J</i> = 8.6, 1.1 Hz, 1H), 8.49 (broad s, 3H), 8.24 (d, <i>J</i> = 8.2 Hz, 1H), 8.20 (dd, <i>J</i> = 7.4, 1.2 Hz, 1H), 8.11–8.05 (m, 1H), 7.72 (dt, <i>J</i> = 8.4, 1.4 Hz, 1H), 7.68–7.66 (m, 1H), 7.63 (t, <i>J</i> = 8.1 Hz, 1H), 4.43 (broad s, 1H), 4.19 (broad s, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.67–8.62 (m, 1H), 8.47 (s, 3H), 8.24 (d, <i>J</i> = 8.2 Hz, 1H), 8.16 (dd, <i>J</i> = 7.3, 1.2 Hz, 1H), 8.08 (m, 1H), 7.74–7.70 (m, 1H), 7.69–7.65 (m, 1H), 7.66–7.62 (m, 1H), 4.45–4.41 (m, 1H), 4.17 (d, <i>J</i> = 4.0 Hz, 1H). Diastereomer 1 (d1) and diastereomer 2 (d2): <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.4 (d2), 167.7 (d2), 167.7 (d1), 167.1 (d1), 135.0, 134.9, 134.3, 134.3, 133.8, 128.9, 128.8, 128.7, 127.8, 127.8, 127.8, 127.7, 126.8, 126.8, 125.1, 124.8, 124.3, 55.5 (d1), 55.3 (d2), 54.8 (d1), 54.0 (d2). LCMS (ES+) <i>m</i>/<i>z</i> 339.0 [M + H]<sup>+</sup>, C<sub>14</sub>H<sub>15</sub>N<sub>2</sub>O<sub>6</sub>S requires 339.1.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (2<i>S</i>)-3-(Naphthalene-2-sulfonamido)aspartic Acid (<b>4c</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b>: 22 mg, 14%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.51 (s, 3H), 8.43 (d, <i>J</i> = 1.7 Hz, 1H), 8.17–8.13 (m, 1H), 8.12 (d, <i>J</i> = 8.8 Hz, 1H), 8.05 (dt, <i>J</i> = 8.1, 1.6 Hz, 1H), 7.88 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H), 7.73–7.70 (m, 1H), 7.69–7.66 (m, 1H), 4.46–4.43 (m, 1H), 4.24 (d, <i>J</i> = 3.1 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.51 (s, 3H), 8.45 (d, <i>J</i> = 1.5 Hz, 1H), 8.17–8.13 (m, 1H), 8.11 (d, <i>J</i> = 8.7 Hz, 1H), 8.05 (dt, <i>J</i> = 8.1, 1.6 Hz, 1H), 7.84 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H), 7.73–7.70 (m, 1H), 7.69–7.66 (m, 1H), 4.48 (d, <i>J</i> = 4.1 Hz, 1H), 4.18 (d, <i>J</i> = 4.2 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.7, 167.2, 137.1, 134.3, 131.5, 129.2, 129.0, 128.8, 127.8, 127.6, 127.5, 122.8, 55.7, 54.5. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.5, 167.8, 137.2, 134.3, 131.5, 129.3, 129.1, 128.8, 127.8, 127.6, 127.5, 122.5, 55.4, 54.1. LCMS (ES+) <i>m</i>/<i>z</i> 339.1 [M + H]<sup>+</sup>, C<sub>14</sub>H<sub>15</sub>N<sub>2</sub>O<sub>6</sub>S requires 339.1.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (2<i>S</i>)-3-((Perfluorophenyl)sulfonamido)aspartic Acid (<b>4d</b>-<b>A</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b>: 7.0 mg, 4%. One single diastereomer: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 4.74–4.69 (m, 2H). <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 169.6, 168.6, 145.7, 145.6, 144.0, 143.8, 138.8, 137.2, 114.2, 56.4, 55.1. <sup>19</sup>F NMR (376 MHz, D<sub>2</sub>O) δ: −136.56 to −136.71 (m), −145.07 (tt, <i>J</i> = 21.1, 7.4 Hz), −159.57 to −159.75 (m). LCMS (ES+) <i>m</i>/<i>z</i> 379.0 [M + H]<sup>+</sup>, C<sub>10</sub>H<sub>8</sub>F<sub>5</sub>N<sub>2</sub>O<sub>6</sub>S requires 379.0.</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (2<i>S</i>)-3-((Perfluorophenyl)sulfonamido)aspartic Acid (<b>4d</b>-<b>B</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b>: 4.3 mg, 2%. One single diastereomer: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 4.90 (d, <i>J</i> = 3.5 Hz, 1H), 4.58 (d, <i>J</i> = 3.5 Hz, 1H). <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 169.7, 168.7, 145.6, 145.5, 143.9, 143.8, 138.8, 137.2, 114.5, 55.4, 54.5. <sup>19</sup>F NMR (376 MHz, D<sub>2</sub>O) δ: −137.13 to −137.28 (m), −145.03 (tt, <i>J</i> = 21.3, 7.5 Hz), −159.56 to −159.74 (m). LCMS (ES+) <i>m</i>/<i>z</i> 379.0 [M + H]<sup>+</sup>, C<sub>10</sub>H<sub>8</sub>F<sub>5</sub>N<sub>2</sub>O<sub>6</sub>S requires 379.0.</div></div><div id="sec4_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (2<i>S</i>)-3-((4-Fluorophenyl)sulfonamido)aspartic Acid (<b>4e</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b>: 44 mg, 30%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.55 (broad s, 3H), 7.94–7.84 (m, 2H), 7.45–7.39 (m, 2H), 4.44–4.36 (m, 1H), 4.22 (dd, <i>J</i> = 3.1 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.55 (s, 3H), 7.94–7.84 (m, 2H), 7.45–7.39 (m, 2H), 4.44–4.36 (m, 1H), 4.15 (dd, <i>J</i> = 4.2, 1.6 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.7, 167.2, 165.1, 165.1, 136.5, 136.5, 130.0, 130.0, 116.0, 116.0, 55.7, 54.4. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.5, 167.8, 163.5, 163.5, 136.7, 129.9, 129.8, 116.2, 116.2, 55.3, 54.1. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ: −106.6. LCMS (ES+) <i>m</i>/<i>z</i> 307.0 [M + H]<sup>+</sup>, C<sub>10</sub>H<sub>12</sub>FN<sub>2</sub>O<sub>6</sub>S requires 307.0.</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (2<i>S</i>)-3-((4-Chlorophenyl)sulfonamido)aspartic Acid (<b>4f</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b>: 46 mg, 30%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.64 (s, 3H), 7.88–7.79 (m, 2H), 7.69–7.63 (m, 2H), 4.44 (m, 1H), 4.16 (d, <i>J</i> = 4.1 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.64 (s, 3H), 7.88–7.79 (m, 2H), 7.69–7.63 (m, 2H), 4.41 (broad s, 1H), 4.25–4.21 (m, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.5, 167.8, 139.2, 137.6, 129.1, 128.7, 55.3, 54.1. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.7, 167.1, 139.0, 137.6, 129.1, 128.9, 55.7, 54.4. LCMS (ES+) <i>m</i>/<i>z</i> 323.0 [M + H]<sup>+</sup>, C<sub>10</sub>H<sub>12</sub>ClN<sub>2</sub>O<sub>6</sub>S requires 323.0.</div></div><div id="sec4_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (2<i>S</i>)-3-((4-Bromophenyl)sulfonamido)aspartic Acid (<b>4g</b>)</h4><div class="NLM_p last">General procedure B; 10 mol % 4-bromobenzenesulfonate. Yield from <b>9</b>: 29 mg, 17%. Diastereomer 1: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 7.83 (s, 4H), 4.67 (d, <i>J</i> = 3.1 Hz, 1H), 4.53 (d, <i>J</i> = 3.1 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 7.83 (s, 4H), 4.53 (d, <i>J</i> = 4.8 Hz, 1H), 4.37 (d, <i>J</i> = 4.3 Hz, 1H). Diastereomer 1 <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.3, 169.5, 137.8, 133.5, 129.6, 129.3, 56.8, 56.0. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 171.2, 170.2, 137.9, 133.6, 129.6, 129.3, 56.6, 55.9. LCMS (ES+) <i>m</i>/<i>z</i> 367.0 [M + H]<sup>+</sup>, 369.0 [m + 2 + H]<sup>+</sup>, C<sub>10</sub>H<sub>12</sub>BrN<sub>2</sub>O<sub>6</sub>S requires 367.0 and 369.0.</div></div><div id="sec4_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (2<i>S</i>)-3-((4-Methylphenyl)sulfonamido)aspartic Acid (<b>4h</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b>: 33 mg, 23%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.35 (br s, 3H), 7.72 (d, <i>J</i> = 8.4 Hz, 2H), 7.40–7.35 (m, 2H), 4.41–4.29 (m, 1H), 4.17–4.12 (m, 1H), 2.38 (s, 3H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.35 (br s, 3H), 7.72 (d, <i>J</i> = 8.4 Hz, 2H), 7.40–7.35 (m, 2H), 4.41–4.29 (m, 1H), 4.11 (d, <i>J</i> = 4.0 Hz, 1H), 2.38 (s, 3H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.7, 167.2, 143.0, 137.1, 129.4, 126.9, 55.7, 54.6, 21.0. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.5, 167.9, 143.0, 137.4, 129.4, 126.8, 55.3, 54.1, 21.0. LCMS (ES+) <i>m</i>/<i>z</i> 303.1 [M + H]<sup>+</sup>, C<sub>11</sub>H<sub>15</sub>N<sub>2</sub>O<sub>6</sub>S requires 303.1.</div></div><div id="sec4_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (2<i>S</i>)-3-((4-(<i>tert</i>-Butyl)phenyl)sulfonamido)aspartic Acid (<b>4i</b>)</h4><div class="NLM_p last">General procedure B; 12 mol % 4-<i>tert</i>-butylbenzenesulfonate. Yield from <b>9</b>: 40 mg, 24%. Diastereomer 1: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 7.87 (dd, <i>J</i> = 8.8, 2.4 Hz, 2H), 7.72 (dd, <i>J</i> = 8.8, 2.5 Hz, 2H), 4.65 (d, <i>J</i> = 3.1 Hz, 1H), 4.50 (d, <i>J</i> = 3.1 Hz, 1H), 1.36 (s, 9H). Diastereomer 2: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 7.87 (dd, <i>J</i> = 8.8, 2.4 Hz, 2H), 7.72 (dd, <i>J</i> = 8.8, 2.5 Hz, 2H), 4.47 (d, <i>J</i> = 4.5 Hz, 1H), 4.35 (d, <i>J</i> = 4.4 Hz, 1H), 1.36 (s, 9H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.3, 169.6, 159.3, 135.4, 127.9, 127.5, 56.8, 56.1, 35.6, 31.1. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 171.2, 170.2, 159.4, 135.4, 127.9, 127.5, 56.6, 55.9, 35.6, 31.1. LCMS (ES+) <i>m</i>/<i>z</i> 345.1 [M + H]<sup>+</sup>, C<sub>14</sub>H<sub>21</sub>N<sub>2</sub>O<sub>6</sub>S requires 345.1.</div></div><div id="sec4_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (2<i>S</i>)-3-((4-(Methylsulfonyl)phenyl)sulfonamido)aspartic Acid (<b>4j</b>)</h4><div class="NLM_p last">General procedure B. Yield from <b>9</b>: 23 mg, 13%. Diastereomer 1: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.16–8.10 (m, 2H), 8.10–8.04 (m, 2H), 4.52–4.45 (m, 1H), 4.22 (d, <i>J</i> = 4.1 Hz, 1H), 3.29 (s, 3H). Diastereomer 2: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.16–8.10 (m, 2H), 8.10–8.04 (m, 2H), 4.52–4.45 (m, 1H), 4.35–4.28 (m, 1H), 3.29 (s, 3H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.6, 166.9, 144.7, 144.2, 128.0, 127.8, 55.2, 54.2, 43.2. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.3, 167.6, 144.9, 144.2, 127.8, 127.7, 55.7, 53.8, 43.2. LCMS (ES+) <i>m</i>/<i>z</i> 367.1 [M + H]<sup>+</sup>, C<sub>11</sub>H<sub>15</sub>N<sub>2</sub>O<sub>8</sub>S<sub>2</sub> requires 367.0.</div></div><div id="sec4_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (2<i>S</i>)-3-((4-Methoxyphenyl)sulfonamido)aspartic Acid (<b>4k</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b>: 43 mg, 28%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.81 (dd, <i>J</i> = 8.9, 3.0 Hz, 2H), 7.07 (dd, <i>J</i> = 9.1, 3.1 Hz, 2H), 4.73 (d, <i>J</i> = 3.1 Hz, 1H), 4.52 (d, <i>J</i> = 3.1 Hz, 1H), 3.85 (s, 3H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.81 (dd, <i>J</i> = 9.0, 3.1 Hz, 2H), 7.07 (dd, <i>J</i> = 9.1, 3.0 Hz, 2H), 4.55 (d, <i>J</i> = 4.1 Hz, 1H), 4.45 (d, <i>J</i> = 4.1 Hz, 1H), 3.86 (s, 3H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.3, 169.3, 164.2, 130.4, 130.2, 115.6, 56.7, 56.6, 55.9. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 171.2, 170.0, 164.3, 130.4, 130.2, 115.6, 56.7, 56.4, 55.7. LCMS (ES+) <i>m</i>/<i>z</i> 319.1 [M + H]<sup>+</sup>, C<sub>11</sub>H<sub>15</sub>N<sub>2</sub>O<sub>7</sub>S requires 319.1.</div></div><div id="sec4_4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (2<i>S</i>)-3-((4-(Trifluoromethyl)phenyl)sulfonamido)aspartic Acid (<b>4l</b>)</h4><div class="NLM_p last">General procedure B. Yield from <b>9</b>: 52 mg, 31%. Diastereomer 1: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 8.10 (d, <i>J</i> = 8.2 Hz, 2H), 7.97 (d, <i>J</i> = 8.8 Hz, 2H), 4.67 (d, <i>J</i> = 4.1 Hz, 1H), 4.48 (d, <i>J</i> = 4.1 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 8.10 (d, <i>J</i> = 8.2 Hz, 2H), 7.96 (d, <i>J</i> = 8.7 Hz, 2H), 4.76 (m, inter alia 1H), 4.63 (d, <i>J</i> = 3.1 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.8, 169.9, 142.6, 135.5, 135.3, 128.7, 127.6, 127.5, 126.9, 125.1, 123.3, 121.5, 56.3, 55.7. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.0, 169.1, 142.4, 135.5, 135.2, 128.7, 127.5, 127.5, 126.9, 125.1, 123.3, 121.5, 56.7, 55.7. <sup>19</sup>F NMR (376 MHz, D<sub>2</sub>O) δ: −63.1. LCMS (ES+) <i>m</i>/<i>z</i> 357.0 [M + H]<sup>+</sup>, C<sub>11</sub>H<sub>12</sub>F<sub>3</sub>N<sub>2</sub>O<sub>6</sub>S requires 357.0.</div></div><div id="sec4_4_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (2<i>S</i>)-3-((4-Nitrophenyl)sulfonamido)aspartic Acid (<b>4m</b>)</h4><div class="NLM_p last">General procedure B. Yield from <b>9</b>: 32 mg, 20%. Diastereomer 1: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 8.48–8.39 (m, 2H), 8.19–8.12 (m, 2H), 4.79 (m, inter alia 1H), 4.66 (d, <i>J</i> = 3.1 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 8.44 (d, <i>J</i> = 9.0 Hz, 2H), 8.15 (d, <i>J</i> = 8.9 Hz, 2H), 4.71 (d, <i>J</i> = 3.9 Hz, 1H), 4.50 (d, <i>J</i> = 3.9 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.0, 169.0, 151.4, 144.7, 129.5, 125.5, 56.7, 55.6. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.8, 169.8, 151.4, 144.8, 129.5, 125.6, 56.3, 55.6. LCMS (ES+) <i>m</i>/<i>z</i> 334.1 [M + H]<sup>+</sup>, C<sub>10</sub>H<sub>12</sub>N<sub>3</sub>O<sub>8</sub>S requires 334.0.</div></div><div id="sec4_4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (2<i>S</i>)-3-((4-Aminophenyl)sulfonamido)aspartic Acid (<b>4n</b>)</h4><div class="NLM_p last">General procedure A; 18 mol % triethylammonium chloride. Yield from <b>9</b> (150 mg, 0.358 mmol): 29 mg, 26%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 8.03–8.01 (m, 2H), 7.59–7.56 (m, 2H), 4.76 (d, <i>J</i> = 3.1 Hz, 1H), 4.61 (d, <i>J</i> = 3.1 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 8.02–8.00 (m, 2H), 7.59–7.56 (m, 2H), 4.66 (d, <i>J</i> = 4.0 Hz, 1H), 4.49 (d, <i>J</i> = 3.9 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.0, 168.9, 139.0, 136.7, 130.1, 124.7, 56.5, 55.6. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.7, 169.7, 139.0, 136.9, 130.1, 124.7, 56.2, 55.5. LCMS (ES+) <i>m</i>/<i>z</i> 303.9 [M + H]<sup>+</sup>, C<sub>10</sub>H<sub>14</sub>N<sub>3</sub>O<sub>6</sub>S requires 304.1.</div></div><div id="sec4_4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (3<i>S</i>)-2-((4-Acetylphenyl)sulfonamido)-3-aminoaspartic Acid (<b>4o</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b> (150 mg, 0.358 mmol): 6.5 mg, 6%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 8.17–8.14 (m, 2H), 8.05–8.02 (m, 2H), 4.78–4.77 (m, inter alia 1H), 4.63 (d, <i>J</i> = 3.1 Hz, 1H), 2.71 (s, 3H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 8.17–8.14 (m, 2H), 8.05–8.02 (m, 2H), 4.69 (d, <i>J</i> = 4.1 Hz, 1H), 4.50 (d, <i>J</i> = 4.1 Hz, 1H), 2.71 (s, 3H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 203.3, 169.9, 169.0, 142.9, 141.2, 130.2, 128.4, 56.6, 55.7, 27.5. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 203.3, 170.7, 169.7, 143.1, 141.3, 130.3, 128.4, 56.2, 55.6, 27.5. LCMS (ES+) <i>m</i>/<i>z</i> 330.8 [M + H]<sup>+</sup>, C<sub>12</sub>H<sub>15</sub>N<sub>2</sub>O<sub>7</sub>S requires 331.0.</div></div><div id="sec4_4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (3<i>S</i>)-2-([1,1′-Biphenyl]-4-sulfonamido)-3-aminoaspartic Acid (<b>4p</b>)</h4><div class="NLM_p last">General procedure B; 6 mol % triethylammonium chloride. Yield from <b>9</b> (150 mg, 0.358 mmol): 25 mg, 19%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>/MeCN-<i>d</i><sub>3</sub> 1:1) δ: 8.00 (d, <i>J</i> = 8.5 Hz, 2H), 7.82 (d, <i>J</i> = 8.4 Hz, 2H), 7.71–7.67 (m, 2H), 7.49 (t, <i>J</i> = 7.7 Hz, 2H), 7.43 (t, <i>J</i> = 7.3 Hz, 1H), 4.59 (d, <i>J</i> = 2.9 Hz, 1H), 4.44 (d, <i>J</i> = 2.8 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, methanol-<i>d</i><sub>4</sub>/MeCN-<i>d</i><sub>3</sub> 1:1) δ: 7.98 (d, <i>J</i> = 8.4 Hz, 2H), 7.83 (d, <i>J</i> = 8.3 Hz, 2H), 7.71–7.67 (m, 2H), 7.49 (t, <i>J</i> = 7.7 Hz, 2H), 7.43 (t, <i>J</i> = 7.3 Hz, 1H), 4.54 (d, <i>J</i> = 4.1 Hz, 1H), 4.34 (d, <i>J</i> = 4.1 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, methanol-<i>d</i><sub>4</sub>/MeCN-<i>d</i><sub>3</sub> 1:1) δ: 168.9, 168.1, 147.2, 140.5, 139.2, 130.2, 129.7, 129.2, 128.6, 128.3, 57.0, 56.2. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, methanol-<i>d</i><sub>4</sub>/MeCN-<i>d</i><sub>3</sub> 1:1) δ: 170.1, 168.8, 147.2, 140.5, 139.5, 130.2, 129.7, 129.1, 128.6, 128.3, 56.6, 55.9. LCMS (ES+) <i>m</i>/<i>z</i> 364.9 [M + H]<sup>+</sup>, C<sub>16</sub>H<sub>17</sub>N<sub>2</sub>O<sub>6</sub>S requires 365.1.</div></div><div id="sec4_4_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (2<i>S</i>)-3-((3-Chlorophenyl)sulfonamido)aspartic Acid (<b>4q</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b>: 41 mg, 27%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.69 (s, 3H), 7.85 (t, <i>J</i> = 1.9 Hz, 1H), 7.73 (ddt, <i>J</i> = 8.1, 2.2, 1.1 Hz, 2H), 7.61 (t, <i>J</i> = 8.0 Hz, 1H), 4.45 (d, <i>J</i> = 4.1 Hz, 1H), 4.14 (d, <i>J</i> = 4.0 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.69 (s, 3H), 7.88 (t, <i>J</i> = 1.9 Hz, 1H), 7.77 (ddt, <i>J</i> = 7.8, 2.7, 1.2 Hz, 2H), 7.61 (t, <i>J</i> = 8.0 Hz, 1H), 4.41 (d, <i>J</i> = 2.9 Hz, 1H), 4.25 (d, <i>J</i> = 3.0 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.5, 167.9, 142.2, 133.5, 132.6, 130.9, 126.5, 125.4, 55.4, 54.1. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.7, 167.2, 142.0, 133.5, 132.6, 131.0, 126.7, 125.5, 55.9, 54.4. LCMS (ES+) <i>m</i>/<i>z</i> 323.0 [M + H]<sup>+</sup>, C<sub>10</sub>H<sub>12</sub>ClN<sub>2</sub>O<sub>6</sub>S requires 323.0.</div></div><div id="sec4_4_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (2<i>S</i>)-3-((3-(Trifluoromethyl)phenyl)sulfonamido)aspartic Acid (<b>4r</b>)</h4><div class="NLM_p last">General procedure B. Yield from <b>9</b>: 27 mg, 16%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.74 (s, 3H), 8.17 (d, <i>J</i> = 1.8 Hz, 1H), 8.13–8.09 (m, 1H), 8.04 (dd, <i>J</i> = 8.0, 2.1 Hz, 1H), 7.83 (td, <i>J</i> = 7.9, 2.4 Hz, 1H), 4.42 (d, <i>J</i> = 4.0 Hz, 1H), 4.29–4.25 (m, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.74 (s, 3H), 8.13 (d, <i>J</i> = 1.7 Hz, 1H), 8.13–8.09 (m, 1H), 8.04 (dd, <i>J</i> = 8.0, 2.1 Hz, 1H), 7.83 (td, <i>J</i> = 7.9, 2.4 Hz, 1H), 4.48 (m, 1H), 4.15 (d, <i>J</i> = 4.0 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.7, 167.2, 141.3, 130.8, 130.4, 129.9, 129.6, 129.4, 129.4, 129.2, 126.2, 124.4, 123.9, 123.8, 123.8, 123.8, 122.6, 120.8, 55.9, 54.3. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.5, 168.0, 167.7, 167.2, 141.6, 130.8, 130.5, 129.9, 129.7, 129.4, 129.4, 129.4, 129.2, 126.2, 124.4, 123.6, 123.6, 123.5, 123.5, 122.6, 120.8, 55.4, 54.1. Diastereomer 1: <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ: −61.36 (d, <i>J</i> = 1.4 Hz). Diastereomer 2: <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ: −61.34 (d, <i>J</i> = 1.3 Hz). LCMS (ES+) <i>m</i>/<i>z</i> 357.0 [M + H]<sup>+</sup>, C<sub>11</sub>H<sub>12</sub>F<sub>3</sub>N<sub>2</sub>O<sub>6</sub>S requires 357.0.</div></div><div id="sec4_4_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (2<i>S</i>)-3-((3-Carboxyphenyl)sulfonamido)aspartic Acid (<b>4s</b>)</h4><div class="NLM_p last">Using a modified general procedure A, <b>9</b> (125 mg, 0.30 mmol) was dissolved in dry CH<sub>2</sub>Cl<sub>2</sub> (3 mL) under argon gas. Triethylamine (125 μL, 0.90 mmol) was added, and after 5 min of stirring, 3-cyanobenzenesulfonyl chloride (91 mg, 0.45 mmol) was added. The reaction mixture was stirred overnight and evaporated. Without further purification, the crude was treated with 6 M HCl (11.5 mL) and stirred in a closed vial overnight at 110 °C. The reaction mixture was washed with Et<sub>2</sub>O (3 × 3 mL) and CH<sub>2</sub>Cl<sub>2</sub> (3 × 3 mL). The solvent was evaporated and purified by preparative HPLC to yield (2<i>S</i>)-3-((3-carboxyphenyl)sulfonamido)aspartic acid (19 mg, 0.06 mmol, 19%). Diastereomer 1: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 8.47 (t, <i>J</i> = 1.8 Hz, 1H), 8.29 (dt, <i>J</i> = 7.9, 1.4 Hz, 1H), 8.15 (ddd, <i>J</i> = 8.0, 2.0, 1.1 Hz, 1H), 7.74 (t, <i>J</i> = 7.9 Hz, 1H), 4.76 (d, <i>J</i> = 3.1 Hz, 1H), 4.61 (d, <i>J</i> = 3.1 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 8.48 (t, <i>J</i> = 1.8 Hz, 1H), 8.30 (dt, <i>J</i> = 7.8, 1.4 Hz, 1H), 8.15 (ddd, <i>J</i> = 8.0, 2.0, 1.1 Hz, 1H), 7.75 (t, <i>J</i> = 7.9 Hz, 1H), 4.62 (d, <i>J</i> = 4.2 Hz, 1H), 4.44 (d, <i>J</i> = 4.2 Hz, 1H). LCMS (ES+) <i>m</i>/<i>z</i> 333.1 [M + H]<sup>+</sup>, C<sub>11</sub>H<sub>13</sub>N<sub>2</sub>O<sub>8</sub>S requires 333.0.</div></div><div id="sec4_4_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (2<i>S</i>)-3-((2-Chlorophenyl)sulfonamido)aspartic Acid (<b>4t</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b>: 59 mg, 38%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.47 (broad s, 3H), 7.98–7.93 (m, 1H), 7.68–7.63 (m, 2H), 7.56–7.50 (m, 1H), 4.49 (d, <i>J</i> = 3.9 Hz, 1H), 4.30 (d, <i>J</i> = 4.0 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.47 (broad s, 3H), 8.02 (dd, <i>J</i> = 7.5, 1.3 Hz, 1H, 7.68–7.63 (m, 2H), 7.56–7.50 (m, 1H), 4.60 (d, <i>J</i> = 3.1 Hz, 1H), 4.22 (d, <i>J</i> = 3.2 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.3, 167.8, 137.4, 134.3, 131.6, 131.2, 130.2, 127.5, 55.6, 53.9. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.1, 167.2, 137.6, 134.3, 131.7, 131.1, 130.4, 127.5, 55.9, 55.0. LCMS (ES+) <i>m</i>/<i>z</i> 323.0 [M + H]<sup>+</sup>, C<sub>10</sub>H<sub>12</sub>ClN<sub>2</sub>O<sub>6</sub>S requires 323.0.</div></div><div id="sec4_4_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (2<i>S</i>)-3-((2-Methylphenyl)sulfonamido)aspartic Acid (<b>4u</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b> (250 mg, 0.597 mmol): 38 mg, 21%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.92 (dd, <i>J</i> = 7.9, 1.0 Hz, 1H), 7.59–7.53 (m, 1H), 7.41 (d, <i>J</i> = 8.2 Hz, 1H), 7.40–7.34 (m, 1H), 4.70 (d, <i>J</i> = 3.2 Hz, 1H), 4.44 (d, <i>J</i> = 3.3 Hz, 1H), 2.64 (s, 3H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.91 (dd, <i>J</i> = 8.0, 1.0 Hz, 1H), 7.59–7.55 (m, 1H), 7.42 (d, <i>J</i> = 7.7 Hz, 1H), 7.40–7.36 (m, 1H), 4.49 (d, <i>J</i> = 4.2 Hz, 1H), 4.43 (d, <i>J</i> = 4.2 Hz, 1H), 2.59 (s, 3H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.1, 169.0, 139.1, 136.0, 135.0, 133.8, 130.4, 127.2, 56.2, 55.7, 20.5. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.9, 169.6, 138.8, 136.2, 135.1, 133.8, 130.4, 127.3, 55.9, 55.3, 20.3. LCMS (ES+) <i>m</i>/<i>z</i> 303.1 [M + H]<sup>+</sup>, C<sub>11</sub>H<sub>15</sub>N<sub>2</sub>O<sub>6</sub>S requires 303.1.</div></div><div id="sec4_4_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (2<i>S</i>)-3-((3,5-Dimethylphenyl)sulfonamido)aspartic Acid (<b>4v</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b>: 23 mg, 15%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.33 (broad s, 3H), 7.43–7.41 (m, 2H), 7.30–7.26 (m, 1H), 4.35–4.30 (m, 1H), 4.08 (d, <i>J</i> = 4.3 Hz, 1H), 2.34 (s, 6H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.33 (br s, 3H), 7.55–7.43 (m, 2H), 7.30–7.26 (m, 1H), 4.29 (br s, 1H), 4.17 (br s, 1H), 2.34 (s, 6H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 168.5, 167.9, 139.9, 138.4, 134.1, 124.2, 55.3, 54.1, 20.7. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.7, 167.2, 139.7, 138.4, 134.1, 124.4, 55.8, 54.6, 20.7. LCMS (ES+) <i>m</i>/<i>z</i> 317.1 [M + H]<sup>+</sup>, C<sub>12</sub>H<sub>17</sub>N<sub>2</sub>O<sub>6</sub>S requires 317.1.</div></div><div id="sec4_4_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (2<i>S</i>)-3-((2,6-Dichlorophenyl)sulfonamido)aspartic Acid (<b>4x</b>)</h4><div class="NLM_p last">General procedure B. Yield from <b>9</b>: 52 mg, 30%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.62–7.59 (m, 2H), 7.54–7.50 (m, 1H), 4.70 (d, <i>J</i> = 3.5 Hz, 1H), 4.69 (d, <i>J</i> = 3.4 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.62–7.59 (m, 2H), 7.54–7.50 (m, 1H), 4.71 (d, <i>J</i> = 4.4 Hz, 1H), 4.49 (d, <i>J</i> = 4.4 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.2, 169.1, 135.4, 135.0, 133.7, 132.5, 56.7, 55.7. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.8, 169.6, 135.3, 134.9, 134.0, 132.5, 56.4, 55.2. LCMS (ES+) <i>m</i>/<i>z</i> 357.0 [M + H]<sup>+</sup>, C<sub>10</sub>H<sub>11</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>6</sub>S requires 357.0.</div></div><div id="sec4_4_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (2<i>S</i>)-3-((3,4-Difluorophenyl)sulfonamido)aspartic Acid (<b>4y</b>)</h4><div class="NLM_p last">General procedure B. Yield from <b>9</b>: 45 mg, 29%. Diastereomer 1: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 7.93–7.86 (m, 1H), 7.81–7.76 (m, 1H), 7.57–7.49 (m, 1H), 4.70 (d, <i>J</i> = 3.1 Hz, 1H), 4.56 (d, <i>J</i> = 3.1 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 7.93–7.86 (m, 1H), 7.81–7.76 (m, 1H), 7.57–7.49 (m, 1H), 4.58 (d, <i>J</i> = 4.2 Hz, 1H), 4.41 (d, <i>J</i> = 4.2 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.3, 169.4, 155.3, 155.3, 153.5, 153.5, 151.6, 150.1, 135.6, 135.6, 135.6, 135.6, 125.8, 125.8, 125.7, 119.6, 119.5, 118.1, 118.0, 56.8, 55.9. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 171.2, 170.1, 155.2, 155.2, 153.6, 153.6, 151.7, 150.0, 135.7, 135.7, 135.7, 135.7, 125.8, 125.8, 125.8, 119.6, 119.5, 118.1, 118.0, 56.6, 55.9. Diastereomer 1: <sup>19</sup>F NMR (376 MHz, D<sub>2</sub>O) δ: −129.36 (d, <i>J</i> = 20.6 Hz), −134.74 (d, <i>J</i> = 20.9 Hz). Diastereomer 2: <sup>19</sup>F NMR (376 MHz, D<sub>2</sub>O) δ: −129.23 (d, <i>J</i> = 20.9 Hz), −134.64 (d, <i>J</i> = 20.4 Hz). LCMS (ES+) <i>m</i>/<i>z</i> 325.0 [M + H]<sup>+</sup>, C<sub>10</sub>H<sub>11</sub>F<sub>2</sub>N<sub>2</sub>O<sub>6</sub>S requires 325.0.</div></div><div id="sec4_4_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (2<i>S</i>)-3-((2,4,5-Trifluorophenyl)sulfonamido)aspartic Acid (<b>4z</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b> (150 mg, 0.358 mmol): 48 mg, 39%. Diastereomer 1: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 7.77–7.68 (m, 1H), 7.32–7.21 (m, 1H), 4.69 (d, <i>J</i> = 3.7 Hz, 1H), 4.47 (d, <i>J</i> = 3.6 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ: 7.77–7.68 (m, 1H), 7.32–7.21 (m, 1H), 4.72 (d, <i>J</i> = 3.1 Hz, 1H), 4.60 (d, <i>J</i> = 3.1 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.6, 169.4, 156.8, 156.7, 156.7, 155.5, 155.1, 155.1, 155.0, 153.8, 147.8, 147.7, 146.2, 146.1, 123.5, 123.4, 119.5, 119.4, 108.8, 108.7, 108.5, 56.0, 55.4. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 169.9, 168.6, 156.8, 156.8, 156.7, 155.5, 155.1, 155.1, 155.0, 153.8, 147.8, 147.7, 146.2, 146.1, 123.3, 123.2, 119.6, 119.4, 108.9, 108.7, 108.5, 56.6, 55.3. Diastereomer 1: <sup>19</sup>F NMR (376 MHz, D<sub>2</sub>O) δ: −110.08 (dd, <i>J</i> = 15.1, 9.4 Hz), −123.54 (dd, <i>J</i> = 21.4, 9.6 Hz), −140.33 (t, <i>J</i> = 15.2 Hz). Diastereomer 2: <sup>19</sup>F NMR (376 MHz, D<sub>2</sub>O) δ: −109.38 (dd, <i>J</i> = 15.1, 9.4 Hz), −123.63 (dd, <i>J</i> = 21.3, 9.5 Hz), −140.39 (t, <i>J</i> = 15.1 Hz). LCMS (ES+) <i>m</i>/<i>z</i> 343.0 [M + H]<sup>+</sup>, C<sub>10</sub>H<sub>10</sub>F<sub>3</sub>N<sub>2</sub>O<sub>6</sub>S requires 343.0.</div></div><div id="sec4_4_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (2<i>S</i>)-3-((Phenylmethyl)sulfonamido)aspartic Acid (<b>4aa</b>)</h4><div class="NLM_p last">General procedure B; 9 mol % phenylmethanesulfonate. Yield from <b>9</b> (150 mg, 0.358 mmol): 22 mg, 20%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.51–7.45 (m, 5H), 4.61 (d, <i>J</i> = 3.5 Hz, inter alia 1H), 4.63–4.56 (m, 2H), 4.28 (d, <i>J</i> = 3.3 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.51–7.45 (m, 5H), 4.65 (d, <i>J</i> = 2.9 Hz, 1H), 4.63–4.56 (m, 2H), 4.53 (d, <i>J</i> = 2.9 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.1, 169.2, 131.9, 130.1, 129.9, 129.0, 60.0, 56.6, 55.9. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 171.6, 170.8, 131.9, 130.1, 129.9, 128.9, 59.8, 57.2, 56.3. LCMS (ES+) <i>m</i>/<i>z</i> 302.9 [M + H]<sup>+</sup>, C<sub>11</sub>H<sub>15</sub>N<sub>2</sub>O<sub>6</sub>S requires 303.1.</div></div><div id="sec4_4_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (2<i>S</i>)-3-(Pyridine-3-sulfonamido)aspartic Acid (<b>4ab</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b> (150 mg, 0.358 mmol): 25 mg, 24%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 9.33 (d, <i>J</i> = 2.0 Hz, 1H), 9.04 (dd, <i>J</i> = 5.8, 1.5 Hz, 1H), 8.98 (dt, <i>J</i> = 8.2, 1.8 Hz, 1H), 8.24 (dd, <i>J</i> = 8.3, 5.7 Hz, 1H), 4.82 (d, <i>J</i> = 3.1 Hz, 1H), 4.73 (d, <i>J</i> = 3.0 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 9.33 (d, <i>J</i> = 2.0 Hz, 1H), 9.04 (dd, <i>J</i> = 5.8, 1.5 Hz, 1H), 8.98 (dt, <i>J</i> = 8.2, 1.8 Hz, 1H), 8.24 (dd, <i>J</i> = 8.3, 5.7 Hz, 1H), 4.84 (d, <i>J</i> = 3.4 Hz, 1H), 4.54 (d, <i>J</i> = 3.4 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 169.2, 168.0, 146.3, 144.1, 141.6, 139.0, 127.9, 56.0, 54.5. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.0, 169.0, 146.3, 144.0, 141.6, 139.3, 127.9, 55.4, 54.7. LCMS (ES+) <i>m</i>/<i>z</i> 289.9 [M + H]<sup>+</sup>, C<sub>9</sub>H<sub>12</sub>N<sub>3</sub>O<sub>6</sub>S requires 290.0.</div></div><div id="sec4_4_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (2<i>S</i>)-3-(Thiophene-2-sulfonamido)aspartic Acid (<b>4ac</b>)</h4><div class="NLM_p last">General procedure A. Yield from <b>9</b> (150 mg, 0.358 mmol): 14 mg, 13%. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.90 (dd, <i>J</i> = 5.0, 1.1 Hz, 1H), 7.80–7.75 (m, 1H), 7.23–7.21 (m, 1H), 4.64 (d, <i>J</i> = 4.2 Hz, 1H), 4.45 (d, <i>J</i> = 4.1 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.88 (dd, <i>J</i> = 5.0, 1.1 Hz, 1H), 7.80–7.75 (m, 1H), 7.23–7.21 (m, 1H), 4.74 (d, <i>J</i> = 3.1 Hz, 1H), 4.63 (d, <i>J</i> = 3.1 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 171.0, 169.9, 138.6, 135.4, 135.0, 129.0, 56.6, 55.7. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.2, 169.2, 138.6, 135.2, 134.7, 129.1, 56.9, 55.8. LCMS (ES+) <i>m</i>/<i>z</i> 294.8 [M + H]<sup>+</sup>, C<sub>8</sub>H<sub>11</sub>N<sub>2</sub>O<sub>6</sub>S<sub>2</sub> requires 295.0.</div></div><div id="sec4_4_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (2<i>S</i>)-3-(<i>N</i>-Methylphenylsulfonamido)aspartic Acid (<b>4ad</b>)</h4><div class="NLM_p last">Amine <b>9</b> (80 mg, 0.191 mmol) was dissolved in anhyd DCM (2.4 mL) and added TEA (40 μL, 0.287 mmol), followed by phenyl sulfonyl chloride (37 μL, 0.287 mmol) and stirred 20 h. Reaction mixture was subsequently diluted with DCM, washed with 1 M HCl, satd NaHCO<sub>3</sub>, and then brine. The organic partition was dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude was dissolved in anhyd DMF (0.46 mL), cooled to 0 °C and K<sub>2</sub>CO<sub>3</sub> (78 mg, 0.573 mmol) added, followed by dropwise addition of methyl iodide (50 μL, 3.82 M, 0.191 mmol). Reaction was stirred for 3 h at 0 °C, and an additional equivalent of methyl iodide was added. Reaction was diluted with H<sub>2</sub>O and EtOAc, washed four times with H<sub>2</sub>O and brine, and dried over MgSO<sub>4</sub>, followed by filtration and evaporated. Crude was refluxed in 6 M HCl (3 mL) for 4 h, cooled and washed four times with Et<sub>2</sub>O and evaporated. Desired compound <b>4ad</b> was isolated by purification on preparative HPLC to yield (5.1 mg, 9%). Diastereomer 1: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.94–7.92 (m, 2H), 7.79–7.74 (m, 1H), 7.69–7.64 (m, 2H), 5.04 (d, <i>J</i> = 8.3 Hz, 1H), 4.54 (d, <i>J</i> = 8.3 Hz, 1H), 2.94 (s, 3H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, D<sub>2</sub>O) δ: 7.94–7.92 (m, 2H), 7.79–7.74 (m, 1H), 7.69–7.64 (m, 2H), 5.22 (d, <i>J</i> = 5.8 Hz, 1H), 4.68 (d, <i>J</i> = 5.8 Hz, 1H), 2.94 (s, 3H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 169.9, 169.5, 136.6, 135.2, 130.3, 128.7, 60.6, 53.4, 33.3. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, D<sub>2</sub>O) δ: 170.2, 169.9, 137.1, 135.0, 130.3, 128.3, 60.4, 54.1, 33.0. LCMS (ES+) <i>m</i>/<i>z</i> 302.9 [M + H]<sup>+</sup>, C<sub>11</sub>H<sub>15</sub>N<sub>2</sub>O<sub>6</sub>S requires 303.1.</div></div><div id="sec4_4_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Dimethyl (2<i>S</i>)-3-Bromo-<i>N</i>-(triphenylmethyl)aspartate (<b>7</b>)</h4><div class="NLM_p last">Following the optimized procedure for the synthesis, dimethyl (2<i>S</i>)-<i>N</i>-(triphenylmethyl)aspartate (<b>6</b>) (1.00 g, 2.48 mmol) was charged to a flame-dried, argon-purged 100 mL round-bottom flask fitted with septum and dissolved in anhydrous THF (40 mL) at ambient temperature, under argon. Once dissolved, the flask was wrapped in tin foil and cooled to −30 °C for 10 min. Lithium hexamethyldisilazide (2.7 mL 1 M in THF, 2.73 mmol) was added over 30 s, and the resulting mixture was stirred at −30 °C for 30 min. <i>N</i>-Bromosuccinimide (500 mg, 2.73 mmol) was added in one portion swiftly to the reaction mixture, which was then allowed to warm to −5 °C over the course of 40 min and maintained at −5 °C for an additional hour. The reaction was quenched by the addition of 15 mL of satd NH<sub>4</sub>Cl, warmed to rt, and concentrated in vacuo. The mixture was extracted twice with EtOAc, the combined organic phases were washed with H<sub>2</sub>O and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo, yielding a brownish oil (diastereomeric ratio 2:3, conversion by NMR), which was used without further purification due to instability. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ: 7.50–7.47 (m, 6H), 7.30–7.27 (m, 6H), 7.22–7.18 (m, 3H), 4.25 (d, <i>J</i> = 4.1 Hz, 1H), 3.93 (dd, <i>J</i> = 10.3, 4.2 Hz, 1H), 3.78 (s, 3H), 3.33 (s, 3H), 3.27 (d, <i>J</i> = 10.4 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ: 7.47–7.45 (m, 6H), 7.29–7.27 (m, 6H), 7.22–7.18 (m, 3H), 4.24 (d, <i>J</i> = 6.2 Hz, 1H), 4.10 (dd, <i>J</i> = 10.5, 6.2 Hz, 1H), 3.74 (s, 3H), 3.31 (s, 3H), 3.06 (d, <i>J</i> = 10.5 Hz, 1H).</div></div><div id="sec4_4_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Dimethyl (2<i>S</i>)-3-Azido-<i>N</i>-(triphenylmethyl)aspartate (<b>8</b>)</h4><div class="NLM_p last">Crude dimethyl (2<i>S</i>)-3-bromo-<i>N</i>-(triphenylmethyl)aspartate (<b>7</b>) (theoretically 7.62 mmol) was dissolved in anhydrous DMF (33 mL) under an argon atmosphere in a tin foil covered flask, and NaN<sub>3</sub> (536 mg, 11,43 mmol) was added in one portion. The solution was stirred for 16 h at rt, then diluted with EtOAc and washed with H<sub>2</sub>O until a clear organic phase was obtained (4–5 times). The organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The resulting crude could be used without purification or purified by flash column chromatography (heptane/EtOAc 8:1, 2% TEA) to give <b>8</b> as a white, sticky, amorphous syrup (1,90 g, 56% over two steps corrected yield as the amorphous nature of the compound inseparably trapped heptane, diastereomeric ratio 1:1.6). IR (neat): 2113, 1743, 1208, 707 cm<sup>–1</sup>. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ: 7.50–7.46 (m, 6H), 7.31–7.27 (m, 6H), 7.24–7.17 (m, 3H), 4.04 (dd, <i>J</i> = 8.2, 4.2 Hz, 1H), 3.72 (s, 3H), 3.71 (d, <i>J</i> = 4.3 Hz, 1H), 3.39 (s, 3H), 3.19 (d, <i>J</i> = 8.9 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ: 7.50–7.46 (m, 6H), 7.31–7.26 (m, 6H), 7.23–7.15 (m, 3H), 3.90 (dd, <i>J</i> = 10.9, 3.2 Hz, 1H), 3.82 (d, <i>J</i> = 3.4 Hz, 1H), 3.78 (s, 3H), 3.26 (s, 3H), 3.11 (d, <i>J</i> = 11.0 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ: 170.9, 168.4, 145.4, 128.9, 128.3, 127.0, 71.5, 65.7, 59.0, 52.8, 52.6. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ: 171.5, 168.9, 145.3, 128.9, 128.1, 126.8, 71.3, 64.4, 59.2, 53.0, 52.5.</div></div><div id="sec4_4_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Dimethyl (2<i>S</i>)-3-Amino-<i>N</i>-(triphenylmethyl)aspartate (<b>9</b>)</h4><div class="NLM_p last">Dimethyl (2<i>S</i>)-3-azido-<i>N</i>-(triphenylmethyl)aspartate (<b>8</b>) (2.47 g, 5.56 mmol) was dissolved in 66 mL of anhydrous THF in an argon-filled flask. Triphenylphosphine (2.19 g, 8.34 mmol) was added in one portion, followed by the addition of H<sub>2</sub>O (150 μL, 8.34 mmol), and the slowly effervescing solution was allowed to stir at ambient temperature for 18 h. The reaction mixture was concentrated in vacuo and purified by flash column chromatography (heptane/EtOAc 8:1 to 4:1 with 5% TEA) to yield <b>9</b> as a viscous syrup (1.83 g, 79%, 1:1.7 diastereomeric ratio). The product was immediately stored at −18 °C due to instability. Diastereomer 1: <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ: 7.52–7.49 (m, 6H), 7.29–7.23 (m, 6H), 7.21–7.15 (m, 3H), 3.82 (dd, <i>J</i> = 9.8, 4.4 Hz, 1H), 3.65 (s, 3H), 3.40 (d, <i>J</i> = 4.6 Hz, 1H), 3.30 (s, 3H), 3.14 (d, <i>J</i> = 9.8 Hz, 1H). Diastereomer 2: <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ: 7.48–7.45 (m, 6H), 7.28–7.23 (m, 6H), 7.21–7.15 (m, 3H), 3.77 (dd, <i>J</i> = 11.1, 2.7 Hz, 1H), 3.72 (s, 3H), 3.59 (d, <i>J</i> = 2.7 Hz, 1H), 3.22 (s, 3H), 2.98 (d, <i>J</i> = 11.0 Hz, 1H). Diastereomer 1: <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ: 173.4, 172.2, 145.8, 128.9, 128.1, 126.7, 71.4, 59.5, 58.4, 52.2, 52.0. Diastereomer 2: <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ: 173.9, 172.9, 145.6, 129.0, 128.0, 126.7, 70.8, 59.3, 58.1, 52.5, 52.1.</div></div></div><div id="sec4_4_38_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> In Silico Study</h3><div class="NLM_p last">The modeling study was performed using the software package MOE 2015 (Molecular Operating Environment, Chemical Computing Group) using the built-in mmff94x force field and the GB/SA continuum solvation model. Docking: The receptor proteins were prepared for docking by running the algorithm Protonate 3D. Docking studies were performed using the <i>Rigid Fit</i> algorithm under standard setup with the mmff94x force field, solvation set to distance, and <i>ligand atoms</i> selected as docking site. Homology models: the amino acid sequences of human EAAT1-3 were aligned with that of the bacterial homolog Glt<sub>Ph</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2nww">2nww</a>). After this a small segment present in the EAATs but not in Glt<sub>Ph</sub> was truncated from the EAAT sequences (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_001.pdf" class="ext-link">Supporting Information</a> for details). Homology models were build on the 3D coordinates of Glt<sub>Ph</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2nww">2nww</a>) by applying parameters from standard setup (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_001.pdf" class="ext-link">Supporting Information</a> for details).</div></div><div id="sec4_4_38_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Cell Culture and [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Aspartate Uptake Assay</h3><div class="NLM_p last">All cell culture reagents were from ThermoFisher Scientific (Waltham, MA). Stable EAAT1-, EAAT2-, and EAAT3-HEK293 cell lines established as described previously<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> were maintained in DMEM with high glucose and GlutaMAX supplemented with 5% dialyzed FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, and 1 mg/L G418, and the uptake assay was performed essentially as previously described.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Briefly, cells were seeded in 96-well OptiPlates (PerkinElmer, Boston, MA), reaching confluence after 16–24 h, where they were washed in 100 μL of room temperature uptake buffer (Hank’s Buffered Saline Solution (ThermoFisher) supplemented with 20 mM HEPES, 1 mM CaCl<sub>2</sub>, and 1 mM MgCl<sub>2</sub> (all from Sigma, St. Louis, MO), pH 7.4). Cells were then incubated for 3 min at room temperature in 50 μL of uptake buffer with 100 nM [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-aspartate (PerkinElmer) and various concentrations of the test compounds, washed twice in ice-cold uptake buffer before 150 μL of MicroScint20 (PerkinElmer) was added, and the plates were shaken vigorously for ≥1 h before reading in a TopCount NXT (PerkinElmer).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01066">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01066" class="ext-link">10.1021/acs.jmedchem.6b01066</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Sequence alignment of EAAT1–3 with Glt<sub>Ph</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2nww">2nww</a>) (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">3D coordinates of <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> (PDB format) (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_001.pdf">jm6b01066_si_001.pdf (196.53 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_002.pdb">jm6b01066_si_002.pdb (518.82 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_003.csv">jm6b01066_si_003.csv (3.48 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01066" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41402" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41402" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lennart Bunch</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#28444d4a5d685b5d464c06435d064c43"><span class="__cf_email__" data-cfemail="78141d1a0d380b0d161c56130d561c13">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacob C. Hansen</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Walden E. Bjørn-Yoshimoto</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Niels Bisballe</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Birgitte Nielsen</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anders A. Jensen</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen
Ø 2100, Denmark</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d39e5498-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Danish Medical Research Council, Lundbeck Foundation, the Novo Nordisk Foundation, the Augustinus Foundation, and the Carlsberg Foundation for financial support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i61" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i61"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i62" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i62"> Abbreviations Used</h2><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">dr</td><td class="NLM_def"><p class="first last">diastereomeric ratio</p></td></tr><tr><td class="NLM_term">EAAT</td><td class="NLM_def"><p class="first last">excitatory amino acid transporter</p></td></tr><tr><td class="NLM_term">KHMDS</td><td class="NLM_def"><p class="first last">potassium hexamethyldisilazide</p></td></tr><tr><td class="NLM_term">LHMDS</td><td class="NLM_def"><p class="first last">lithium hexamethyldisilazide</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">Tr</td><td class="NLM_def"><p class="first last">trityl</p></td></tr><tr><td class="NLM_term">TBOA</td><td class="NLM_def"><p class="first last"><i>threo</i>-benzyloxy aspartate</p></td></tr><tr><td class="NLM_term">EBOA</td><td class="NLM_def"><p class="first last"><i>erythro</i>-benzyloxy aspartate</p></td></tr><tr><td class="NLM_term">DHK</td><td class="NLM_def"><p class="first last">dihydrokainic acid</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethyl amine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13057" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13057" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Moghaddam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitt, D.</span><span> </span><span class="NLM_article-title">From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and Its Implication for Treatment</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1038/npp.2011.181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1038%2Fnpp.2011.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=21956446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=4-15&author=B.+Moghaddamauthor=D.+Javitt&title=From+Revolution+to+Evolution%3A+The+Glutamate+Hypothesis+of+Schizophrenia+and+Its+Implication+for+Treatment&doi=10.1038%2Fnpp.2011.181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment</span></div><div class="casAuthors">Moghaddam, Bita; Javitt, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glutamate is the primary excitatory neurotransmitter in mammalian brain.  Disturbances in glutamate-mediated neurotransmission have been increasingly documented in a range of neuropsychiatric disorders including schizophrenia, substance abuse, mood disorders, Alzheimer's disease, and autism-spectrum disorders.  Glutamatergic theories of schizophrenia are based on the ability of N-methyl--aspartate receptor (NMDAR) antagonists to induce schizophrenia-like symptoms, as well as emergent literature documenting disturbances of NMDAR-related gene expression and metabolic pathways in schizophrenia.  Research over the past two decades has highlighted promising new targets for drug development based on potential pre- and postsynaptic, and glial mechanisms leading to NMDAR dysfunction.  Reduced NMDAR activity on inhibitory neurons leads to disinhibition of glutamate neurons increasing synaptic activity of glutamate, esp. in the prefrontal cortex.  Based on this mechanism, normalizing excess glutamate levels by metabotropic glutamate group 2/3 receptor agonists has led to potential identification of the first non-monoaminergic target with comparable efficacy as conventional antipsychotic drugs for treating pos. and neg. symptoms of schizophrenia.  In addn., NMDAR has intrinsic modulatory sites that are active targets for drug development, several of which show promise in preclin./early clin. trials targeting both symptoms and cognition.  To date, most studies have been done with orthosteric agonists and/or antagonists at specific sites.  However, allosteric modulators, both pos. and neg., may offer superior efficacy with less danger of downregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeNMlez-A7MbVg90H21EOLACvtfcHk0lhsAkRDhmiunQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N&md5=0bf82fc0e3cb5c3ad2bed91414672e6f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.181%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DB.%26aulast%3DJavitt%26aufirst%3DD.%26atitle%3DFrom%2520Revolution%2520to%2520Evolution%253A%2520The%2520Glutamate%2520Hypothesis%2520of%2520Schizophrenia%2520and%2520Its%2520Implication%2520for%2520Treatment%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D4%26epage%3D15%26doi%3D10.1038%2Fnpp.2011.181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Machado-Vieira, R.; Henter, I. D.; Zarate, C. A.,  Jr.</span><span> </span><span class="NLM_article-title">New Targets for Rapid Antidepressant Action</span>.  <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2015.12.001</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2Fj.pneurobio.2015.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=26724279" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=R.+Machado-Vieira&author=I.+D.+Henter&author=C.+A.+Zarate&title=New+Targets+for+Rapid+Antidepressant+Action&doi=10.1016%2Fj.pneurobio.2015.12.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2015.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DMachado-Vieira%26aufirst%3DR.%26atitle%3DNew%2520Targets%2520for%2520Rapid%2520Antidepressant%2520Action%26jtitle%3DProg.%2520Neurobiol.%26date%3D2015%26doi%3D10.1016%2Fj.pneurobio.2015.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurado-Coronel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ávila, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabogal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreto, G. E.</span><span> </span><span class="NLM_article-title">NMDARs in Neurological Diseases: A Potential Therapeutic Target</span> <span class="citation_source-journal">Int. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.3109/00207454.2014.940941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.3109%2F00207454.2014.940941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=25051426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVaju7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=315-327&author=J.+Gonzalezauthor=J.+C.+Jurado-Coronelauthor=M.+F.+%C3%81vilaauthor=A.+Sabogalauthor=F.+Capaniauthor=G.+E.+Barreto&title=NMDARs+in+Neurological+Diseases%3A+A+Potential+Therapeutic+Target&doi=10.3109%2F00207454.2014.940941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">NMDARs in neurological diseases: a potential therapeutic target</span></div><div class="casAuthors">Gonzalez, Janneth; Jurado-Coronel, Juan Camilo; Avila, Marcos Fidel; Sabogal, Angelica; Capani, Francisco; Barreto, George E.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">315-327</span>CODEN:
                <span class="NLM_cas:coden">IJNUB7</span>;
        ISSN:<span class="NLM_cas:issn">0020-7454</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate ionotropic glutamate receptor (NMDARs) is a ligand-gated ion channel that plays a crit. role in excitatory neurotransmission, brain development, synaptic plasticity assocd. with memory formation, central sensitization during persistent pain, excitotoxicity and neurodegenerative diseases in the central nervous system (CNS).  Within iGluRs, NMDA receptors have been the most actively investigated for their role in neurol. diseases, esp. neurodegenerative pathologies such as Alzheimer's and Parkinson's diseases.  It has been demonstrated that excessive activation of NMDA receptors (NMDARs) plays a key role in mediating some aspects of synaptic dysfunction in several CNS disorders, so extensive research has been directed on the discovery of compds. that are able to reduce NMDARs activity.  This review discusses the role of NMDARs on neurol. pathologies and the possible therapeutic use of agents that target this receptor.  Addnl., we delve into the role of NMDARs in Alzheimer's and Parkinson's diseases and the receptor antagonists that have been tested on in vivo models of these pathologies.  Finally, we put into consideration the importance of antioxidants to counteract oxidative capacity of the signaling cascade in which NMDARs are involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpab8NK1TOnqrVg90H21EOLACvtfcHk0lj3_NeT0DA1vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVaju7fJ&md5=50f77e6ec1187bba03ed53eb61e721a4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3109%2F00207454.2014.940941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00207454.2014.940941%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DJurado-Coronel%26aufirst%3DJ.%2BC.%26aulast%3D%25C3%2581vila%26aufirst%3DM.%2BF.%26aulast%3DSabogal%26aufirst%3DA.%26aulast%3DCapani%26aufirst%3DF.%26aulast%3DBarreto%26aufirst%3DG.%2BE.%26atitle%3DNMDARs%2520in%2520Neurological%2520Diseases%253A%2520A%2520Potential%2520Therapeutic%2520Target%26jtitle%3DInt.%2520J.%2520Neurosci.%26date%3D2015%26volume%3D125%26spage%3D315%26epage%3D327%26doi%3D10.3109%2F00207454.2014.940941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Finlay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duty, S.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Targeting Glutamate Receptors in Parkinson’s Disease</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span><span class="NLM_x">–</span> <span class="NLM_lpage">880</span><span class="refDoi"> DOI: 10.1007/s00702-014-1176-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1007%2Fs00702-014-1176-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2014&pages=861-880&author=C.+Finlayauthor=S.+Duty&title=Therapeutic+Potential+of+Targeting+Glutamate+Receptors+in+Parkinson%E2%80%99s+Disease&doi=10.1007%2Fs00702-014-1176-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00702-014-1176-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-014-1176-4%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DC.%26aulast%3DDuty%26aufirst%3DS.%26atitle%3DTherapeutic%2520Potential%2520of%2520Targeting%2520Glutamate%2520Receptors%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2014%26volume%3D121%26spage%3D861%26epage%3D880%26doi%3D10.1007%2Fs00702-014-1176-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Danbolt, N. C.</span><span> </span><span class="NLM_article-title">Glutamate Uptake</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/S0301-0082(00)00067-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2FS0301-0082%2800%2900067-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=11369436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsFWns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2001&pages=1-105&author=N.+C.+Danbolt&title=Glutamate+Uptake&doi=10.1016%2FS0301-0082%2800%2900067-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate uptake</span></div><div class="casAuthors">Danbolt, N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-105</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with >1200 refs.  Brain tissue has a remarkable ability to accumulate glutamate.  This ability is due to glutamate transporter proteins present in the plasma membranes of both glial cells and neurons.  The transporter proteins represent the only (significant) mechanism for removal of glutamate from the extracellular fluid and their importance for the long-term maintenance of low and non-toxic concns. of glutamate is now well documented.  In addn. to this simple, but essential glutamate removal role, the glutamate transporters appear to have more sophisticated functions in the modulation of neurotransmission.  They may modify the time course of synaptic events, the extent and pattern of activation and desensitization of receptors outside the synaptic cleft and at neighboring synapses (intersynaptic cross-talk).  Further, the glutamate transporters provide glutamate for synthesis of e.g.  GABA, glutathione, and protein, and for energy prodn.  They also play roles in peripheral organs and tissues (e.g. bone, heart, intestine, kidneys, pancreas, and placenta).  Glutamate uptake appears to be modulated on virtually all possible levels, i.e. DNA transcription, mRNA splicing and degrdn., protein synthesis and targeting, and actual amino acid transport activity and assocd. ion channel activities.  A variety of sol. compds. (e.g. glutamate, cytokines, and growth factors) influence glutamate transporter expression and activities.  Neither the normal functioning of glutamatergic synapses nor the pathogenesis of major neurol. diseases (e.g. cerebral ischemia, hypoglycemia, amyotrophic lateral sclerosis, Alzheimer's disease, traumatic brain injury, epilepsy, and schizophrenia) as well as non-neurol. diseases (e.g. osteoporosis) can be properly understood unless more is learned about these transporter proteins.  Like glutamate itself, glutamate transporters are somehow involved in almost all aspects of normal and abnormal brain activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrbDph2PBuBbVg90H21EOLACvtfcHk0lj3_NeT0DA1vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsFWns74%253D&md5=a7118c1df858a0994af6207f852f82b6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2800%2900067-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252800%252900067-8%26sid%3Dliteratum%253Aachs%26aulast%3DDanbolt%26aufirst%3DN.%2BC.%26atitle%3DGlutamate%2520Uptake%26jtitle%3DProg.%2520Neurobiol.%26date%3D2001%26volume%3D65%26spage%3D1%26epage%3D105%26doi%3D10.1016%2FS0301-0082%2800%2900067-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span> </span><span class="NLM_article-title">Excitatory Amino Acid Transporters as Potential Drug Targets</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span><span class="refDoi"> DOI: 10.1517/14728220902926127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1517%2F14728220902926127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=19456273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFCitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=719-731&author=L.+Bunchauthor=M.+N.+Erichsenauthor=A.+A.+Jensen&title=Excitatory+Amino+Acid+Transporters+as+Potential+Drug+Targets&doi=10.1517%2F14728220902926127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acid transporters as potential drug targets</span></div><div class="casAuthors">Bunch, Lennart; Erichsen, Mette N.; Jensen, Anders A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-731</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Excitatory amino acid transporters (EAATs) are transmembrane proteins responsible for the uptake of (S)-glutamate (Glu) from the synaptic cleft, thereby terminating the glutamatergic neurotransmitter signal.  Today five subtypes have been identified.  Except for EAAT2, their individual roles or functions in the CNS are yet to be fully understood due to the shortage of subtype-selective ligands.  Objective/methods: We examine the latest developments in this field by addressing EAAT expression pattern, localization and pharmacol.  We present highlights of published work on inhibitors as well as enhancers which display subtype preference or selectivity and discuss which pathol. conditions in the CNS such ligands may be beneficial to.  Results/conclusions: Not until subtype-selective enhancers, inhibitors and substrates for all five EAAT subtypes have been discovered can a full and detailed understanding of EAATs be obtained.  Thus we encourage collaboration between org. chemists and mol. pharmacologists, who, together, may pave the way for new EAAT ligands of importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlwp3CUxYad7Vg90H21EOLACvtfcHk0lj3_NeT0DA1vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFCitrw%253D&md5=a7af1f649527b26e6e8052caf6598446</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F14728220902926127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220902926127%26sid%3Dliteratum%253Aachs%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26atitle%3DExcitatory%2520Amino%2520Acid%2520Transporters%2520as%2520Potential%2520Drug%2520Targets%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D719%26epage%3D731%26doi%3D10.1517%2F14728220902926127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S. G.</span><span> </span><span class="NLM_article-title">New Views of Glutamate Transporter Structure and Function: Advances and Challenges</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2Fj.neuropharm.2010.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=20708631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=172-181&author=J.+Jiangauthor=S.+G.+Amara&title=New+Views+of+Glutamate+Transporter+Structure+and+Function%3A+Advances+and+Challenges&doi=10.1016%2Fj.neuropharm.2010.07.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">New views of glutamate transporter structure and function: Advances and challenges</span></div><div class="casAuthors">Jiang, Jie; Amara, Susan G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-181</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neuronal and glial glutamate transporters limit the action of excitatory amino acids after their release during synaptic transmission.  Recent structural and functional investigations have revealed much about the transport and conducting mechanisms of members of the sodium-coupled symporter family responsible for glutamate clearance in the nervous system.  In this review we summarize emerging views on the general structure, binding sites for substrates and coupled ions, and transport mechanisms of mammalian glutamate transporters, integrating results from a large body of work on carrier structure-function relationships with several crystal structures obtained for the archaeal ortholog, GltPh.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAUxmtx--OBLVg90H21EOLACvtfcHk0liqGz6yqgGCHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FF&md5=4df5a1e8ea9f5be507e3a403aadb2f67</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DAmara%26aufirst%3DS.%2BG.%26atitle%3DNew%2520Views%2520of%2520Glutamate%2520Transporter%2520Structure%2520and%2520Function%253A%2520Advances%2520and%2520Challenges%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D60%26spage%3D172%26epage%3D181%26doi%3D10.1016%2Fj.neuropharm.2010.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Vandenberg, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, R. M.</span><span> </span><span class="NLM_article-title">Mechanisms of Glutamate Transport</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1621</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span><span class="refDoi"> DOI: 10.1152/physrev.00007.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1152%2Fphysrev.00007.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=24137018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2013&pages=1621-1657&author=R.+J.+Vandenbergauthor=R.+M.+Ryan&title=Mechanisms+of+Glutamate+Transport&doi=10.1152%2Fphysrev.00007.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of glutamate transport</span></div><div class="casAuthors">Vandenberg, Robert J.; Ryan, Renae M.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1621-1657</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  L-Glutamate is the predominant excitatory neurotransmitter in the mammalian central nervous system and plays important roles in a wide variety of brain functions, but it is also a key player in the pathogenesis of many neurol. disorders.  The control of glutamate concns. is crit. to the normal functioning of the central nervous system, and in this review we discuss how glutamate transporters regulate glutamate concns. to maintain dynamic signaling mechanisms between neurons.  In 2004, the crystal structure of a prokaryotic homolog of the mammalian glutamate transporter family of proteins was crystd. and its structure detd.  This has paved the way for a better understanding of the structural basis for glutamate transporter function.  In this review we provide a broad perspective of this field of research, but focus primarily on the more recent studies with a particular emphasis on how our understanding of the structure of glutamate transporters has generated new insights.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzAmcjroPMPLVg90H21EOLACvtfcHk0liqGz6yqgGCHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShtrrP&md5=b573b96bbaf6f03c835c471cf2aaf7b8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00007.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00007.2013%26sid%3Dliteratum%253Aachs%26aulast%3DVandenberg%26aufirst%3DR.%2BJ.%26aulast%3DRyan%26aufirst%3DR.%2BM.%26atitle%3DMechanisms%2520of%2520Glutamate%2520Transport%26jtitle%3DPhysiol.%2520Rev.%26date%3D2013%26volume%3D93%26spage%3D1621%26epage%3D1657%26doi%3D10.1152%2Fphysrev.00007.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahlke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørn-Yoshimoto, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1016/j.coph.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2Fj.coph.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=25466154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVCktbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=116-123&author=A.+A.+Jensenauthor=C.+Fahlkeauthor=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=L.+Bunch&title=Excitatory+amino+acid+transporters%3A+recent+insights+into+molecular+mechanisms%2C+novel+modes+of+modulation+and+new+therapeutic+possibilities&doi=10.1016%2Fj.coph.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities</span></div><div class="casAuthors">Jensen, Anders A.; Fahlke, Christoph; Bjoern-Yoshimoto, Walden E.; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">116-123</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The five excitatory amino acid transporters (EAAT1-5) mediating the synaptic uptake of the major excitatory neurotransmitter glutamate are differently expressed throughout the CNS and at the synaptic level.  Although EAATs are crucial for normal excitatory neurotransmission, explorations into the physiol. functions mediated by the different transporter subtypes and their resp. therapeutic potential have so far been sparse, in no small part due to the limited selection of pharmacol. tools available.  In the present update, we outline important new insights into the mol. compns. of EAATs and their intricate transport process, the novel approaches to pharmacol. modulation of the transporters that have emerged, and interesting new perspectives in EAAT as drug targets proposed in recent years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHCPIMplW6KLVg90H21EOLACvtfcHk0liqGz6yqgGCHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVCktbvF&md5=4619d6aebdc64cfd77a44bae4379eb53</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DFahlke%26aufirst%3DC.%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DExcitatory%2520amino%2520acid%2520transporters%253A%2520recent%2520insights%2520into%2520molecular%2520mechanisms%252C%2520novel%2520modes%2520of%2520modulation%2520and%2520new%2520therapeutic%2520possibilities%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2015%26volume%3D20%26spage%3D116%26epage%3D123%26doi%3D10.1016%2Fj.coph.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Grewer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gameiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauen, T.</span><span> </span><span class="NLM_article-title">SLC1 Glutamate Transporters</span> <span class="citation_source-journal">Pfluegers Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1007/s00424-013-1397-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1007%2Fs00424-013-1397-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=24240778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyls7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2014&pages=3-24&author=C.+Grewerauthor=A.+Gameiroauthor=T.+Rauen&title=SLC1+Glutamate+Transporters&doi=10.1007%2Fs00424-013-1397-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">SLC1 glutamate transporters</span></div><div class="casAuthors">Grewer, Christof; Gameiro, Armanda; Rauen, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Pfluegers Archiv</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-24</span>CODEN:
                <span class="NLM_cas:coden">PFLABK</span>;
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The plasma membrane transporters for the neurotransmitter glutamate belong to the solute carrier 1 family.  They are secondary active transporters, taking up glutamate into the cell against a substantial concn. gradient.  The driving force for concentrative uptake is provided by the cotransport of Na+ ions and the countertransport of one K+ in a step independent of the glutamate translocation step.  Due to eletrogenicity of transport, the transmembrane potential can also act as a driving force.  Glutamate transporters are expressed in many tissues, but are of particular importance in the brain, where they contribute to the termination of excitatory neurotransmission.  Glutamate transporters can also run in reverse, resulting in glutamate release from cells.  Due to these important physiol. functions, glutamate transporter expression and, therefore, the transport rate, are tightly regulated.  This review summarizes recent literature on the functional and biophys. properties, structure-function relationships, regulation, physiol. significance, and pharmacol. of glutamate transporters.  Particular emphasis is on the insight from rapid kinetic and electrophysiol. studies, transcriptional regulation of transporter expression, and reverse transport and its importance for pathophysiol. glutamate release under ischemic conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7CB_CXRaoDrVg90H21EOLACvtfcHk0liqGz6yqgGCHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyls7%252FK&md5=a15133383ebbc3dbe813b7f34bd02821</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00424-013-1397-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-013-1397-7%26sid%3Dliteratum%253Aachs%26aulast%3DGrewer%26aufirst%3DC.%26aulast%3DGameiro%26aufirst%3DA.%26aulast%3DRauen%26aufirst%3DT.%26atitle%3DSLC1%2520Glutamate%2520Transporters%26jtitle%3DPfluegers%2520Arch.%26date%3D2014%26volume%3D466%26spage%3D3%26epage%3D24%26doi%3D10.1007%2Fs00424-013-1397-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollmuth, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Glutamate Receptor Ion Channels: Structure, Regulation, and Function</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1124/pr.109.002451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1124%2Fpr.109.002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=20716669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+F.+Traynelisauthor=L.+P.+Wollmuthauthor=C.+J.+McBainauthor=F.+S.+Mennitiauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=K.+B.+Hansenauthor=H.+Yuanauthor=S.+J.+Myersauthor=R.+Dingledine&title=Glutamate+Receptor+Ion+Channels%3A+Structure%2C+Regulation%2C+and+Function&doi=10.1124%2Fpr.109.002451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor ion channels: structure, regulation, and function</span></div><div class="casAuthors">Traynelis, Stephen F.; Wollmuth, Lonnie P.; McBain, Chris J.; Menniti, Frank S.; Vance, Katie M.; Ogden, Kevin K.; Hansen, Kasper B.; Yuan, Hongjie; Myers, Scott J.; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-496</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels contg. an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore.  Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells.  These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system.  Glutamate receptors are postulated to play important roles in numerous neurol. diseases and have attracted intense scrutiny.  The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel.  In this review we discuss International Union of Basic and Clin. Pharmacol. glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacol., allosteric modulation, mechanisms of gating and permeation, roles in normal physiol. function, as well as the potential therapeutic use of pharmacol. agents acting at glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0rj4nMr5ObVg90H21EOLACvtfcHk0lgJy2IYoBrCSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ&md5=5d0a7945b5ad99113adf9f6312bafe13</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002451%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWollmuth%26aufirst%3DL.%2BP.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520Receptor%2520Ion%2520Channels%253A%2520Structure%252C%2520Regulation%252C%2520and%2520Function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496%26doi%3D10.1124%2Fpr.109.002451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Shimamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda-Kamatani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaitani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeri, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yumoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span> </span><span class="NLM_article-title">DL-Threo-Beta-Benzyloxyaspartate, a Potent Blocker of Excitatory Amino Acid Transporters</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1124/mol.53.2.195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1124%2Fmol.53.2.195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=9463476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADyaK1cXht12htrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1998&pages=195-201&author=K.+Shimamotoauthor=B.+Lebrunauthor=Y.+Yasuda-Kamataniauthor=M.+Sakaitaniauthor=Y.+Shigeriauthor=N.+Yumotoauthor=T.+Nakajima&title=DL-Threo-Beta-Benzyloxyaspartate%2C+a+Potent+Blocker+of+Excitatory+Amino+Acid+Transporters&doi=10.1124%2Fmol.53.2.195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">DL-threo-β-Benzyloxyaspartate, a potent blocker of excitatory amino acid transporters</span></div><div class="casAuthors">Shimamoto, Keiko; Lebrun, Bruno; Yasuda-Kamatani, Yoshimi; Sakaitani, Masahiro; Shigeri, Yasushi; Yumoto, Noboru; Nakajima, Terumi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-201</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">DL-Threo-β-Benzyloxyaspartate (DL-TBOA), a novel deriv. of DL-threo-β-hydroxyaspartate, was synthesized and examd. as an inhibitor of sodium-dependent glutamate/aspartate (excitatory amino acid) transporters.  DL-TBOA inhibited the uptake of [14C]glutamate in COS-1 cells expressing the human excitatory amino acid transporter-1 (EAAT1) (Ki = 42 μM) with almost the same potency as DL-threo-β-hydroxyaspartate (Ki = 58 μM).  With regard to the human excitatory amino acid transporter-2 (EAAT2), the inhibitory effect of DL-TBOA (Ki = 5.7 μM) was much more potent than that of dihydrokainate (Ki = 79 μM), which is well known as a selective blocker of this subtype.  Electrophysiol., DL-TBOA induced no detectable inward currents in Xenopus laevis oocytes expressing human EAAT1 or EAAT2.  However, it significantly reduced the glutamate-induced currents, indicating the prevention of transport.  The dose-response curve of glutamate was shifted by adding DL-TBOA without a significant change in the max. current.  The Kb values for human EAAT1 and EAAT2 expressed in X. laevis oocytes were 9.0 μM and 116 nM, resp.  These results demonstrated that DL-TBOA is, so far, the most potent competitive blocker of glutamate transporters.  DL-TBOA did not show any significant effects on either the ionotropic or metabotropic glutamate receptors.  Moreover, DL-TBOA is chem. much more stable than its benzoyl analog, a previously reported blocker of excitatory amino acid transporters; therefore, DL-TBOA should be a useful tool for investigating the physiol. roles of transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouRwxsbOa8JrVg90H21EOLACvtfcHk0lgJy2IYoBrCSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXht12htrw%253D&md5=90eb235209edbbcaa9bf5a7e69dae743</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fmol.53.2.195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.53.2.195%26sid%3Dliteratum%253Aachs%26aulast%3DShimamoto%26aufirst%3DK.%26aulast%3DLebrun%26aufirst%3DB.%26aulast%3DYasuda-Kamatani%26aufirst%3DY.%26aulast%3DSakaitani%26aufirst%3DM.%26aulast%3DShigeri%26aufirst%3DY.%26aulast%3DYumoto%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DT.%26atitle%3DDL-Threo-Beta-Benzyloxyaspartate%252C%2520a%2520Potent%2520Blocker%2520of%2520Excitatory%2520Amino%2520Acid%2520Transporters%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D53%26spage%3D195%26epage%3D201%26doi%3D10.1124%2Fmol.53.2.195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Lebrun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaitani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda-Kamatani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span> </span><span class="NLM_article-title">New β-Hydroxyaspartate Derivatives Are Competitive Blockers for the Bovine Glutamate/Aspartate Transporter</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">20336</span><span class="NLM_x">–</span> <span class="NLM_lpage">20339</span><span class="refDoi"> DOI: 10.1074/jbc.272.33.20336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1074%2Fjbc.272.33.20336" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=20336-20339&author=B.+Lebrunauthor=M.+Sakaitaniauthor=K.+Shimamotoauthor=Y.+Yasuda-Kamataniauthor=T.+Nakajima&title=New+%CE%B2-Hydroxyaspartate+Derivatives+Are+Competitive+Blockers+for+the+Bovine+Glutamate%2FAspartate+Transporter&doi=10.1074%2Fjbc.272.33.20336"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.33.20336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.33.20336%26sid%3Dliteratum%253Aachs%26aulast%3DLebrun%26aufirst%3DB.%26aulast%3DSakaitani%26aufirst%3DM.%26aulast%3DShimamoto%26aufirst%3DK.%26aulast%3DYasuda-Kamatani%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DT.%26atitle%3DNew%2520%25CE%25B2-Hydroxyaspartate%2520Derivatives%2520Are%2520Competitive%2520Blockers%2520for%2520the%2520Bovine%2520Glutamate%252FAspartate%2520Transporter%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D20336%26epage%3D20339%26doi%3D10.1074%2Fjbc.272.33.20336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span> </span><span class="NLM_article-title">Pharmacological Characterization of Human Excitatory Amino Acid Transporters EAAT1, EAAT2 and EAAT3 in a Fluorescence-Based Membrane Potential Assay</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2115</span><span class="NLM_x">–</span> <span class="NLM_lpage">2127</span><span class="refDoi"> DOI: 10.1016/j.bcp.2004.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2Fj.bcp.2004.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=15135308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVCis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=2115-2127&author=A.+A.+Jensenauthor=H.+Br%C3%A4uner-Osborne&title=Pharmacological+Characterization+of+Human+Excitatory+Amino+Acid+Transporters+EAAT1%2C+EAAT2+and+EAAT3+in+a+Fluorescence-Based+Membrane+Potential+Assay&doi=10.1016%2Fj.bcp.2004.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay</span></div><div class="casAuthors">Jensen, Anders A.; Brauner-Osborne, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2115-2127</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We have expressed the human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 stably in HEK293 cells and characterized the transporters pharmacol. in a conventional [3H]-d-aspartate uptake assay and in a fluorescence-based membrane potential assay, the FLIPR Membrane Potential (FMP) assay.  The Km and Ki values obtained for 12 std. EAAT ligands at EAAT1, EAAT2 and EAAT3 in the FMP assay correlated well with the Ki values obtained in the [3H]-d-aspartate assay (r2 values of 0.92, 0.92, and 0.95, resp.).  Furthermore, the pharmacol. characteristics of the cell lines in the FMP assay were in good agreement with previous findings in electrophysiol. studies of the transporters.  The FMP assay was capable of distinguishing between substrates and non-substrate inhibitors and to discriminate between "full" and "partial" substrates at the transporters.  Taking advantage of the prolific nature of the FMP assay, interactions of the EAATs with substrates and inhibitors were studied in some detail.  This is the first report of a high throughput screening assay for EAATs.  We propose that the assay will be of great use in future studies of the transporters.  Although conventional electrophysiol. set-ups might be superior in terms of studying sophisticated kinetic aspects of the uptake process, the FMP assay enables the collection of considerable amts. of highly reproducible data with relatively little labor.  Furthermore, considering that the no. of EAAT ligands presently available is limited, and that almost all of these are characterized by low potency and a low degree of subtype selectivity, future screening of compd. libraries at the EAAT-cell lines in the FMP assay could help identify structurally and pharmacol. novel ligands for the transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS6Um79wVYz7Vg90H21EOLACvtfcHk0lgJy2IYoBrCSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVCis78%253D&md5=06e3c536844acca52fdba733175a93c6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2004.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2004.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26atitle%3DPharmacological%2520Characterization%2520of%2520Human%2520Excitatory%2520Amino%2520Acid%2520Transporters%2520EAAT1%252C%2520EAAT2%2520and%2520EAAT3%2520in%2520a%2520Fluorescence-Based%2520Membrane%2520Potential%2520Assay%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D67%26spage%3D2115%26epage%3D2127%26doi%3D10.1016%2Fj.bcp.2004.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Arriza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadiche, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdoch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S.</span><span> </span><span class="NLM_article-title">Functional Comparisons of Three Glutamate Transporter Subtypes Cloned from Human Motor Cortex</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5559</span><span class="NLM_x">–</span> <span class="NLM_lpage">5569</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1523%2FJNEUROSCI.14-09-05559.1994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=7521911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADyaK2MXnvVyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=5559-5569&author=J.+Arrizaauthor=W.+Fairmanauthor=J.+Wadicheauthor=G.+Murdochauthor=M.+Kavanaughauthor=S.+Amara&title=Functional+Comparisons+of+Three+Glutamate+Transporter+Subtypes+Cloned+from+Human+Motor+Cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex</span></div><div class="casAuthors">Arriza, Jeffrey L.; Fairman, Wendy A.; Wadiche, Jacques I.; Murdoch, Geoffrey H.; Kavanaugh, Michael P.; Amara, Susan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5559-69</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">Reuptake plays an important role in regulating synaptic and extracellular concns. of glutamate.  Three glutamate transporters expressed in human motor cortex, termed EAAT1, EAAT2, and EAAT3 (for excitatory amino acid transporter), have been characterized by their mol. cloning and functional expression.  Each EAAT subtype mRNA was found in all human brain regions analyzed.  The most prominent regional variation in message content was in cerebellum where EAAT1 expression predominated.  EAAT1 and EAAT3 mRNAs were also expressed in various non-nervous tissues, whereas expression of EAAT2 was largely restricted to brain.  The kinetic parameters and pharmacol. characteristics of transport mediated by each EAAT subtype were detd. in transfected mammalian cells by radiolabel uptake and in microinjected oocytes by voltage-clamp measurements.  The affinities of the EAAT subtypes for L-glutamate were similar, with Km detns. varying from 48 to 97 μm in the mammalian cell assay and from 18 to 28 μM in oocytes.  Glutamate uptake inhibitors were used to compare the pharmacologies of the EAAT subtypes.  The EAAT2 subtype was distinguishable from the EAAT1/EAAT3 subtypes by the potency of several inhibitors, but most notably by sensitivity to kainic acid (KA) and dihydrokainic acid (DHK).  KA and DHK potently inhibited EAAT2 transport, but did not significantly affect transport by EAAT1/EAAT3.  Using voltage-clamp measurements, most inhibitors were found to be substrates that elicited transport currents.  In contrast, KA and DHK did not evoke currents and they were found to block EAAT2-mediated transport competitively.  This selective interaction with the EAAT2 subtype could be a significant factor in KA neurotoxicity.  These studies provide a foundation for understanding the role of glutamate transporters in human excitatory neurotransmission and in neuropathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdLh7iGWaRnbVg90H21EOLACvtfcHk0lgQmd_iKTsnCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvVyrsQ%253D%253D&md5=27b0072f8a4cd584e3b3bcb5582e697f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.14-09-05559.1994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.14-09-05559.1994%26sid%3Dliteratum%253Aachs%26aulast%3DArriza%26aufirst%3DJ.%26aulast%3DFairman%26aufirst%3DW.%26aulast%3DWadiche%26aufirst%3DJ.%26aulast%3DMurdoch%26aufirst%3DG.%26aulast%3DKavanaugh%26aufirst%3DM.%26aulast%3DAmara%26aufirst%3DS.%26atitle%3DFunctional%2520Comparisons%2520of%2520Three%2520Glutamate%2520Transporter%2520Subtypes%2520Cloned%2520from%2520Human%2520Motor%2520Cortex%26jtitle%3DJ.%2520Neurosci.%26date%3D1994%26volume%3D14%26spage%3D5559%26epage%3D5569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sagot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umberti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assaf, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboab, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gefflaut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Chemo-Enzymatic Synthesis of (2S,4R)-2-Amino-4-(3-(2,2-Diphenylethylamino)-3-Oxopropyl)pentanedioic Acid: A Novel Selective Inhibitor of Human Excitatory Amino Acid Transporter Subtype 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4085</span><span class="NLM_x">–</span> <span class="NLM_lpage">4092</span><span class="refDoi"> DOI: 10.1021/jm800091e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800091e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsl2rtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4085-4092&author=E.+Sagotauthor=A.+A.+Jensenauthor=D.+S.+Pickeringauthor=X.+Puauthor=M.+Umbertiauthor=T.+B.+Stensb%C3%B8lauthor=B.+Nielsenauthor=Z.+Assafauthor=B.+Aboabauthor=J.+Bolteauthor=T.+Gefflautauthor=L.+Bunch&title=Chemo-Enzymatic+Synthesis+of+%282S%2C4R%29-2-Amino-4-%283-%282%2C2-Diphenylethylamino%29-3-Oxopropyl%29pentanedioic+Acid%3A+A+Novel+Selective+Inhibitor+of+Human+Excitatory+Amino+Acid+Transporter+Subtype+2&doi=10.1021%2Fjm800091e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chemo-enzymatic synthesis of (2S,4R)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid: A novel selective inhibitor of human excitatory amino acid transporter subtype 2</span></div><div class="casAuthors">Sagot, Emanuelle; Jensen, Anders A.; Pickering, Darryl S.; Pu, Xiaosui; Umberti, Michelle; Stensboel, Tine B.; Nielsen, Birgitte; Assaf, Zeinab; Aboab, Betina; Bolte, Jean; Gefflaut, Thierry; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4085-4092</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the mammalian central nervous system (CNS), the action of sodium dependent excitatory amino acid transporters (EAATs) is responsible for termination of glutamatergic neurotransmission by reuptake of (S)-glutamate (Glu) from the synaptic cleft.  Five EAAT subtypes have been identified, of which EAAT1-4 are present in the CNS, while EAAT5 is localized exclusively in the retina.  In this study, we have used an enantioselective chemo-enzymic strategy to synthesize 10 new Glu analogs (I) [R1 = CH2OH, CH2OCH2Ph, CH2CO2H, (CH2)2CO2Me, (CH2)2CO2H, (CH2)2CONH2, (CH2)2CONHMe, (CH2)2CONH(CH2)Me, (CH2)2COCH2Ph,, (CH2)2CONHCH2CH(Ph)Ph] with different functionalities in the 4R-position and characterized their pharmacol. properties at the human EAAT1-3.  In particular, one compd., I [(CH2)2CONHCH2CH(Ph)Ph], displayed a significant preference as inhibitor of the EAAT2 subtype over EAAT1,3.  The compd. also displayed very low affinities toward ionotropic and metabotropic Glu receptors, making it the most selective EAAT2 inhibitor described so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7PMaEobCIcLVg90H21EOLACvtfcHk0lgQmd_iKTsnCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsl2rtrk%253D&md5=5017089c747af7a7ef37639d5473dc55</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm800091e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800091e%26sid%3Dliteratum%253Aachs%26aulast%3DSagot%26aufirst%3DE.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DPickering%26aufirst%3DD.%2BS.%26aulast%3DPu%26aufirst%3DX.%26aulast%3DUmberti%26aufirst%3DM.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DAssaf%26aufirst%3DZ.%26aulast%3DAboab%26aufirst%3DB.%26aulast%3DBolte%26aufirst%3DJ.%26aulast%3DGefflaut%26aufirst%3DT.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DChemo-Enzymatic%2520Synthesis%2520of%2520%25282S%252C4R%2529-2-Amino-4-%25283-%25282%252C2-Diphenylethylamino%2529-3-Oxopropyl%2529pentanedioic%2520Acid%253A%2520A%2520Novel%2520Selective%2520Inhibitor%2520of%2520Human%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4085%26epage%3D4092%26doi%3D10.1021%2Fjm800091e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIlvain, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrick, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosanu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butera, J.</span><span> </span><span class="NLM_article-title">Characterization of Novel Aryl-Ether, Biaryl, and Fluorene Aspartic Acid and Diaminopropionic Acid Analogs as Potent Inhibitors of the High-Affinity Glutamate Transporter EAAT2</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">974</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span><span class="refDoi"> DOI: 10.1124/mol.105.012005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1124%2Fmol.105.012005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=16014807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyhu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=974-982&author=J.+Dunlopauthor=H.+B.+McIlvainauthor=T.+A.+Carrickauthor=B.+Jowauthor=Q.+Luauthor=D.+Kowalauthor=S.+Linauthor=A.+Greenfieldauthor=C.+Grosanuauthor=K.+Fanauthor=R.+Petroskiauthor=J.+Williamsauthor=A.+Fosterauthor=J.+Butera&title=Characterization+of+Novel+Aryl-Ether%2C+Biaryl%2C+and+Fluorene+Aspartic+Acid+and+Diaminopropionic+Acid+Analogs+as+Potent+Inhibitors+of+the+High-Affinity+Glutamate+Transporter+EAAT2&doi=10.1124%2Fmol.105.012005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT2</span></div><div class="casAuthors">Dunlop, John; McIlvain, H. Beal; Carrick, Tikva A.; Jow, Brian; Lu, Qiang; Kowal, Dianne; Lin, Steven; Greenfield, Alexander; Grosanu, Cristina; Fan, Kristi; Petroski, Robert; Williams, John; Foster, Alan; Butera, John</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">974-982</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In this study, we describe the pharmacol. characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of EAAT2, the predominant glutamate transporter in forebrain regions.  The rank order of potency detd. for the inhibition of human EAAT2 was N4-[4-(2-bromo-4,5-difluorophenoxy)phenyl]-L-asparagine (WAY-213613) (IC50 = 85 ± 5 nM) > N4-(2'-methyl-1,1'-biphenyl-4-yl)-L-asparagine (WAY-213394) (IC50 = 145 ± 22 nM) = N4-[7-(trifluoromethyl)-9H-fluoren-2-yl]-L-asparagine (WAY-212922) (IC50 = 157 ± 11 nM) = 3-{[(4'-chloro-2-methyl-1,1'-biphenyl-4-yl)carbonyl]amino}- L-alanine (WAY-211686) (IC50 = 190 ± 10 nM).  WAY-213613 was the most selective of the compds. examd., with IC50 values for inhibition of EAAT1 and EAAT3 of 5 and 3.8 μM, resp., corresponding to a 59- and 45-fold selectivity toward EAAT2.  An identical rank order to potency [WAY-213613 (35 ± 7 nM) > WAY-213394 (92 ± 13 nM) = WAY-212922 (95 ± 8 nM) = WAY-211686 (101 ± 20 nM)] was obsd. for the inhibition of glutamate uptake in rat cortical synaptosomes, consistent with the predominant contribution of EAAT2 to this activity.  Kinetic studies with each of the compds. in synaptosomes revealed a competitive mechanism of inhibition.  All compds. were detd. to be nonsubstrates by evaluating both the stimulation of currents in EAAT2-injected oocytes and the heteroexchange of D-[3H]aspartate from cortical synaptosomes.  WAY-213613 represents the most potent and selective inhibitor of EAAT2 identified to date.  Taken in combination with its selectivity over ionotropic and metabotropic glutamate receptors, this compd. represents a potential tool for the further elucidation of EAAT2 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVqqndi70Gr7Vg90H21EOLACvtfcHk0lhBTkfji-0GXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyhu7nK&md5=933a42c1c37af6a8bf8390f8a93e5f82</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.012005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.012005%26sid%3Dliteratum%253Aachs%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DMcIlvain%26aufirst%3DH.%2BB.%26aulast%3DCarrick%26aufirst%3DT.%2BA.%26aulast%3DJow%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DGreenfield%26aufirst%3DA.%26aulast%3DGrosanu%26aufirst%3DC.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DA.%26aulast%3DButera%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520Novel%2520Aryl-Ether%252C%2520Biaryl%252C%2520and%2520Fluorene%2520Aspartic%2520Acid%2520and%2520Diaminopropionic%2520Acid%2520Analogs%2520as%2520Potent%2520Inhibitors%2520of%2520the%2520High-Affinity%2520Glutamate%2520Transporter%2520EAAT2%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D974%26epage%3D982%26doi%3D10.1124%2Fmol.105.012005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Vandenberg, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitrovic, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chebib, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balcar, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, G. A. R.</span><span> </span><span class="NLM_article-title">Contrasting Modes of Action of Methylglutamate Derivatives on the Excitatory Amino Acid Transporters, EAAT1 and EAAT2</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span><span class="refDoi"> DOI: 10.1124/mol.51.5.809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1124%2Fmol.51.5.809" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1997&pages=809-815&author=R.+J.+Vandenbergauthor=A.+D.+Mitrovicauthor=M.+Chebibauthor=V.+J.+Balcarauthor=G.+A.+R.+Johnston&title=Contrasting+Modes+of+Action+of+Methylglutamate+Derivatives+on+the+Excitatory+Amino+Acid+Transporters%2C+EAAT1+and+EAAT2&doi=10.1124%2Fmol.51.5.809"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fmol.51.5.809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.51.5.809%26sid%3Dliteratum%253Aachs%26aulast%3DVandenberg%26aufirst%3DR.%2BJ.%26aulast%3DMitrovic%26aufirst%3DA.%2BD.%26aulast%3DChebib%26aufirst%3DM.%26aulast%3DBalcar%26aufirst%3DV.%2BJ.%26aulast%3DJohnston%26aufirst%3DG.%2BA.%2BR.%26atitle%3DContrasting%2520Modes%2520of%2520Action%2520of%2520Methylglutamate%2520Derivatives%2520on%2520the%2520Excitatory%2520Amino%2520Acid%2520Transporters%252C%2520EAAT1%2520and%2520EAAT2%26jtitle%3DMol.%2520Pharmacol.%26date%3D1997%26volume%3D51%26spage%3D809%26epage%3D815%26doi%3D10.1124%2Fmol.51.5.809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Alaux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gefflaut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Chemoenzymatic Synthesis of a Series of 4-Substituted Glutamate Analogues and Pharmacological Characterization at Human Glutamate Transporters Subtypes 1–3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7980</span><span class="NLM_x">–</span> <span class="NLM_lpage">7992</span><span class="refDoi"> DOI: 10.1021/jm050597z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050597z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2htrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7980-7992&author=S.+Alauxauthor=M.+Kuskauthor=E.+Sagotauthor=J.+Bolteauthor=A.+a+Jensenauthor=H.+Br%C3%A4uner-Osborneauthor=T.+Gefflautauthor=L.+Bunch&title=Chemoenzymatic+Synthesis+of+a+Series+of+4-Substituted+Glutamate+Analogues+and+Pharmacological+Characterization+at+Human+Glutamate+Transporters+Subtypes+1%E2%80%933&doi=10.1021%2Fjm050597z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoenzymatic Synthesis of a Series of 4-Substituted Glutamate Analogues and Pharmacological Characterization at Human Glutamate Transporters Subtypes 1-3</span></div><div class="casAuthors">Alaux, Sebastien; Kusk, Mie; Sagot, Emanuelle; Bolte, Jean; Jensen, Anders A.; Braeuner-Osborne, Hans; Gefflaut, Thierry; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7980-7992</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of L-2,4-syn-4-alkylglutamic acid analogs I (R = Me, Et, Pr, Bu, i-Pr, i-Bu, pentyl, iso-pentyl, CH2Ph) were synthesized in high yields and high enantiomeric excess (> 99%) from their corresponding 4-substituted ketoglutaric acids dilithium salts II via enzymic transamination using aspartate aminotransferase (AAT) from pig heart or E. coli.  I were evaluated as potential ligands for the glutamate transporters EAAT1, EAAT2, and EAAT3 (excitatory amino acid transporter, subtypes 1-3) in the FLIPR membrane potential (FMP) assay.  The results showed a distinct change in the pharmacol. profile when the 4-Me group (an EAAT1 substrate and EAAT2,3 inhibitor) was extended to a 4-Et group, as this analog is an inhibitor at all three subtypes, EAAT1-3.  In addn., both large and bulky hydrophobic substituents in the 4-position of L-2,4-syn-glutamic acid are allowed by all three glutamate transporter subtypes EAAT1-3 while maintaining inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSrh51A-3q1rVg90H21EOLACvtfcHk0lhBTkfji-0GXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2htrfP&md5=5bad1a4908b9df5f7d5e8a6da9b35af7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm050597z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050597z%26sid%3Dliteratum%253Aachs%26aulast%3DAlaux%26aufirst%3DS.%26aulast%3DKusk%26aufirst%3DM.%26aulast%3DSagot%26aufirst%3DE.%26aulast%3DBolte%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DA.%2Ba%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DGefflaut%26aufirst%3DT.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DChemoenzymatic%2520Synthesis%2520of%2520a%2520Series%2520of%25204-Substituted%2520Glutamate%2520Analogues%2520and%2520Pharmacological%2520Characterization%2520at%2520Human%2520Glutamate%2520Transporters%2520Subtypes%25201%25E2%2580%25933%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7980%26epage%3D7992%26doi%3D10.1021%2Fjm050597z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahlke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span> </span><span class="NLM_article-title">Allosteric Modulation of an Excitatory Amino Acid Transporter: The Subtype-Selective Inhibitor UCPH-101 Exerts Sustained Inhibition of EAAT1 through an Intramonomeric Site in the Trimerization Domain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1068</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3396-12.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1523%2FJNEUROSCI.3396-12.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=23325245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVemsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1068-1087&author=B.+Abrahamsenauthor=N.+Schneiderauthor=M.+N.+Erichsenauthor=T.+H.+Huynhauthor=C.+Fahlkeauthor=L.+Bunchauthor=A.+A.+Jensen&title=Allosteric+Modulation+of+an+Excitatory+Amino+Acid+Transporter%3A+The+Subtype-Selective+Inhibitor+UCPH-101+Exerts+Sustained+Inhibition+of+EAAT1+through+an+Intramonomeric+Site+in+the+Trimerization+Domain&doi=10.1523%2FJNEUROSCI.3396-12.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of an excitatory amino acid transporter:the subtype-selective inhibitor UCPH-101 exerts sustained inhibition of EAAT1 through an intramonomeric site in the trimerization domain</span></div><div class="casAuthors">Abrahamsen, Bjarke; Schneider, Nicole; Erichsen, Mette N.; Huynh, Tri H. V.; Fahlke, Christoph; Bunch, Lennart; Jensen, Anders A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1068-1087</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In the present study, the mechanism of action and mol. basis for the activity of the first class of selective inhibitors of the human excitatory amino acid transporter subtype 1 (EAAT1) and its rodent ortholog GLAST are elucidated.  The previously reported specificity of UCPH-101 and UCPH-102 for EAAT1 over EAAT2 and EAAT3 is demonstrated to extend to the EAAT4 and EAAT5 subtypes as well.  Interestingly, brief exposure to UCPH-101 induces a long-lasting inactive state of EAAT1, whereas the inhibition exerted by closely related analogs is substantially more reversible in nature.  In agreement with this, the kinetic properties of UCPH-101 unblocking of the transporter are considerably slower than those of UCPH-102.  UCPH-101 exhibits noncompetitive inhibition of EAAT1, and its binding site in GLAST has been delineated in an elaborate mutagenesis study.  Substitutions of several residues in TM3, TM4c, and TM7a of GLAST have detrimental effects on the inhibitory potency and/or efficacy of UCPH-101 while not affecting the pharmacol. properties of (S)-glutamate or the competitive EAAT inhibitor TBOA significantly.  Hence, UCPH-101 is proposed to target a predominantly hydrophobic crevice in the "trimerization domain" of the GLAST monomer, and the inhibitor is demonstrated to inhibit the uptake through the monomer that it binds to exclusively and not to affect substrate translocation through the other monomers in the GLAST trimer.  The allosteric mode of UCPH-101 inhibition underlines the functional importance of the trimerization domain of the EAAT and demonstrates the feasibility of modulating transporter function through ligand binding to regions distant from its "transport domain.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqARUXvJR5bE7Vg90H21EOLACvtfcHk0lhBTkfji-0GXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVemsLg%253D&md5=5e2b79367256a04008e6180cb9856d6f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3396-12.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3396-12.2013%26sid%3Dliteratum%253Aachs%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DSchneider%26aufirst%3DN.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%26aulast%3DFahlke%26aufirst%3DC.%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26atitle%3DAllosteric%2520Modulation%2520of%2520an%2520Excitatory%2520Amino%2520Acid%2520Transporter%253A%2520The%2520Subtype-Selective%2520Inhibitor%2520UCPH-101%2520Exerts%2520Sustained%2520Inhibition%2520of%2520EAAT1%2520through%2520an%2520Intramonomeric%2520Site%2520in%2520the%2520Trimerization%2520Domain%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D1068%26epage%3D1087%26doi%3D10.1523%2FJNEUROSCI.3396-12.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Discovery of the First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">912</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span><span class="refDoi"> DOI: 10.1021/jm8013458</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8013458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=912-915&author=A.+A.+Jensenauthor=M.+N.+Erichsenauthor=C.+W.+Nielsenauthor=T.+B.+Stensb%C3%B8lauthor=J.+Kehlerauthor=L.+Bunch&title=Discovery+of+the+First+Selective+Inhibitor+of+Excitatory+Amino+Acid+Transporter+Subtype+1&doi=10.1021%2Fjm8013458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1</span></div><div class="casAuthors">Jensen, Anders A.; Erichsen, Mette N.; Nielsen, Christina W.; Stensboel, Tine B.; Kehler, Jan; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">912-915</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of the first class of subtype-selective inhibitors of the human excitatory amino acid transporter subtype 1 (EAAT1) and its rat orthologue GLAST is reported.  An opening structure-activity relationship of 25 analogs is presented that addresses the influence of substitutions at the 4- and 7-positions of the parental skeleton 2-amino-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile.  The most potent analog 10 displays high nanomolar inhibitory activity at EAAT1 and a >400-fold selectivity over EAAT2 and EAAT3, making it a highly valuable pharmacol. tool.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVu7PAOshxerVg90H21EOLACvtfcHk0ljN7G6xs7ulpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSqs78%253D&md5=7036a6fe617a9908a36fda6a87400e2c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm8013458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8013458%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DNielsen%26aufirst%3DC.%2BW.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DKehler%26aufirst%3DJ.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520the%2520First%2520Selective%2520Inhibitor%2520of%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D912%26epage%3D915%26doi%3D10.1021%2Fjm8013458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastlund, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monrad, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekker-Jensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationship Study of First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1:2-Amino-4-(4-Methoxyphenyl)-7-(Naphthalen-1-Yl)-5-Oxo-5,6,7,8-Tetrahydro-4 H -Chromene-3-Carbonitrile (UCPH-101)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7180</span><span class="NLM_x">–</span> <span class="NLM_lpage">7191</span><span class="refDoi"> DOI: 10.1021/jm1009154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1009154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7180-7191&author=M.+N.+Erichsenauthor=T.+H.+V.+Huynhauthor=B.+Abrahamsenauthor=J.+F.+Bastlundauthor=C.+Bundgaardauthor=O.+Monradauthor=A.+Bekker-Jensenauthor=C.+W.+Nielsenauthor=K.+Frydenvangauthor=A.+A.+Jensenauthor=L.+Bunch&title=Structure%E2%80%93Activity+Relationship+Study+of+First+Selective+Inhibitor+of+Excitatory+Amino+Acid+Transporter+Subtype+1%3A2-Amino-4-%284-Methoxyphenyl%29-7-%28Naphthalen-1-Yl%29-5-Oxo-5%2C6%2C7%2C8-Tetrahydro-4+H+-Chromene-3-Carbonitrile+%28UCPH-101%29&doi=10.1021%2Fjm1009154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm1009154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1009154%26sid%3Dliteratum%253Aachs%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%2BV.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DBastlund%26aufirst%3DJ.%2BF.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DMonrad%26aufirst%3DO.%26aulast%3DBekker-Jensen%26aufirst%3DA.%26aulast%3DNielsen%26aufirst%3DC.%2BW.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationship%2520Study%2520of%2520First%2520Selective%2520Inhibitor%2520of%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%253A2-Amino-4-%25284-Methoxyphenyl%2529-7-%2528Naphthalen-1-Yl%2529-5-Oxo-5%252C6%252C7%252C8-Tetrahydro-4%2520H%2520-Chromene-3-Carbonitrile%2520%2528UCPH-101%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7180%26epage%3D7191%26doi%3D10.1021%2Fjm1009154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Haym, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H. V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, M. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørn-Yoshimoto, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastlund, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Bioavailability Studies and in Vitro Profiling of the Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitor UCPH-102</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1002/cmdc.201500527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1002%2Fcmdc.201500527" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=403-419&author=I.+Haymauthor=T.+H.+V+Huynhauthor=S.+W.+Hansenauthor=M.+H.+F.+Pedersenauthor=J.+A.+Ruizauthor=M.+N.+Erichsenauthor=M.+Gyntherauthor=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=B.+Abrahamsenauthor=J.+F.+Bastlundauthor=C.+Bundgaardauthor=A.+L.+Eriksenauthor=A.+A.+Jensenauthor=L.+Bunch&title=Bioavailability+Studies+and+in+Vitro+Profiling+of+the+Selective+Excitatory+Amino+Acid+Transporter+Subtype+1+%28EAAT1%29+Inhibitor+UCPH-102&doi=10.1002%2Fcmdc.201500527"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500527%26sid%3Dliteratum%253Aachs%26aulast%3DHaym%26aufirst%3DI.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%2BV%26aulast%3DHansen%26aufirst%3DS.%2BW.%26aulast%3DPedersen%26aufirst%3DM.%2BH.%2BF.%26aulast%3DRuiz%26aufirst%3DJ.%2BA.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DGynther%26aufirst%3DM.%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DBastlund%26aufirst%3DJ.%2BF.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DEriksen%26aufirst%3DA.%2BL.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DBioavailability%2520Studies%2520and%2520in%2520Vitro%2520Profiling%2520of%2520the%2520Selective%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%2520%2528EAAT1%2529%2520Inhibitor%2520UCPH-102%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D403%26epage%3D419%26doi%3D10.1002%2Fcmdc.201500527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hansen, S. W.; Erichsen, M. N.; Fu, B.; Bjørn-Yoshimoto, W. E.; Abrahamsen, B.; Hansen, J. C.; Jensen, A. A.; Bunch, L.</span><span> </span><span class="NLM_article-title">Identification of a New Class of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors Followed by a Structure–Activity Relationship Study</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01058</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&author=S.+W.+Hansen&author=M.+N.+Erichsen&author=B.+Fu&author=W.+E.+Bj%C3%B8rn-Yoshimoto&author=B.+Abrahamsen&author=J.+C.+Hansen&author=A.+A.+Jensen&author=L.+Bunch&title=Identification+of+a+New+Class+of+Selective+Excitatory+Amino+Acid+Transporter+Subtype+1+%28EAAT1%29+Inhibitors+Followed+by+a+Structure%E2%80%93Activity+Relationship+Study&doi=10.1021%2Facs.jmedchem.6b01058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01058%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DS.%2BW.%26atitle%3DIdentification%2520of%2520a%2520New%2520Class%2520of%2520Selective%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%2520%2528EAAT1%2529%2520Inhibitors%2520Followed%2520by%2520a%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26doi%3D10.1021%2Facs.jmedchem.6b01058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Esslinger, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerdes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awes, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mavencamp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhoderick, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlin, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, R. J.</span><span> </span><span class="NLM_article-title">The Substituted Aspartate Analogue L-Beta-Threo-Benzyl-Aspartate Preferentially Inhibits the Neuronal Excitatory Amino Acid Transporter EAAT3</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2Fj.neuropharm.2005.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=16183084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFehsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=850-861&author=C.+S.+Esslingerauthor=S.+Agarwalauthor=J.+Gerdesauthor=P.+A.+Wilsonauthor=E.+S.+Davisauthor=A.+N.+Awesauthor=E.+O%E2%80%99Brienauthor=T.+Mavencampauthor=H.+P.+Kochauthor=D.+J.+Poulsenauthor=J.+F.+Rhoderickauthor=A.+R.+Chamberlinauthor=M.+P.+Kavanaughauthor=R.+J.+Bridges&title=The+Substituted+Aspartate+Analogue+L-Beta-Threo-Benzyl-Aspartate+Preferentially+Inhibits+the+Neuronal+Excitatory+Amino+Acid+Transporter+EAAT3&doi=10.1016%2Fj.neuropharm.2005.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The substituted aspartate analogue L-β-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3</span></div><div class="casAuthors">Esslinger, C. Sean; Agarwal, Shailesh; Gerdes, John; Wilson, Paul A.; Davis, Erin S.; Awes, Alicia N.; O'Brien, Erin; Mavencamp, Teri; Koch, Hans P.; Poulsen, David J.; Rhoderick, Joseph F.; Chamberlin, A. Richard; Kavanaugh, Michael P.; Bridges, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">850-861</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The excitatory amino acid transporters (EAATs) play key roles in the regulation of CNS L-glutamate, esp. related to synthesis, signal termination, synaptic spillover, and excitotoxic protection.  Inhibitors available to delineate EAAT pharmacol. and function are essentially limited to those that non-selectively block all EAATs or those that exhibit a substantial preference for EAAT2.  Thus, it is difficult to selectively study the other subtypes, particularly EAAT1 and EAAT3.  Structure activity studies on a series of β-substituted aspartate analogs identify L-β-benzyl-aspartate (L-β-BA) as among the first blockers that potently and preferentially inhibits the neuronal EAAT3 subtype.  Kinetic anal. of D-[3H]aspartate uptake into C17.2 cells expressing the hEAATs demonstrate that L-β-threo-BA is the more potent diastereomer, acts competitively, and exhibits a 10-fold preference for EAAT3 compared to EAAT1 and EAAT2.  Electrophysiol. recordings of EAAT-mediated currents in Xenopus oocytes identify L-β-BA as a non-substrate inhibitor.  Analyzing L-β-threo-BA within the context of a novel EAAT2 pharmacophore model suggests: a highly conserved positioning of the electrostatic carboxyl and amino groups; nearby regions that accommodate select structural modifications (cyclopropyl rings, Me groups, oxygen atoms); and a unique region L-β-threo-BA occupied by the benzyl moieties of L-TBOA, L-β-threo-BA and related analogs.  It is plausible that the preference of L-β-threo-BA and L-TBOA for EAAT3 and EAAT2, resp., could reside in the latter two pharmacophore regions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4vqhxyJbFa7Vg90H21EOLACvtfcHk0ljN7G6xs7ulpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFehsL7I&md5=5bf2793da482cf7bbf27e6a3b0d1bce8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DEsslinger%26aufirst%3DC.%2BS.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DGerdes%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DP.%2BA.%26aulast%3DDavis%26aufirst%3DE.%2BS.%26aulast%3DAwes%26aufirst%3DA.%2BN.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DE.%26aulast%3DMavencamp%26aufirst%3DT.%26aulast%3DKoch%26aufirst%3DH.%2BP.%26aulast%3DPoulsen%26aufirst%3DD.%2BJ.%26aulast%3DRhoderick%26aufirst%3DJ.%2BF.%26aulast%3DChamberlin%26aufirst%3DA.%2BR.%26aulast%3DKavanaugh%26aufirst%3DM.%2BP.%26aulast%3DBridges%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520Substituted%2520Aspartate%2520Analogue%2520L-Beta-Threo-Benzyl-Aspartate%2520Preferentially%2520Inhibits%2520the%2520Neuronal%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520EAAT3%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D850%26epage%3D861%26doi%3D10.1016%2Fj.neuropharm.2005.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span> </span><span class="NLM_article-title">Rational Design and Enantioselective Synthesis of (1R,4S,5R,6S)-3-azabicyclo[3.3.0]octane-4,6-Dicarboxylic Acid - a Novel Inhibitor at Human Glutamate Transporter Subtypes 1, 2, and 3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1021/jm0508336</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0508336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=172-178&author=L.+Bunchauthor=B.+Nielsenauthor=A.+a+Jensenauthor=H.+Br%C3%A4uner-Osborne&title=Rational+Design+and+Enantioselective+Synthesis+of+%281R%2C4S%2C5R%2C6S%29-3-azabicyclo%5B3.3.0%5Doctane-4%2C6-Dicarboxylic+Acid+-+a+Novel+Inhibitor+at+Human+Glutamate+Transporter+Subtypes+1%2C+2%2C+and+3&doi=10.1021%2Fjm0508336"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0508336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508336%26sid%3Dliteratum%253Aachs%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DA.%2Ba%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26atitle%3DRational%2520Design%2520and%2520Enantioselective%2520Synthesis%2520of%2520%25281R%252C4S%252C5R%252C6S%2529-3-azabicyclo%255B3.3.0%255Doctane-4%252C6-Dicarboxylic%2520Acid%2520-%2520a%2520Novel%2520Inhibitor%2520at%2520Human%2520Glutamate%2520Transporter%2520Subtypes%25201%252C%25202%252C%2520and%25203%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D172%26epage%3D178%26doi%3D10.1021%2Fjm0508336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kanai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hediger, M. A.</span><span> </span><span class="NLM_article-title">Primary Structure and Functional Characterization of a High-Affinity Glutamate Transporter</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1038/360467a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1038%2F360467a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1280334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADyaK3sXltV2itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=1992&pages=467-471&author=Y.+Kanaiauthor=M.+A.+Hediger&title=Primary+Structure+and+Functional+Characterization+of+a+High-Affinity+Glutamate+Transporter&doi=10.1038%2F360467a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Primary structure and functional characterization of a high-affinity glutamate transporter</span></div><div class="casAuthors">Kanai, Yoshikatsu; Hediger, Matthias A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">6403</span>),
    <span class="NLM_cas:pages">467-71</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Glutamate transport across plasma membranes of neurons, glial cells and epithelial cells of the small intestine and kidney proceeds by high- and low-affinity transport systems.  High-affinity (Km 2-50 μM) transport systems have been described that are dependent on Na+ but not Cl- ions and have a preference for L-glutamate and D- and L-aspartate.  In neurons high-affinity glutamate transporters are essential for terminating the postsynaptic action of glutamate by rapidly removing released glutamate from the synaptic cleft.  The authors have isolated a cDNA encoding an electrogenic Na+- but not Cl--dependent high-affinity glutamate transporter (named EAAC1) from rabbit small intestine by expression in Xenopus oocytes.  The authors find EAAC1 transcripts in specific neuronal structures in the central nervous system as well as in the small intestine, kidney, liver, and heart.  The function and pharmacol. of the expressed protein are characteristic of the high-affinity glutamate transporter already identified in neuronal tissues.  The abnormal glutamate transport that is assocd. with certain neurodegenerative diseases and which occurs during ischemia and anoxia could be due to abnormalities in the function of this protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBZsP6SEUAH7Vg90H21EOLACvtfcHk0liFtGDmWmZJdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltV2itbY%253D&md5=bf04c9f2aa0e6e1d50d43a0778b8a13e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F360467a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F360467a0%26sid%3Dliteratum%253Aachs%26aulast%3DKanai%26aufirst%3DY.%26aulast%3DHediger%26aufirst%3DM.%2BA.%26atitle%3DPrimary%2520Structure%2520and%2520Functional%2520Characterization%2520of%2520a%2520High-Affinity%2520Glutamate%2520Transporter%26jtitle%3DNature%26date%3D1992%26volume%3D360%26spage%3D467%26epage%3D471%26doi%3D10.1038%2F360467a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Leuenberger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hediger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochner, M.</span><span> </span><span class="NLM_article-title">Concise Asymmetric Synthesis and Pharmacological Characterization of All Stereoisomers of Glutamate Transporter Inhibitor TFB-TBOA and Synthesis of EAAT Photoaffinity Probes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">539</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00311</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00311" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1aqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=534-539&author=M.+Leuenbergerauthor=A.+Ritlerauthor=A.+Simoninauthor=M.+A.+Hedigerauthor=M.+Lochner&title=Concise+Asymmetric+Synthesis+and+Pharmacological+Characterization+of+All+Stereoisomers+of+Glutamate+Transporter+Inhibitor+TFB-TBOA+and+Synthesis+of+EAAT+Photoaffinity+Probes&doi=10.1021%2Facschemneuro.5b00311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Concise Asymmetric Synthesis and Pharmacological Characterization of All Stereoisomers of Glutamate Transporter Inhibitor TFB-TBOA and Synthesis of EAAT Photoaffinity Probes</span></div><div class="casAuthors">Leuenberger, Michele; Ritler, Andreas; Simonin, Alexandre; Hediger, Matthias A.; Lochner, Martin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">534-539</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutamate is the major excitatory neurotransmitter in the mammalian brain.  Its rapid clearance after the release into the synaptic cleft is vital in order to avoid toxic effects and is ensured by several transmembrane transport proteins, so-called excitatory amino acid transporters (EAATs).  Impairment of glutamate removal has been linked to several neurodegenerative diseases and EAATs have therefore received increased attention as therapeutic targets.  O-Benzylated L-threo-β-hydroxyaspartate derivs. have been developed previously as highly potent inhibitors of EAATs with TFB-TBOA ((2S,3S)-2-amino-3-((3-(4-(trifluoromethyl)benzamido)benzyl)oxy)succinic acid) standing out as low-nanomolar inhibitor.  We report the stereoselective synthesis of all four stereoisomers of TFB-TBOA in less than a fifth of synthetic steps than the published route.  For the first time, the inhibitory activity and isoform selectivity of these TFB-TBOA enantio- and diastereomers were assessed on human glutamate transporters EAAT1-3.  Furthermore, we synthesized potent photoaffinity probes based on TFB-TBOA using our novel synthetic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9MiV2FJQk37Vg90H21EOLACvtfcHk0liFtGDmWmZJdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1aqsL4%253D&md5=1fa263356d6adc8a79bcafc26b463b7e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00311%26sid%3Dliteratum%253Aachs%26aulast%3DLeuenberger%26aufirst%3DM.%26aulast%3DRitler%26aufirst%3DA.%26aulast%3DSimonin%26aufirst%3DA.%26aulast%3DHediger%26aufirst%3DM.%2BA.%26aulast%3DLochner%26aufirst%3DM.%26atitle%3DConcise%2520Asymmetric%2520Synthesis%2520and%2520Pharmacological%2520Characterization%2520of%2520All%2520Stereoisomers%2520of%2520Glutamate%2520Transporter%2520Inhibitor%2520TFB-TBOA%2520and%2520Synthesis%2520of%2520EAAT%2520Photoaffinity%2520Probes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D534%26epage%3D539%26doi%3D10.1021%2Facschemneuro.5b00311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Shimamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yumoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeri, Y.</span><span> </span><span class="NLM_article-title">Characterization of Novel L-Threo- -Benzyloxyaspartate Derivatives, Potent Blockers of the Glutamate Transporters</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span><span class="refDoi"> DOI: 10.1124/mol.65.4.1008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1124%2Fmol.65.4.1008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=1008-1015&author=K.+Shimamotoauthor=R.+Sakaiauthor=K.+Takaokaauthor=N.+Yumotoauthor=T.+Nakajimaauthor=S.+G.+Amaraauthor=Y.+Shigeri&title=Characterization+of+Novel+L-Threo-+-Benzyloxyaspartate+Derivatives%2C+Potent+Blockers+of+the+Glutamate+Transporters&doi=10.1124%2Fmol.65.4.1008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fmol.65.4.1008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.65.4.1008%26sid%3Dliteratum%253Aachs%26aulast%3DShimamoto%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DR.%26aulast%3DTakaoka%26aufirst%3DK.%26aulast%3DYumoto%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DAmara%26aufirst%3DS.%2BG.%26aulast%3DShigeri%26aufirst%3DY.%26atitle%3DCharacterization%2520of%2520Novel%2520L-Threo-%2520-Benzyloxyaspartate%2520Derivatives%252C%2520Potent%2520Blockers%2520of%2520the%2520Glutamate%2520Transporters%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D65%26spage%3D1008%26epage%3D1015%26doi%3D10.1124%2Fmol.65.4.1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Shimamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeri, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda-Kamatani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yumoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span> </span><span class="NLM_article-title">Syntheses of Optically Pure β-Hydroxyaspartate Derivatives as Glutamate Transporter Blockers</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2407</span><span class="NLM_x">–</span> <span class="NLM_lpage">2410</span><span class="refDoi"> DOI: 10.1016/S0960-894X(00)00487-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2FS0960-894X%2800%2900487-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=11078189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVSlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2407-2410&author=K.+Shimamotoauthor=Y.+Shigeriauthor=Y.+Yasuda-Kamataniauthor=B.+Lebrunauthor=N.+Yumotoauthor=T.+Nakajima&title=Syntheses+of+Optically+Pure+%CE%B2-Hydroxyaspartate+Derivatives+as+Glutamate+Transporter+Blockers&doi=10.1016%2FS0960-894X%2800%2900487-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses of optically pure β-hydroxyaspartate derivatives as glutamate transporter blockers</span></div><div class="casAuthors">Shimamoto, Keiko; Shigeri, Yasushi; Yasuda-Kamatani, Yoshimi; Lebrun, Bruno; Yumoto, Noboru; Nakajima, Terumi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2407-2410</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">DL-threo-β-Benzyloxyaspartate (DL-TBOA) is a non-transportable blocker of the glutamate transporters that serves as an indispensable tool for the investigation of the physiol. roles of the transporters.  To examine the precise interaction between a blocker and the transporters, we synthesized the optically pure isomers (L- and D-TBOA) and its erythro-isomers.  L-TBOA is the most potent blocker for the human excitatory amino acid transporters (EAAT1-3), while D-TBOA revealed a difference in the pharmacophores between EAAT1 and EAAT3.  We also synthesized the substituent variants (Me or naphthylmethyl derivs.) of L-TBOA.  The results obtained here suggest that bulky substituents are crucial for non-transportable blockers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDvbv44N8TjbVg90H21EOLACvtfcHk0lh5GdbSuPcULg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVSlsbc%253D&md5=0278099dbaff566e6e480645d6b7815e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900487-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900487-X%26sid%3Dliteratum%253Aachs%26aulast%3DShimamoto%26aufirst%3DK.%26aulast%3DShigeri%26aufirst%3DY.%26aulast%3DYasuda-Kamatani%26aufirst%3DY.%26aulast%3DLebrun%26aufirst%3DB.%26aulast%3DYumoto%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DT.%26atitle%3DSyntheses%2520of%2520Optically%2520Pure%2520%25CE%25B2-Hydroxyaspartate%2520Derivatives%2520as%2520Glutamate%2520Transporter%2520Blockers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2407%26epage%3D2410%26doi%3D10.1016%2FS0960-894X%2800%2900487-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Mavencamp, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhoderick, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esslinger, C. S.</span><span> </span><span class="NLM_article-title">Synthesis and Preliminary Pharmacological Evaluation of Novel Derivatives of L-β-Threo-Benzylaspartate as Inhibitors of the Neuronal Glutamate Transporter EAAT3</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">7740</span><span class="NLM_x">–</span> <span class="NLM_lpage">7748</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2Fj.bmc.2008.07.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=7740-7748&author=T.+L.+Mavencampauthor=J.+F.+Rhoderickauthor=R.+J.+Bridgesauthor=C.+S.+Esslinger&title=Synthesis+and+Preliminary+Pharmacological+Evaluation+of+Novel+Derivatives+of+L-%CE%B2-Threo-Benzylaspartate+as+Inhibitors+of+the+Neuronal+Glutamate+Transporter+EAAT3&doi=10.1016%2Fj.bmc.2008.07.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DMavencamp%26aufirst%3DT.%2BL.%26aulast%3DRhoderick%26aufirst%3DJ.%2BF.%26aulast%3DBridges%26aufirst%3DR.%2BJ.%26aulast%3DEsslinger%26aufirst%3DC.%2BS.%26atitle%3DSynthesis%2520and%2520Preliminary%2520Pharmacological%2520Evaluation%2520of%2520Novel%2520Derivatives%2520of%2520L-%25CE%25B2-Threo-Benzylaspartate%2520as%2520Inhibitors%2520of%2520the%2520Neuronal%2520Glutamate%2520Transporter%2520EAAT3%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D7740%26epage%3D7748%26doi%3D10.1016%2Fj.bmc.2008.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Meadows, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Wall, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokel, G. W.</span><span> </span><span class="NLM_article-title">Alkali Metal Cation - π Interactions Observed by Using a Lariat Ether Model System</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">3092</span><span class="NLM_x">–</span> <span class="NLM_lpage">3107</span><span class="refDoi"> DOI: 10.1021/ja003059e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja003059e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=3092-3107&author=E.+S.+Meadowsauthor=S.+L.+De+Wallauthor=L.+J.+Barbourauthor=G.+W.+Gokel&title=Alkali+Metal+Cation+-+%CF%80+Interactions+Observed+by+Using+a+Lariat+Ether+Model+System&doi=10.1021%2Fja003059e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja003059e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja003059e%26sid%3Dliteratum%253Aachs%26aulast%3DMeadows%26aufirst%3DE.%2BS.%26aulast%3DDe%2BWall%26aufirst%3DS.%2BL.%26aulast%3DBarbour%26aufirst%3DL.%2BJ.%26aulast%3DGokel%26aufirst%3DG.%2BW.%26atitle%3DAlkali%2520Metal%2520Cation%2520-%2520%25CF%2580%2520Interactions%2520Observed%2520by%2520Using%2520a%2520Lariat%2520Ether%2520Model%2520System%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D3092%26epage%3D3107%26doi%3D10.1021%2Fja003059e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, D. A.</span><span> </span><span class="NLM_article-title">From Ab Initio Quantum Mechanics to Molecular Neurobiology: A Cation-Pi Binding Site in the Nicotinic Receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">12088</span><span class="NLM_x">–</span> <span class="NLM_lpage">12093</span><span class="refDoi"> DOI: 10.1073/pnas.95.21.12088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1073%2Fpnas.95.21.12088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=9770444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADyaK1cXmsl2ktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12088-12093&author=W.+Zhongauthor=J.+P.+Gallivanauthor=Y.+Zhangauthor=L.+Liauthor=H.+A.+Lesterauthor=D.+A.+Dougherty&title=From+Ab+Initio+Quantum+Mechanics+to+Molecular+Neurobiology%3A+A+Cation-Pi+Binding+Site+in+the+Nicotinic+Receptor&doi=10.1073%2Fpnas.95.21.12088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">From ab initio quantum mechanics to molecular neurobiology: a cation-π binding site in the nicotinic receptor</span></div><div class="casAuthors">Zhong, Wenge; Gallivan, Justin P.; Zhang, Yinong; Li, Lintong; Lester, Henry A.; Dougherty, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12088-12093</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The nicotinic acetylcholine receptor is the prototype ligand-gated ion channel.  A no. of arom. amino acids have been identified as contributing to the agonist binding site, suggesting that cation-π interactions may be involved in binding the quaternary ammonium group of the agonist, acetylcholine.  Here we show a compelling correlation between: (i) ab initio quantum mech. predictions of cation-π binding abilities and (ii) EC50 values for acetylcholine at the receptor for a series of tryptophan derivs. that were incorporated into the receptor by using the in vivo nonsense-suppression method for unnatural amino acid incorporation.  Such a correlation is seen at one, and only one, of the arom. residues-tryptophan-149 of the α subunit.  This finding indicates that, on binding, the cationic, quaternary ammonium group of acetylcholine makes van der Waals contact with the indole side chain of α tryptophan-149, providing the most precise structural information to date on this receptor.  Consistent with this model, a tethered quaternary ammonium group emanating from position α149 produces a constitutively active receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonDdfCh77JjbVg90H21EOLACvtfcHk0lh5GdbSuPcULg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsl2ktL8%253D&md5=b120a73093e2243336924cd7d17867df</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.21.12088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.21.12088%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DGallivan%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLester%26aufirst%3DH.%2BA.%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DFrom%2520Ab%2520Initio%2520Quantum%2520Mechanics%2520to%2520Molecular%2520Neurobiology%253A%2520A%2520Cation-Pi%2520Binding%2520Site%2520in%2520the%2520Nicotinic%2520Receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D12088%26epage%3D12093%26doi%3D10.1073%2Fpnas.95.21.12088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">True, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gard, G. L.</span><span> </span><span class="NLM_article-title">Electronegativities from Core-Ionization Energies: Electronegativities of SF5 and CF3</span> <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">4437</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span><span class="refDoi"> DOI: 10.1021/ic0343298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic0343298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVChsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=4437-4441&author=J.+E.+Trueauthor=T.+D.+Thomasauthor=R.+W.+Winterauthor=G.+L.+Gard&title=Electronegativities+from+Core-Ionization+Energies%3A+Electronegativities+of+SF5+and+CF3&doi=10.1021%2Fic0343298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Electronegativities from Core-Ionization Energies: Electronegativities of SF5 and CF3</span></div><div class="casAuthors">True, Jan E.; Thomas, T. Darrah; Winter, Rolf W.; Gard, Gary L.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4437-4441</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Core-ionization energies have been measured for SF6 (S 2p), SF5SF5 (S 2p), SF5Br (S 2p and Br 3d), and SF5CF3 (S 2p and C 1s).  These results, together with others that establish correlations between core-ionization energies and Pauling electronegativities, make it possible to assign group electronegativities to SF5 and CF3.  This method gives electronegativities for these groups comparable to that of bromine, whereas anal. of the effect of these groups on acidity indicates electronegativities comparable to that of fluorine.  Other methods of estg. electronegativity fall between these extremes.  These disparities can be understood in part as reflecting the effects of polarizability of the substituent, which tends to lower both the core-ionization energy and the deprotonation energy, making the electronegativity appear to be less in one case and more in the other.  In addn., and possibly more important, the core-ionization energies presented here reflect the effect of the group on an adjacent atom, whereas the acidity reflects the effect on a remote atom.  It appears that fluorine has a large effect on an adjacent atom but a relatively small effect on a remote atom.  By contrast SF5 and CF3 have a relatively small effect on an adjacent atom, but this effect falls off only slowly with distance from the substituent. Thus, the effective electronegativities of CF3 and SF5 relative to those of the halogens depend on the site at which the mol. is probed as well as on the process that is under consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLSd9igLbkerVg90H21EOLACvtfcHk0ljA2IxqMElVGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVChsrY%253D&md5=db5801cf330faffd54ca770aeb236ea5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fic0343298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic0343298%26sid%3Dliteratum%253Aachs%26aulast%3DTrue%26aufirst%3DJ.%2BE.%26aulast%3DThomas%26aufirst%3DT.%2BD.%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DGard%26aufirst%3DG.%2BL.%26atitle%3DElectronegativities%2520from%2520Core-Ionization%2520Energies%253A%2520Electronegativities%2520of%2520SF5%2520and%2520CF3%26jtitle%3DInorg.%2520Chem.%26date%3D2003%26volume%3D42%26spage%3D4437%26epage%3D4441%26doi%3D10.1021%2Fic0343298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Assaf, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venskutonytė, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajhede, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gefflaut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Chemoenzymatic Synthesis of New 2,4-Syn-Functionalized (S)-Glutamate Analogues and Structure-Activity Relationship Studies at Ionotropic Glutamate Receptors and Excitatory Amino Acid Transporters</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1628</span><span class="refDoi"> DOI: 10.1021/jm301433m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301433m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Sktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1614-1628&author=Z.+Assafauthor=A.+P.+Larsenauthor=R.+Venskutonyt%C4%97author=L.+Hanauthor=B.+Abrahamsenauthor=B.+Nielsenauthor=M.+Gajhedeauthor=J.+S.+Kastrupauthor=A.+a+Jensenauthor=D.+S.+Pickeringauthor=K.+Frydenvangauthor=T.+Gefflautauthor=L.+Bunch&title=Chemoenzymatic+Synthesis+of+New+2%2C4-Syn-Functionalized+%28S%29-Glutamate+Analogues+and+Structure-Activity+Relationship+Studies+at+Ionotropic+Glutamate+Receptors+and+Excitatory+Amino+Acid+Transporters&doi=10.1021%2Fjm301433m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoenzymatic synthesis of new 2,4-syn-functionalized (S)-glutamate analogues and structure-activity relationship studies at ionotropic glutamate receptors and excitatory amino acid transporters</span></div><div class="casAuthors">Assaf, Zeinab; Larsen, Anja P.; Venskutonyte, Raminta; Han, Liwei; Abrahamsen, Bjarke; Nielsen, Birgitte; Gajhede, Michael; Kastrup, Jette S.; Jensen, Anders A.; Pickering, Darryl S.; Frydenvang, Karla; Gefflaut, Thierry; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1614-1628</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the mammalian central nervous system, (S)-glutamate (Glu) is released from the presynaptic neuron where it activates a plethora of pre- and postsynaptic Glu receptors.  The fast acting ionotropic Glu receptors (iGluRs) are ligand gated ion channels and are believed to be involved in a vast no. of neurol. functions such as memory and learning, synaptic plasticity, and motor function.  The synthesis of 14 enantiopure 2,4-syn-Glu analogs, e.g. (I), (II), (III), is accessed by a short and efficient chemoenzymic approach starting from readily available cyclohexanone (IV).  Pharmacol. characterization at the iGluRs and EAAT1-3 subtypes revealed analog II as a selective GluK1 ligand with low nanomolar affinity.  Two X-ray crystal structures of the key analog II in the ligand-binding domain (LBD) of GluA2 and GluK3 were detd.  Partial domain closure was seen in the GluA2-LBD complex with II comparable to that induced by kainate.  In contrast, full domain closure was obsd. in the GluK3-LBD complex with II, similar to that of GluK3-LBD with glutamate bound.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNDU3_wI6ErbVg90H21EOLACvtfcHk0ljA2IxqMElVGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Sktbs%253D&md5=820d359e25bfc4d9505c20bc303cd67d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm301433m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301433m%26sid%3Dliteratum%253Aachs%26aulast%3DAssaf%26aufirst%3DZ.%26aulast%3DLarsen%26aufirst%3DA.%2BP.%26aulast%3DVenskutonyt%25C4%2597%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DGajhede%26aufirst%3DM.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26aulast%3DJensen%26aufirst%3DA.%2Ba%26aulast%3DPickering%26aufirst%3DD.%2BS.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DGefflaut%26aufirst%3DT.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DChemoenzymatic%2520Synthesis%2520of%2520New%25202%252C4-Syn-Functionalized%2520%2528S%2529-Glutamate%2520Analogues%2520and%2520Structure-Activity%2520Relationship%2520Studies%2520at%2520Ionotropic%2520Glutamate%2520Receptors%2520and%2520Excitatory%2520Amino%2520Acid%2520Transporters%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1614%26epage%3D1628%26doi%3D10.1021%2Fjm301433m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Boudker, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yernool, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Coupling Substrate and Ion Binding to Extracellular Gate of a Sodium-Dependent Aspartate Transporter</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">445</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1038/nature05455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1038%2Fnature05455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=17230192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD2sXos12ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=445&publication_year=2007&pages=387-393&author=O.+Boudkerauthor=R.+M.+Ryanauthor=D.+Yernoolauthor=K.+Shimamotoauthor=E.+Gouaux&title=Coupling+Substrate+and+Ion+Binding+to+Extracellular+Gate+of+a+Sodium-Dependent+Aspartate+Transporter&doi=10.1038%2Fnature05455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter</span></div><div class="casAuthors">Boudker, Olga; Ryan, Renae M.; Yernool, Dinesh; Shimamoto, Keiko; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">445</span>
        (<span class="NLM_cas:issue">7126</span>),
    <span class="NLM_cas:pages">387-393</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Secondary transporters are integral membrane proteins that catalyze the movement of substrate mols. across the lipid bilayer by coupling substrate transport to one or more ion gradients, thereby providing a mechanism for the concentrative uptake of substrates.  Here we describe crystallog. and thermodn. studies of GltPh, a sodium (Na+)-coupled aspartate transporter, defining sites for aspartate, two sodium ions and D,L-threo-β-benzyloxyaspartate, an inhibitor.  We further show that helical hairpin 2 is the extracellular gate that controls access of substrate and ions to the internal binding sites.  At least two sodium ions bind in close proximity to the substrate and these sodium-binding sites, together with the sodium-binding sites in another sodium-coupled transporter, LeuT, define an unwound α-helix as the central element of the ion-binding motif, a motif well suited to the binding of sodium and to participation in conformational changes that accompany ion binding and unbinding during the transport cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2WzQl5jvETrVg90H21EOLACvtfcHk0ljA2IxqMElVGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXos12ntQ%253D%253D&md5=f6ad5a2c7b561a8f38bd907db63640d2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature05455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05455%26sid%3Dliteratum%253Aachs%26aulast%3DBoudker%26aufirst%3DO.%26aulast%3DRyan%26aufirst%3DR.%2BM.%26aulast%3DYernool%26aufirst%3DD.%26aulast%3DShimamoto%26aufirst%3DK.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DCoupling%2520Substrate%2520and%2520Ion%2520Binding%2520to%2520Extracellular%2520Gate%2520of%2520a%2520Sodium-Dependent%2520Aspartate%2520Transporter%26jtitle%3DNature%26date%3D2007%26volume%3D445%26spage%3D387%26epage%3D393%26doi%3D10.1038%2Fnature05455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Na Liu, Anders A. Jensen, <span class="NLM_string-name hlFld-ContribAuthor">Lennart Bunch</span>. </span><span class="cited-content_cbyCitation_article-title">β-Indolyloxy Functionalized Aspartate Analogs as Inhibitors of the Excitatory Amino Acid Transporters (EAATs). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (11)
                                     , 2212-2220. <a href="https://doi.org/10.1021/acsmedchemlett.0c00342" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00342%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D%2525CE%2525B2-Indolyloxy%252BFunctionalized%252BAspartate%252BAnalogs%252Bas%252BInhibitors%252Bof%252Bthe%252BExcitatory%252BAmino%252BAcid%252BTransporters%252B%252528EAATs%252529%26aulast%3DLiu%26aufirst%3DNa%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22062020%26date%3D26082020%26date%3D01092020%26volume%3D11%26issue%3D11%26spage%3D2212%26epage%3D2220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peng Wu, Walden E. Bjørn-Yoshimoto, Markus Staudt, Anders A. Jensen, <span class="NLM_string-name hlFld-ContribAuthor">Lennart Bunch</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Structure–Activity Relationship Study of Imidazo[1,2-a]pyridine-3-amines as First Selective Inhibitors of Excitatory Amino Acid Transporter Subtype 3 (EAAT3). </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (10)
                                     , 4414-4429. <a href="https://doi.org/10.1021/acschemneuro.9b00447" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00447</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00447%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIdentification%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudy%252Bof%252BImidazo%25255B1%25252C2-a%25255Dpyridine-3-amines%252Bas%252BFirst%252BSelective%252BInhibitors%252Bof%252BExcitatory%252BAmino%252BAcid%252BTransporter%252BSubtype%252B3%252B%252528EAAT3%252529%26aulast%3DWu%26aufirst%3DPeng%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13082019%26date%3D17092019%26date%3D01102019%26volume%3D10%26issue%3D10%26spage%3D4414%26epage%3D4429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Haigen Fu, Jielin Zhang, Pieter G. Tepper, Lennart Bunch, Anders A. Jensen, <span class="NLM_string-name hlFld-ContribAuthor">Gerrit J. Poelarends</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoenzymatic Synthesis and Pharmacological Characterization of Functionalized Aspartate Analogues As Novel Excitatory Amino Acid Transporter Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 7741-7753. <a href="https://doi.org/10.1021/acs.jmedchem.8b00700" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00700</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00700%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemoenzymatic%252BSynthesis%252Band%252BPharmacological%252BCharacterization%252Bof%252BFunctionalized%252BAspartate%252BAnalogues%252BAs%252BNovel%252BExcitatory%252BAmino%252BAcid%252BTransporter%252BInhibitors%26aulast%3DFu%26aufirst%3DHaigen%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D02052018%26date%3D15082018%26date%3D16072018%26volume%3D61%26issue%3D17%26spage%3D7741%26epage%3D7753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stinne W.  Hansen</span>, <span class="hlFld-ContribAuthor ">Mette N.  Erichsen</span>, <span class="hlFld-ContribAuthor ">Bingru  Fu</span>, <span class="hlFld-ContribAuthor ">Walden E.  Bjørn-Yoshimoto</span>, <span class="hlFld-ContribAuthor ">Bjarke  Abrahamsen</span>, <span class="hlFld-ContribAuthor ">Jacob C.  Hansen</span>, <span class="hlFld-ContribAuthor ">Anders A.  Jensen</span>, and <span class="hlFld-ContribAuthor ">Lennart  Bunch</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a New Class of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors Followed by a Structure–Activity Relationship Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8757-8770. <a href="https://doi.org/10.1021/acs.jmedchem.6b01058" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01058%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252BNew%252BClass%252Bof%252BSelective%252BExcitatory%252BAmino%252BAcid%252BTransporter%252BSubtype%252B1%252B%252528EAAT1%252529%252BInhibitors%252BFollowed%252Bby%252Ba%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudy%26aulast%3DHansen%26aufirst%3DStinne%2BW.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D18072016%26date%3D14092016%26date%3D13102016%26volume%3D59%26issue%3D19%26spage%3D8757%26epage%3D8770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingjiao  Liu</span>, <span class="hlFld-ContribAuthor ">Shifeng  Chu</span>, <span class="hlFld-ContribAuthor ">Yaomei  Hu</span>, <span class="hlFld-ContribAuthor ">Songwei  Yang</span>, <span class="hlFld-ContribAuthor ">Xun  Li</span>, <span class="hlFld-ContribAuthor ">Qinglian  Zheng</span>, <span class="hlFld-ContribAuthor ">Qidi  Ai</span>, <span class="hlFld-ContribAuthor ">Siyu  Ren</span>, <span class="hlFld-ContribAuthor ">Huiqin  Wang</span>, <span class="hlFld-ContribAuthor ">Limin  Gong</span>, <span class="hlFld-ContribAuthor ">Xin  Xu</span>, <span class="hlFld-ContribAuthor ">Nai-Hong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Exogenous Adenosine Antagonizes Excitatory Amino Acid Toxicity in Primary Astrocytes. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Neurobiology</span><span> <strong>2021,</strong> <em>41 </em>
                                    (4)
                                     , 687-704. <a href="https://doi.org/10.1007/s10571-020-00876-5" title="DOI URL">https://doi.org/10.1007/s10571-020-00876-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10571-020-00876-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10571-020-00876-5%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Neurobiology%26atitle%3DExogenous%252BAdenosine%252BAntagonizes%252BExcitatory%252BAmino%252BAcid%252BToxicity%252Bin%252BPrimary%252BAstrocytes%26aulast%3DLiu%26aufirst%3DYingjiao%26date%3D2021%26date%3D2020%26volume%3D41%26issue%3D4%26spage%3D687%26epage%3D704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elias  Ndaru</span>, <span class="hlFld-ContribAuthor ">Rachel-Ann A.  Garibsingh</span>, <span class="hlFld-ContribAuthor ">YueYue  Shi</span>, <span class="hlFld-ContribAuthor ">Evan  Wallace</span>, <span class="hlFld-ContribAuthor ">Paul  Zakrepine</span>, <span class="hlFld-ContribAuthor ">Jiali  Wang</span>, <span class="hlFld-ContribAuthor ">Avner  Schlessinger</span>, <span class="hlFld-ContribAuthor ">Christof  Grewer</span>. </span><span class="cited-content_cbyCitation_article-title">Novel alanine serine cysteine transporter 2 (ASCT2) inhibitors based on sulfonamide and sulfonic acid ester scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Journal of General Physiology</span><span> <strong>2019,</strong> <em>151 </em>
                                    (3)
                                     , 357-368. <a href="https://doi.org/10.1085/jgp.201812276" title="DOI URL">https://doi.org/10.1085/jgp.201812276</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1085/jgp.201812276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1085%2Fjgp.201812276%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520General%2520Physiology%26atitle%3DNovel%252Balanine%252Bserine%252Bcysteine%252Btransporter%252B2%252B%252528ASCT2%252529%252Binhibitors%252Bbased%252Bon%252Bsulfonamide%252Band%252Bsulfonic%252Bacid%252Bester%252Bscaffolds%26aulast%3DNdaru%26aufirst%3DElias%26date%3D2019%26date%3D2019%26volume%3D151%26issue%3D3%26spage%3D357%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haigen  Fu</span>, <span class="hlFld-ContribAuthor ">Sabry H. H.  Younes</span>, <span class="hlFld-ContribAuthor ">Mohammad  Saifuddin</span>, <span class="hlFld-ContribAuthor ">Pieter G.  Tepper</span>, <span class="hlFld-ContribAuthor ">Jielin  Zhang</span>, <span class="hlFld-ContribAuthor ">Erik  Keller</span>, <span class="hlFld-ContribAuthor ">André  Heeres</span>, <span class="hlFld-ContribAuthor ">Wiktor  Szymanski</span>, <span class="hlFld-ContribAuthor ">Gerrit J.  Poelarends</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid chemoenzymatic route to glutamate transporter inhibitor
              l
              -TFB-TBOA and related amino acids. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (11)
                                     , 2341-2344. <a href="https://doi.org/10.1039/C7OB00305F" title="DOI URL">https://doi.org/10.1039/C7OB00305F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB00305F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB00305F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRapid%252Bchemoenzymatic%252Broute%252Bto%252Bglutamate%252Btransporter%252Binhibitor%252Bl%252B-TFB-TBOA%252Band%252Brelated%252Bamino%252Bacids%26aulast%3DFu%26aufirst%3DHaigen%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D11%26spage%3D2341%26epage%3D2344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of: (A) Endogenous EAAT substrates Glu and Asp. (B) Competitive EAAT inhibitors TBOA,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a><b>18</b>,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><b>14</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> DHK,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> and <b>13</b>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (C) Noncompetitive EAAT1 inhibitors <b>15</b>,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a><b>16</b>,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and <b>17</b>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of rationally designed β-functionalized Asp analogues <b>1</b>, <b>2</b>, <b>3</b>-<b>A</b>/<b>B</b>, and <b>4a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of β-Functionalized Asp Analogues <b>1</b>, <b>2</b>, <b>3</b>-<b>A</b>/<b>B</b>, and <b>4a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeOH, H<sub>2</sub>SO<sub>4</sub>, reflux, quant; (b) TrCl, TEA, DCM, 75% (2 steps); (c) <b>6</b>, LHMDS, THF, 30 min, −30 °C, then NBS 100 min, −30 to −5 °C; (d) NaN<sub>3</sub>, DMF, 56% (2 steps); (e) PPh<sub>3</sub>, THF, 79%; (f) phenylacetylene, sodium ascorbate, CuSO<sub>4</sub>·5H<sub>2</sub>O, H<sub>2</sub>O/<i>t</i>-BuOH; (g) PhCOCl, TEA, DCM; (h) PhOCOCl, TEA, DCM; (i) PhSO<sub>2</sub>Cl, TEA, DCM; (j) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF; (k) 6 M HCl, reflux, 1 h, preparative HPLC.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Concentration–inhibition curves for TBOA and β-sulfonamide Asp analogues <b>4a</b>-<b>B</b>, <b>4d</b>-<b>B</b>, <b>4r</b>, and <b>4ac</b> at stable EAAT1-, EAAT2-, and EAAT3-HEK293 cell lines in the [<sup>3</sup>H]-<span class="smallcaps smallerCapital">d</span>-Asp uptake assay. Data are given as mean ± SEM (<i>n</i> = 3–5).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Assignment of Absolute Configurations of the Diastereomers Phenylsulfonamides <b>4a</b>-<b>A</b> and <b>4a</b>-<b>B</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) PhSO<sub>2</sub>Cl, NaOH, DIPEA, acetone</p></p></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/medium/jm-2016-01066g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Superimposition of binding mode of TBOA (black) when crystallized in Glt<sub>Ph</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2nww">2nww</a>) with the two most favorable binding modes of <b>4a</b>-<b>B</b> (magenta and green) obtained by docking into a homology model of EAAT1 built from the Glt<sub>Ph</sub>/TBOA crystal structure.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> (B) Binding of magenta <b>4a</b>-<b>B</b> in EAAT1. (C) Binding of green <b>4a-B</b> in EAAT1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-19/acs.jmedchem.6b01066/20161007/images/large/jm-2016-01066g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01066&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88401" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88401" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Moghaddam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitt, D.</span><span> </span><span class="NLM_article-title">From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and Its Implication for Treatment</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1038/npp.2011.181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1038%2Fnpp.2011.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=21956446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=4-15&author=B.+Moghaddamauthor=D.+Javitt&title=From+Revolution+to+Evolution%3A+The+Glutamate+Hypothesis+of+Schizophrenia+and+Its+Implication+for+Treatment&doi=10.1038%2Fnpp.2011.181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment</span></div><div class="casAuthors">Moghaddam, Bita; Javitt, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glutamate is the primary excitatory neurotransmitter in mammalian brain.  Disturbances in glutamate-mediated neurotransmission have been increasingly documented in a range of neuropsychiatric disorders including schizophrenia, substance abuse, mood disorders, Alzheimer's disease, and autism-spectrum disorders.  Glutamatergic theories of schizophrenia are based on the ability of N-methyl--aspartate receptor (NMDAR) antagonists to induce schizophrenia-like symptoms, as well as emergent literature documenting disturbances of NMDAR-related gene expression and metabolic pathways in schizophrenia.  Research over the past two decades has highlighted promising new targets for drug development based on potential pre- and postsynaptic, and glial mechanisms leading to NMDAR dysfunction.  Reduced NMDAR activity on inhibitory neurons leads to disinhibition of glutamate neurons increasing synaptic activity of glutamate, esp. in the prefrontal cortex.  Based on this mechanism, normalizing excess glutamate levels by metabotropic glutamate group 2/3 receptor agonists has led to potential identification of the first non-monoaminergic target with comparable efficacy as conventional antipsychotic drugs for treating pos. and neg. symptoms of schizophrenia.  In addn., NMDAR has intrinsic modulatory sites that are active targets for drug development, several of which show promise in preclin./early clin. trials targeting both symptoms and cognition.  To date, most studies have been done with orthosteric agonists and/or antagonists at specific sites.  However, allosteric modulators, both pos. and neg., may offer superior efficacy with less danger of downregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeNMlez-A7MbVg90H21EOLACvtfcHk0ljxE-GMgLMb1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N&md5=0bf82fc0e3cb5c3ad2bed91414672e6f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.181%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DB.%26aulast%3DJavitt%26aufirst%3DD.%26atitle%3DFrom%2520Revolution%2520to%2520Evolution%253A%2520The%2520Glutamate%2520Hypothesis%2520of%2520Schizophrenia%2520and%2520Its%2520Implication%2520for%2520Treatment%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D4%26epage%3D15%26doi%3D10.1038%2Fnpp.2011.181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Machado-Vieira, R.; Henter, I. D.; Zarate, C. A.,  Jr.</span><span> </span><span class="NLM_article-title">New Targets for Rapid Antidepressant Action</span>.  <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2015.12.001</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2Fj.pneurobio.2015.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=26724279" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=R.+Machado-Vieira&author=I.+D.+Henter&author=C.+A.+Zarate&title=New+Targets+for+Rapid+Antidepressant+Action&doi=10.1016%2Fj.pneurobio.2015.12.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2015.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DMachado-Vieira%26aufirst%3DR.%26atitle%3DNew%2520Targets%2520for%2520Rapid%2520Antidepressant%2520Action%26jtitle%3DProg.%2520Neurobiol.%26date%3D2015%26doi%3D10.1016%2Fj.pneurobio.2015.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurado-Coronel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ávila, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabogal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreto, G. E.</span><span> </span><span class="NLM_article-title">NMDARs in Neurological Diseases: A Potential Therapeutic Target</span> <span class="citation_source-journal">Int. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.3109/00207454.2014.940941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.3109%2F00207454.2014.940941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=25051426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVaju7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=315-327&author=J.+Gonzalezauthor=J.+C.+Jurado-Coronelauthor=M.+F.+%C3%81vilaauthor=A.+Sabogalauthor=F.+Capaniauthor=G.+E.+Barreto&title=NMDARs+in+Neurological+Diseases%3A+A+Potential+Therapeutic+Target&doi=10.3109%2F00207454.2014.940941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">NMDARs in neurological diseases: a potential therapeutic target</span></div><div class="casAuthors">Gonzalez, Janneth; Jurado-Coronel, Juan Camilo; Avila, Marcos Fidel; Sabogal, Angelica; Capani, Francisco; Barreto, George E.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">315-327</span>CODEN:
                <span class="NLM_cas:coden">IJNUB7</span>;
        ISSN:<span class="NLM_cas:issn">0020-7454</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate ionotropic glutamate receptor (NMDARs) is a ligand-gated ion channel that plays a crit. role in excitatory neurotransmission, brain development, synaptic plasticity assocd. with memory formation, central sensitization during persistent pain, excitotoxicity and neurodegenerative diseases in the central nervous system (CNS).  Within iGluRs, NMDA receptors have been the most actively investigated for their role in neurol. diseases, esp. neurodegenerative pathologies such as Alzheimer's and Parkinson's diseases.  It has been demonstrated that excessive activation of NMDA receptors (NMDARs) plays a key role in mediating some aspects of synaptic dysfunction in several CNS disorders, so extensive research has been directed on the discovery of compds. that are able to reduce NMDARs activity.  This review discusses the role of NMDARs on neurol. pathologies and the possible therapeutic use of agents that target this receptor.  Addnl., we delve into the role of NMDARs in Alzheimer's and Parkinson's diseases and the receptor antagonists that have been tested on in vivo models of these pathologies.  Finally, we put into consideration the importance of antioxidants to counteract oxidative capacity of the signaling cascade in which NMDARs are involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpab8NK1TOnqrVg90H21EOLACvtfcHk0liEujpQ57Q5xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVaju7fJ&md5=50f77e6ec1187bba03ed53eb61e721a4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3109%2F00207454.2014.940941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00207454.2014.940941%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DJurado-Coronel%26aufirst%3DJ.%2BC.%26aulast%3D%25C3%2581vila%26aufirst%3DM.%2BF.%26aulast%3DSabogal%26aufirst%3DA.%26aulast%3DCapani%26aufirst%3DF.%26aulast%3DBarreto%26aufirst%3DG.%2BE.%26atitle%3DNMDARs%2520in%2520Neurological%2520Diseases%253A%2520A%2520Potential%2520Therapeutic%2520Target%26jtitle%3DInt.%2520J.%2520Neurosci.%26date%3D2015%26volume%3D125%26spage%3D315%26epage%3D327%26doi%3D10.3109%2F00207454.2014.940941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Finlay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duty, S.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Targeting Glutamate Receptors in Parkinson’s Disease</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span><span class="NLM_x">–</span> <span class="NLM_lpage">880</span><span class="refDoi"> DOI: 10.1007/s00702-014-1176-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1007%2Fs00702-014-1176-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2014&pages=861-880&author=C.+Finlayauthor=S.+Duty&title=Therapeutic+Potential+of+Targeting+Glutamate+Receptors+in+Parkinson%E2%80%99s+Disease&doi=10.1007%2Fs00702-014-1176-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00702-014-1176-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-014-1176-4%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DC.%26aulast%3DDuty%26aufirst%3DS.%26atitle%3DTherapeutic%2520Potential%2520of%2520Targeting%2520Glutamate%2520Receptors%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2014%26volume%3D121%26spage%3D861%26epage%3D880%26doi%3D10.1007%2Fs00702-014-1176-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Danbolt, N. C.</span><span> </span><span class="NLM_article-title">Glutamate Uptake</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/S0301-0082(00)00067-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2FS0301-0082%2800%2900067-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=11369436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsFWns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2001&pages=1-105&author=N.+C.+Danbolt&title=Glutamate+Uptake&doi=10.1016%2FS0301-0082%2800%2900067-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate uptake</span></div><div class="casAuthors">Danbolt, N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-105</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with >1200 refs.  Brain tissue has a remarkable ability to accumulate glutamate.  This ability is due to glutamate transporter proteins present in the plasma membranes of both glial cells and neurons.  The transporter proteins represent the only (significant) mechanism for removal of glutamate from the extracellular fluid and their importance for the long-term maintenance of low and non-toxic concns. of glutamate is now well documented.  In addn. to this simple, but essential glutamate removal role, the glutamate transporters appear to have more sophisticated functions in the modulation of neurotransmission.  They may modify the time course of synaptic events, the extent and pattern of activation and desensitization of receptors outside the synaptic cleft and at neighboring synapses (intersynaptic cross-talk).  Further, the glutamate transporters provide glutamate for synthesis of e.g.  GABA, glutathione, and protein, and for energy prodn.  They also play roles in peripheral organs and tissues (e.g. bone, heart, intestine, kidneys, pancreas, and placenta).  Glutamate uptake appears to be modulated on virtually all possible levels, i.e. DNA transcription, mRNA splicing and degrdn., protein synthesis and targeting, and actual amino acid transport activity and assocd. ion channel activities.  A variety of sol. compds. (e.g. glutamate, cytokines, and growth factors) influence glutamate transporter expression and activities.  Neither the normal functioning of glutamatergic synapses nor the pathogenesis of major neurol. diseases (e.g. cerebral ischemia, hypoglycemia, amyotrophic lateral sclerosis, Alzheimer's disease, traumatic brain injury, epilepsy, and schizophrenia) as well as non-neurol. diseases (e.g. osteoporosis) can be properly understood unless more is learned about these transporter proteins.  Like glutamate itself, glutamate transporters are somehow involved in almost all aspects of normal and abnormal brain activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrbDph2PBuBbVg90H21EOLACvtfcHk0liEujpQ57Q5xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsFWns74%253D&md5=a7118c1df858a0994af6207f852f82b6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2800%2900067-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252800%252900067-8%26sid%3Dliteratum%253Aachs%26aulast%3DDanbolt%26aufirst%3DN.%2BC.%26atitle%3DGlutamate%2520Uptake%26jtitle%3DProg.%2520Neurobiol.%26date%3D2001%26volume%3D65%26spage%3D1%26epage%3D105%26doi%3D10.1016%2FS0301-0082%2800%2900067-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span> </span><span class="NLM_article-title">Excitatory Amino Acid Transporters as Potential Drug Targets</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span><span class="refDoi"> DOI: 10.1517/14728220902926127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1517%2F14728220902926127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=19456273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFCitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=719-731&author=L.+Bunchauthor=M.+N.+Erichsenauthor=A.+A.+Jensen&title=Excitatory+Amino+Acid+Transporters+as+Potential+Drug+Targets&doi=10.1517%2F14728220902926127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acid transporters as potential drug targets</span></div><div class="casAuthors">Bunch, Lennart; Erichsen, Mette N.; Jensen, Anders A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-731</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Excitatory amino acid transporters (EAATs) are transmembrane proteins responsible for the uptake of (S)-glutamate (Glu) from the synaptic cleft, thereby terminating the glutamatergic neurotransmitter signal.  Today five subtypes have been identified.  Except for EAAT2, their individual roles or functions in the CNS are yet to be fully understood due to the shortage of subtype-selective ligands.  Objective/methods: We examine the latest developments in this field by addressing EAAT expression pattern, localization and pharmacol.  We present highlights of published work on inhibitors as well as enhancers which display subtype preference or selectivity and discuss which pathol. conditions in the CNS such ligands may be beneficial to.  Results/conclusions: Not until subtype-selective enhancers, inhibitors and substrates for all five EAAT subtypes have been discovered can a full and detailed understanding of EAATs be obtained.  Thus we encourage collaboration between org. chemists and mol. pharmacologists, who, together, may pave the way for new EAAT ligands of importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlwp3CUxYad7Vg90H21EOLACvtfcHk0lh8X22_TEm7Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFCitrw%253D&md5=a7af1f649527b26e6e8052caf6598446</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F14728220902926127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220902926127%26sid%3Dliteratum%253Aachs%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26atitle%3DExcitatory%2520Amino%2520Acid%2520Transporters%2520as%2520Potential%2520Drug%2520Targets%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D719%26epage%3D731%26doi%3D10.1517%2F14728220902926127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S. G.</span><span> </span><span class="NLM_article-title">New Views of Glutamate Transporter Structure and Function: Advances and Challenges</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2Fj.neuropharm.2010.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=20708631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=172-181&author=J.+Jiangauthor=S.+G.+Amara&title=New+Views+of+Glutamate+Transporter+Structure+and+Function%3A+Advances+and+Challenges&doi=10.1016%2Fj.neuropharm.2010.07.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">New views of glutamate transporter structure and function: Advances and challenges</span></div><div class="casAuthors">Jiang, Jie; Amara, Susan G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-181</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neuronal and glial glutamate transporters limit the action of excitatory amino acids after their release during synaptic transmission.  Recent structural and functional investigations have revealed much about the transport and conducting mechanisms of members of the sodium-coupled symporter family responsible for glutamate clearance in the nervous system.  In this review we summarize emerging views on the general structure, binding sites for substrates and coupled ions, and transport mechanisms of mammalian glutamate transporters, integrating results from a large body of work on carrier structure-function relationships with several crystal structures obtained for the archaeal ortholog, GltPh.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAUxmtx--OBLVg90H21EOLACvtfcHk0lh8X22_TEm7Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FF&md5=4df5a1e8ea9f5be507e3a403aadb2f67</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DAmara%26aufirst%3DS.%2BG.%26atitle%3DNew%2520Views%2520of%2520Glutamate%2520Transporter%2520Structure%2520and%2520Function%253A%2520Advances%2520and%2520Challenges%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D60%26spage%3D172%26epage%3D181%26doi%3D10.1016%2Fj.neuropharm.2010.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Vandenberg, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, R. M.</span><span> </span><span class="NLM_article-title">Mechanisms of Glutamate Transport</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1621</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span><span class="refDoi"> DOI: 10.1152/physrev.00007.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1152%2Fphysrev.00007.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=24137018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2013&pages=1621-1657&author=R.+J.+Vandenbergauthor=R.+M.+Ryan&title=Mechanisms+of+Glutamate+Transport&doi=10.1152%2Fphysrev.00007.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of glutamate transport</span></div><div class="casAuthors">Vandenberg, Robert J.; Ryan, Renae M.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1621-1657</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  L-Glutamate is the predominant excitatory neurotransmitter in the mammalian central nervous system and plays important roles in a wide variety of brain functions, but it is also a key player in the pathogenesis of many neurol. disorders.  The control of glutamate concns. is crit. to the normal functioning of the central nervous system, and in this review we discuss how glutamate transporters regulate glutamate concns. to maintain dynamic signaling mechanisms between neurons.  In 2004, the crystal structure of a prokaryotic homolog of the mammalian glutamate transporter family of proteins was crystd. and its structure detd.  This has paved the way for a better understanding of the structural basis for glutamate transporter function.  In this review we provide a broad perspective of this field of research, but focus primarily on the more recent studies with a particular emphasis on how our understanding of the structure of glutamate transporters has generated new insights.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzAmcjroPMPLVg90H21EOLACvtfcHk0lh8X22_TEm7Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShtrrP&md5=b573b96bbaf6f03c835c471cf2aaf7b8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00007.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00007.2013%26sid%3Dliteratum%253Aachs%26aulast%3DVandenberg%26aufirst%3DR.%2BJ.%26aulast%3DRyan%26aufirst%3DR.%2BM.%26atitle%3DMechanisms%2520of%2520Glutamate%2520Transport%26jtitle%3DPhysiol.%2520Rev.%26date%3D2013%26volume%3D93%26spage%3D1621%26epage%3D1657%26doi%3D10.1152%2Fphysrev.00007.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahlke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørn-Yoshimoto, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1016/j.coph.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2Fj.coph.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=25466154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVCktbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=116-123&author=A.+A.+Jensenauthor=C.+Fahlkeauthor=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=L.+Bunch&title=Excitatory+amino+acid+transporters%3A+recent+insights+into+molecular+mechanisms%2C+novel+modes+of+modulation+and+new+therapeutic+possibilities&doi=10.1016%2Fj.coph.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities</span></div><div class="casAuthors">Jensen, Anders A.; Fahlke, Christoph; Bjoern-Yoshimoto, Walden E.; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">116-123</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The five excitatory amino acid transporters (EAAT1-5) mediating the synaptic uptake of the major excitatory neurotransmitter glutamate are differently expressed throughout the CNS and at the synaptic level.  Although EAATs are crucial for normal excitatory neurotransmission, explorations into the physiol. functions mediated by the different transporter subtypes and their resp. therapeutic potential have so far been sparse, in no small part due to the limited selection of pharmacol. tools available.  In the present update, we outline important new insights into the mol. compns. of EAATs and their intricate transport process, the novel approaches to pharmacol. modulation of the transporters that have emerged, and interesting new perspectives in EAAT as drug targets proposed in recent years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHCPIMplW6KLVg90H21EOLACvtfcHk0lh8X22_TEm7Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVCktbvF&md5=4619d6aebdc64cfd77a44bae4379eb53</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DFahlke%26aufirst%3DC.%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DExcitatory%2520amino%2520acid%2520transporters%253A%2520recent%2520insights%2520into%2520molecular%2520mechanisms%252C%2520novel%2520modes%2520of%2520modulation%2520and%2520new%2520therapeutic%2520possibilities%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2015%26volume%3D20%26spage%3D116%26epage%3D123%26doi%3D10.1016%2Fj.coph.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Grewer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gameiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauen, T.</span><span> </span><span class="NLM_article-title">SLC1 Glutamate Transporters</span> <span class="citation_source-journal">Pfluegers Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1007/s00424-013-1397-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1007%2Fs00424-013-1397-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=24240778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyls7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2014&pages=3-24&author=C.+Grewerauthor=A.+Gameiroauthor=T.+Rauen&title=SLC1+Glutamate+Transporters&doi=10.1007%2Fs00424-013-1397-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">SLC1 glutamate transporters</span></div><div class="casAuthors">Grewer, Christof; Gameiro, Armanda; Rauen, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Pfluegers Archiv</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-24</span>CODEN:
                <span class="NLM_cas:coden">PFLABK</span>;
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The plasma membrane transporters for the neurotransmitter glutamate belong to the solute carrier 1 family.  They are secondary active transporters, taking up glutamate into the cell against a substantial concn. gradient.  The driving force for concentrative uptake is provided by the cotransport of Na+ ions and the countertransport of one K+ in a step independent of the glutamate translocation step.  Due to eletrogenicity of transport, the transmembrane potential can also act as a driving force.  Glutamate transporters are expressed in many tissues, but are of particular importance in the brain, where they contribute to the termination of excitatory neurotransmission.  Glutamate transporters can also run in reverse, resulting in glutamate release from cells.  Due to these important physiol. functions, glutamate transporter expression and, therefore, the transport rate, are tightly regulated.  This review summarizes recent literature on the functional and biophys. properties, structure-function relationships, regulation, physiol. significance, and pharmacol. of glutamate transporters.  Particular emphasis is on the insight from rapid kinetic and electrophysiol. studies, transcriptional regulation of transporter expression, and reverse transport and its importance for pathophysiol. glutamate release under ischemic conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7CB_CXRaoDrVg90H21EOLACvtfcHk0ljJ40OPgS6L6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyls7%252FK&md5=a15133383ebbc3dbe813b7f34bd02821</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00424-013-1397-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-013-1397-7%26sid%3Dliteratum%253Aachs%26aulast%3DGrewer%26aufirst%3DC.%26aulast%3DGameiro%26aufirst%3DA.%26aulast%3DRauen%26aufirst%3DT.%26atitle%3DSLC1%2520Glutamate%2520Transporters%26jtitle%3DPfluegers%2520Arch.%26date%3D2014%26volume%3D466%26spage%3D3%26epage%3D24%26doi%3D10.1007%2Fs00424-013-1397-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollmuth, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Glutamate Receptor Ion Channels: Structure, Regulation, and Function</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1124/pr.109.002451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1124%2Fpr.109.002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=20716669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+F.+Traynelisauthor=L.+P.+Wollmuthauthor=C.+J.+McBainauthor=F.+S.+Mennitiauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=K.+B.+Hansenauthor=H.+Yuanauthor=S.+J.+Myersauthor=R.+Dingledine&title=Glutamate+Receptor+Ion+Channels%3A+Structure%2C+Regulation%2C+and+Function&doi=10.1124%2Fpr.109.002451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor ion channels: structure, regulation, and function</span></div><div class="casAuthors">Traynelis, Stephen F.; Wollmuth, Lonnie P.; McBain, Chris J.; Menniti, Frank S.; Vance, Katie M.; Ogden, Kevin K.; Hansen, Kasper B.; Yuan, Hongjie; Myers, Scott J.; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-496</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels contg. an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore.  Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells.  These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system.  Glutamate receptors are postulated to play important roles in numerous neurol. diseases and have attracted intense scrutiny.  The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel.  In this review we discuss International Union of Basic and Clin. Pharmacol. glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacol., allosteric modulation, mechanisms of gating and permeation, roles in normal physiol. function, as well as the potential therapeutic use of pharmacol. agents acting at glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0rj4nMr5ObVg90H21EOLACvtfcHk0ljJ40OPgS6L6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ&md5=5d0a7945b5ad99113adf9f6312bafe13</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002451%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWollmuth%26aufirst%3DL.%2BP.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520Receptor%2520Ion%2520Channels%253A%2520Structure%252C%2520Regulation%252C%2520and%2520Function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496%26doi%3D10.1124%2Fpr.109.002451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Shimamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda-Kamatani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaitani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeri, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yumoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span> </span><span class="NLM_article-title">DL-Threo-Beta-Benzyloxyaspartate, a Potent Blocker of Excitatory Amino Acid Transporters</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1124/mol.53.2.195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1124%2Fmol.53.2.195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=9463476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADyaK1cXht12htrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1998&pages=195-201&author=K.+Shimamotoauthor=B.+Lebrunauthor=Y.+Yasuda-Kamataniauthor=M.+Sakaitaniauthor=Y.+Shigeriauthor=N.+Yumotoauthor=T.+Nakajima&title=DL-Threo-Beta-Benzyloxyaspartate%2C+a+Potent+Blocker+of+Excitatory+Amino+Acid+Transporters&doi=10.1124%2Fmol.53.2.195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">DL-threo-β-Benzyloxyaspartate, a potent blocker of excitatory amino acid transporters</span></div><div class="casAuthors">Shimamoto, Keiko; Lebrun, Bruno; Yasuda-Kamatani, Yoshimi; Sakaitani, Masahiro; Shigeri, Yasushi; Yumoto, Noboru; Nakajima, Terumi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-201</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">DL-Threo-β-Benzyloxyaspartate (DL-TBOA), a novel deriv. of DL-threo-β-hydroxyaspartate, was synthesized and examd. as an inhibitor of sodium-dependent glutamate/aspartate (excitatory amino acid) transporters.  DL-TBOA inhibited the uptake of [14C]glutamate in COS-1 cells expressing the human excitatory amino acid transporter-1 (EAAT1) (Ki = 42 μM) with almost the same potency as DL-threo-β-hydroxyaspartate (Ki = 58 μM).  With regard to the human excitatory amino acid transporter-2 (EAAT2), the inhibitory effect of DL-TBOA (Ki = 5.7 μM) was much more potent than that of dihydrokainate (Ki = 79 μM), which is well known as a selective blocker of this subtype.  Electrophysiol., DL-TBOA induced no detectable inward currents in Xenopus laevis oocytes expressing human EAAT1 or EAAT2.  However, it significantly reduced the glutamate-induced currents, indicating the prevention of transport.  The dose-response curve of glutamate was shifted by adding DL-TBOA without a significant change in the max. current.  The Kb values for human EAAT1 and EAAT2 expressed in X. laevis oocytes were 9.0 μM and 116 nM, resp.  These results demonstrated that DL-TBOA is, so far, the most potent competitive blocker of glutamate transporters.  DL-TBOA did not show any significant effects on either the ionotropic or metabotropic glutamate receptors.  Moreover, DL-TBOA is chem. much more stable than its benzoyl analog, a previously reported blocker of excitatory amino acid transporters; therefore, DL-TBOA should be a useful tool for investigating the physiol. roles of transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouRwxsbOa8JrVg90H21EOLACvtfcHk0ljJ40OPgS6L6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXht12htrw%253D&md5=90eb235209edbbcaa9bf5a7e69dae743</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fmol.53.2.195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.53.2.195%26sid%3Dliteratum%253Aachs%26aulast%3DShimamoto%26aufirst%3DK.%26aulast%3DLebrun%26aufirst%3DB.%26aulast%3DYasuda-Kamatani%26aufirst%3DY.%26aulast%3DSakaitani%26aufirst%3DM.%26aulast%3DShigeri%26aufirst%3DY.%26aulast%3DYumoto%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DT.%26atitle%3DDL-Threo-Beta-Benzyloxyaspartate%252C%2520a%2520Potent%2520Blocker%2520of%2520Excitatory%2520Amino%2520Acid%2520Transporters%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D53%26spage%3D195%26epage%3D201%26doi%3D10.1124%2Fmol.53.2.195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Lebrun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaitani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda-Kamatani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span> </span><span class="NLM_article-title">New β-Hydroxyaspartate Derivatives Are Competitive Blockers for the Bovine Glutamate/Aspartate Transporter</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">20336</span><span class="NLM_x">–</span> <span class="NLM_lpage">20339</span><span class="refDoi"> DOI: 10.1074/jbc.272.33.20336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1074%2Fjbc.272.33.20336" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=20336-20339&author=B.+Lebrunauthor=M.+Sakaitaniauthor=K.+Shimamotoauthor=Y.+Yasuda-Kamataniauthor=T.+Nakajima&title=New+%CE%B2-Hydroxyaspartate+Derivatives+Are+Competitive+Blockers+for+the+Bovine+Glutamate%2FAspartate+Transporter&doi=10.1074%2Fjbc.272.33.20336"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.33.20336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.33.20336%26sid%3Dliteratum%253Aachs%26aulast%3DLebrun%26aufirst%3DB.%26aulast%3DSakaitani%26aufirst%3DM.%26aulast%3DShimamoto%26aufirst%3DK.%26aulast%3DYasuda-Kamatani%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DT.%26atitle%3DNew%2520%25CE%25B2-Hydroxyaspartate%2520Derivatives%2520Are%2520Competitive%2520Blockers%2520for%2520the%2520Bovine%2520Glutamate%252FAspartate%2520Transporter%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D20336%26epage%3D20339%26doi%3D10.1074%2Fjbc.272.33.20336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span> </span><span class="NLM_article-title">Pharmacological Characterization of Human Excitatory Amino Acid Transporters EAAT1, EAAT2 and EAAT3 in a Fluorescence-Based Membrane Potential Assay</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2115</span><span class="NLM_x">–</span> <span class="NLM_lpage">2127</span><span class="refDoi"> DOI: 10.1016/j.bcp.2004.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2Fj.bcp.2004.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=15135308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVCis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=2115-2127&author=A.+A.+Jensenauthor=H.+Br%C3%A4uner-Osborne&title=Pharmacological+Characterization+of+Human+Excitatory+Amino+Acid+Transporters+EAAT1%2C+EAAT2+and+EAAT3+in+a+Fluorescence-Based+Membrane+Potential+Assay&doi=10.1016%2Fj.bcp.2004.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay</span></div><div class="casAuthors">Jensen, Anders A.; Brauner-Osborne, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2115-2127</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We have expressed the human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 stably in HEK293 cells and characterized the transporters pharmacol. in a conventional [3H]-d-aspartate uptake assay and in a fluorescence-based membrane potential assay, the FLIPR Membrane Potential (FMP) assay.  The Km and Ki values obtained for 12 std. EAAT ligands at EAAT1, EAAT2 and EAAT3 in the FMP assay correlated well with the Ki values obtained in the [3H]-d-aspartate assay (r2 values of 0.92, 0.92, and 0.95, resp.).  Furthermore, the pharmacol. characteristics of the cell lines in the FMP assay were in good agreement with previous findings in electrophysiol. studies of the transporters.  The FMP assay was capable of distinguishing between substrates and non-substrate inhibitors and to discriminate between "full" and "partial" substrates at the transporters.  Taking advantage of the prolific nature of the FMP assay, interactions of the EAATs with substrates and inhibitors were studied in some detail.  This is the first report of a high throughput screening assay for EAATs.  We propose that the assay will be of great use in future studies of the transporters.  Although conventional electrophysiol. set-ups might be superior in terms of studying sophisticated kinetic aspects of the uptake process, the FMP assay enables the collection of considerable amts. of highly reproducible data with relatively little labor.  Furthermore, considering that the no. of EAAT ligands presently available is limited, and that almost all of these are characterized by low potency and a low degree of subtype selectivity, future screening of compd. libraries at the EAAT-cell lines in the FMP assay could help identify structurally and pharmacol. novel ligands for the transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS6Um79wVYz7Vg90H21EOLACvtfcHk0ljrwuhsjHTp0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVCis78%253D&md5=06e3c536844acca52fdba733175a93c6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2004.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2004.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26atitle%3DPharmacological%2520Characterization%2520of%2520Human%2520Excitatory%2520Amino%2520Acid%2520Transporters%2520EAAT1%252C%2520EAAT2%2520and%2520EAAT3%2520in%2520a%2520Fluorescence-Based%2520Membrane%2520Potential%2520Assay%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D67%26spage%3D2115%26epage%3D2127%26doi%3D10.1016%2Fj.bcp.2004.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Arriza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadiche, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdoch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S.</span><span> </span><span class="NLM_article-title">Functional Comparisons of Three Glutamate Transporter Subtypes Cloned from Human Motor Cortex</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5559</span><span class="NLM_x">–</span> <span class="NLM_lpage">5569</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1523%2FJNEUROSCI.14-09-05559.1994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=7521911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADyaK2MXnvVyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=5559-5569&author=J.+Arrizaauthor=W.+Fairmanauthor=J.+Wadicheauthor=G.+Murdochauthor=M.+Kavanaughauthor=S.+Amara&title=Functional+Comparisons+of+Three+Glutamate+Transporter+Subtypes+Cloned+from+Human+Motor+Cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex</span></div><div class="casAuthors">Arriza, Jeffrey L.; Fairman, Wendy A.; Wadiche, Jacques I.; Murdoch, Geoffrey H.; Kavanaugh, Michael P.; Amara, Susan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5559-69</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">Reuptake plays an important role in regulating synaptic and extracellular concns. of glutamate.  Three glutamate transporters expressed in human motor cortex, termed EAAT1, EAAT2, and EAAT3 (for excitatory amino acid transporter), have been characterized by their mol. cloning and functional expression.  Each EAAT subtype mRNA was found in all human brain regions analyzed.  The most prominent regional variation in message content was in cerebellum where EAAT1 expression predominated.  EAAT1 and EAAT3 mRNAs were also expressed in various non-nervous tissues, whereas expression of EAAT2 was largely restricted to brain.  The kinetic parameters and pharmacol. characteristics of transport mediated by each EAAT subtype were detd. in transfected mammalian cells by radiolabel uptake and in microinjected oocytes by voltage-clamp measurements.  The affinities of the EAAT subtypes for L-glutamate were similar, with Km detns. varying from 48 to 97 μm in the mammalian cell assay and from 18 to 28 μM in oocytes.  Glutamate uptake inhibitors were used to compare the pharmacologies of the EAAT subtypes.  The EAAT2 subtype was distinguishable from the EAAT1/EAAT3 subtypes by the potency of several inhibitors, but most notably by sensitivity to kainic acid (KA) and dihydrokainic acid (DHK).  KA and DHK potently inhibited EAAT2 transport, but did not significantly affect transport by EAAT1/EAAT3.  Using voltage-clamp measurements, most inhibitors were found to be substrates that elicited transport currents.  In contrast, KA and DHK did not evoke currents and they were found to block EAAT2-mediated transport competitively.  This selective interaction with the EAAT2 subtype could be a significant factor in KA neurotoxicity.  These studies provide a foundation for understanding the role of glutamate transporters in human excitatory neurotransmission and in neuropathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdLh7iGWaRnbVg90H21EOLACvtfcHk0ljrwuhsjHTp0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvVyrsQ%253D%253D&md5=27b0072f8a4cd584e3b3bcb5582e697f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.14-09-05559.1994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.14-09-05559.1994%26sid%3Dliteratum%253Aachs%26aulast%3DArriza%26aufirst%3DJ.%26aulast%3DFairman%26aufirst%3DW.%26aulast%3DWadiche%26aufirst%3DJ.%26aulast%3DMurdoch%26aufirst%3DG.%26aulast%3DKavanaugh%26aufirst%3DM.%26aulast%3DAmara%26aufirst%3DS.%26atitle%3DFunctional%2520Comparisons%2520of%2520Three%2520Glutamate%2520Transporter%2520Subtypes%2520Cloned%2520from%2520Human%2520Motor%2520Cortex%26jtitle%3DJ.%2520Neurosci.%26date%3D1994%26volume%3D14%26spage%3D5559%26epage%3D5569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sagot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umberti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assaf, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboab, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gefflaut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Chemo-Enzymatic Synthesis of (2S,4R)-2-Amino-4-(3-(2,2-Diphenylethylamino)-3-Oxopropyl)pentanedioic Acid: A Novel Selective Inhibitor of Human Excitatory Amino Acid Transporter Subtype 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4085</span><span class="NLM_x">–</span> <span class="NLM_lpage">4092</span><span class="refDoi"> DOI: 10.1021/jm800091e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800091e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsl2rtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4085-4092&author=E.+Sagotauthor=A.+A.+Jensenauthor=D.+S.+Pickeringauthor=X.+Puauthor=M.+Umbertiauthor=T.+B.+Stensb%C3%B8lauthor=B.+Nielsenauthor=Z.+Assafauthor=B.+Aboabauthor=J.+Bolteauthor=T.+Gefflautauthor=L.+Bunch&title=Chemo-Enzymatic+Synthesis+of+%282S%2C4R%29-2-Amino-4-%283-%282%2C2-Diphenylethylamino%29-3-Oxopropyl%29pentanedioic+Acid%3A+A+Novel+Selective+Inhibitor+of+Human+Excitatory+Amino+Acid+Transporter+Subtype+2&doi=10.1021%2Fjm800091e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chemo-enzymatic synthesis of (2S,4R)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid: A novel selective inhibitor of human excitatory amino acid transporter subtype 2</span></div><div class="casAuthors">Sagot, Emanuelle; Jensen, Anders A.; Pickering, Darryl S.; Pu, Xiaosui; Umberti, Michelle; Stensboel, Tine B.; Nielsen, Birgitte; Assaf, Zeinab; Aboab, Betina; Bolte, Jean; Gefflaut, Thierry; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4085-4092</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the mammalian central nervous system (CNS), the action of sodium dependent excitatory amino acid transporters (EAATs) is responsible for termination of glutamatergic neurotransmission by reuptake of (S)-glutamate (Glu) from the synaptic cleft.  Five EAAT subtypes have been identified, of which EAAT1-4 are present in the CNS, while EAAT5 is localized exclusively in the retina.  In this study, we have used an enantioselective chemo-enzymic strategy to synthesize 10 new Glu analogs (I) [R1 = CH2OH, CH2OCH2Ph, CH2CO2H, (CH2)2CO2Me, (CH2)2CO2H, (CH2)2CONH2, (CH2)2CONHMe, (CH2)2CONH(CH2)Me, (CH2)2COCH2Ph,, (CH2)2CONHCH2CH(Ph)Ph] with different functionalities in the 4R-position and characterized their pharmacol. properties at the human EAAT1-3.  In particular, one compd., I [(CH2)2CONHCH2CH(Ph)Ph], displayed a significant preference as inhibitor of the EAAT2 subtype over EAAT1,3.  The compd. also displayed very low affinities toward ionotropic and metabotropic Glu receptors, making it the most selective EAAT2 inhibitor described so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7PMaEobCIcLVg90H21EOLACvtfcHk0ljrwuhsjHTp0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsl2rtrk%253D&md5=5017089c747af7a7ef37639d5473dc55</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm800091e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800091e%26sid%3Dliteratum%253Aachs%26aulast%3DSagot%26aufirst%3DE.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DPickering%26aufirst%3DD.%2BS.%26aulast%3DPu%26aufirst%3DX.%26aulast%3DUmberti%26aufirst%3DM.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DAssaf%26aufirst%3DZ.%26aulast%3DAboab%26aufirst%3DB.%26aulast%3DBolte%26aufirst%3DJ.%26aulast%3DGefflaut%26aufirst%3DT.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DChemo-Enzymatic%2520Synthesis%2520of%2520%25282S%252C4R%2529-2-Amino-4-%25283-%25282%252C2-Diphenylethylamino%2529-3-Oxopropyl%2529pentanedioic%2520Acid%253A%2520A%2520Novel%2520Selective%2520Inhibitor%2520of%2520Human%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4085%26epage%3D4092%26doi%3D10.1021%2Fjm800091e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIlvain, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrick, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosanu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butera, J.</span><span> </span><span class="NLM_article-title">Characterization of Novel Aryl-Ether, Biaryl, and Fluorene Aspartic Acid and Diaminopropionic Acid Analogs as Potent Inhibitors of the High-Affinity Glutamate Transporter EAAT2</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">974</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span><span class="refDoi"> DOI: 10.1124/mol.105.012005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1124%2Fmol.105.012005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=16014807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyhu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=974-982&author=J.+Dunlopauthor=H.+B.+McIlvainauthor=T.+A.+Carrickauthor=B.+Jowauthor=Q.+Luauthor=D.+Kowalauthor=S.+Linauthor=A.+Greenfieldauthor=C.+Grosanuauthor=K.+Fanauthor=R.+Petroskiauthor=J.+Williamsauthor=A.+Fosterauthor=J.+Butera&title=Characterization+of+Novel+Aryl-Ether%2C+Biaryl%2C+and+Fluorene+Aspartic+Acid+and+Diaminopropionic+Acid+Analogs+as+Potent+Inhibitors+of+the+High-Affinity+Glutamate+Transporter+EAAT2&doi=10.1124%2Fmol.105.012005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT2</span></div><div class="casAuthors">Dunlop, John; McIlvain, H. Beal; Carrick, Tikva A.; Jow, Brian; Lu, Qiang; Kowal, Dianne; Lin, Steven; Greenfield, Alexander; Grosanu, Cristina; Fan, Kristi; Petroski, Robert; Williams, John; Foster, Alan; Butera, John</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">974-982</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In this study, we describe the pharmacol. characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of EAAT2, the predominant glutamate transporter in forebrain regions.  The rank order of potency detd. for the inhibition of human EAAT2 was N4-[4-(2-bromo-4,5-difluorophenoxy)phenyl]-L-asparagine (WAY-213613) (IC50 = 85 ± 5 nM) > N4-(2'-methyl-1,1'-biphenyl-4-yl)-L-asparagine (WAY-213394) (IC50 = 145 ± 22 nM) = N4-[7-(trifluoromethyl)-9H-fluoren-2-yl]-L-asparagine (WAY-212922) (IC50 = 157 ± 11 nM) = 3-{[(4'-chloro-2-methyl-1,1'-biphenyl-4-yl)carbonyl]amino}- L-alanine (WAY-211686) (IC50 = 190 ± 10 nM).  WAY-213613 was the most selective of the compds. examd., with IC50 values for inhibition of EAAT1 and EAAT3 of 5 and 3.8 μM, resp., corresponding to a 59- and 45-fold selectivity toward EAAT2.  An identical rank order to potency [WAY-213613 (35 ± 7 nM) > WAY-213394 (92 ± 13 nM) = WAY-212922 (95 ± 8 nM) = WAY-211686 (101 ± 20 nM)] was obsd. for the inhibition of glutamate uptake in rat cortical synaptosomes, consistent with the predominant contribution of EAAT2 to this activity.  Kinetic studies with each of the compds. in synaptosomes revealed a competitive mechanism of inhibition.  All compds. were detd. to be nonsubstrates by evaluating both the stimulation of currents in EAAT2-injected oocytes and the heteroexchange of D-[3H]aspartate from cortical synaptosomes.  WAY-213613 represents the most potent and selective inhibitor of EAAT2 identified to date.  Taken in combination with its selectivity over ionotropic and metabotropic glutamate receptors, this compd. represents a potential tool for the further elucidation of EAAT2 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVqqndi70Gr7Vg90H21EOLACvtfcHk0li5Xup8OJXwsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyhu7nK&md5=933a42c1c37af6a8bf8390f8a93e5f82</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.012005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.012005%26sid%3Dliteratum%253Aachs%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DMcIlvain%26aufirst%3DH.%2BB.%26aulast%3DCarrick%26aufirst%3DT.%2BA.%26aulast%3DJow%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DGreenfield%26aufirst%3DA.%26aulast%3DGrosanu%26aufirst%3DC.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DA.%26aulast%3DButera%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520Novel%2520Aryl-Ether%252C%2520Biaryl%252C%2520and%2520Fluorene%2520Aspartic%2520Acid%2520and%2520Diaminopropionic%2520Acid%2520Analogs%2520as%2520Potent%2520Inhibitors%2520of%2520the%2520High-Affinity%2520Glutamate%2520Transporter%2520EAAT2%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D974%26epage%3D982%26doi%3D10.1124%2Fmol.105.012005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Vandenberg, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitrovic, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chebib, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balcar, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, G. A. R.</span><span> </span><span class="NLM_article-title">Contrasting Modes of Action of Methylglutamate Derivatives on the Excitatory Amino Acid Transporters, EAAT1 and EAAT2</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span><span class="refDoi"> DOI: 10.1124/mol.51.5.809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1124%2Fmol.51.5.809" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1997&pages=809-815&author=R.+J.+Vandenbergauthor=A.+D.+Mitrovicauthor=M.+Chebibauthor=V.+J.+Balcarauthor=G.+A.+R.+Johnston&title=Contrasting+Modes+of+Action+of+Methylglutamate+Derivatives+on+the+Excitatory+Amino+Acid+Transporters%2C+EAAT1+and+EAAT2&doi=10.1124%2Fmol.51.5.809"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fmol.51.5.809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.51.5.809%26sid%3Dliteratum%253Aachs%26aulast%3DVandenberg%26aufirst%3DR.%2BJ.%26aulast%3DMitrovic%26aufirst%3DA.%2BD.%26aulast%3DChebib%26aufirst%3DM.%26aulast%3DBalcar%26aufirst%3DV.%2BJ.%26aulast%3DJohnston%26aufirst%3DG.%2BA.%2BR.%26atitle%3DContrasting%2520Modes%2520of%2520Action%2520of%2520Methylglutamate%2520Derivatives%2520on%2520the%2520Excitatory%2520Amino%2520Acid%2520Transporters%252C%2520EAAT1%2520and%2520EAAT2%26jtitle%3DMol.%2520Pharmacol.%26date%3D1997%26volume%3D51%26spage%3D809%26epage%3D815%26doi%3D10.1124%2Fmol.51.5.809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Alaux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gefflaut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Chemoenzymatic Synthesis of a Series of 4-Substituted Glutamate Analogues and Pharmacological Characterization at Human Glutamate Transporters Subtypes 1–3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7980</span><span class="NLM_x">–</span> <span class="NLM_lpage">7992</span><span class="refDoi"> DOI: 10.1021/jm050597z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050597z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2htrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7980-7992&author=S.+Alauxauthor=M.+Kuskauthor=E.+Sagotauthor=J.+Bolteauthor=A.+a+Jensenauthor=H.+Br%C3%A4uner-Osborneauthor=T.+Gefflautauthor=L.+Bunch&title=Chemoenzymatic+Synthesis+of+a+Series+of+4-Substituted+Glutamate+Analogues+and+Pharmacological+Characterization+at+Human+Glutamate+Transporters+Subtypes+1%E2%80%933&doi=10.1021%2Fjm050597z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoenzymatic Synthesis of a Series of 4-Substituted Glutamate Analogues and Pharmacological Characterization at Human Glutamate Transporters Subtypes 1-3</span></div><div class="casAuthors">Alaux, Sebastien; Kusk, Mie; Sagot, Emanuelle; Bolte, Jean; Jensen, Anders A.; Braeuner-Osborne, Hans; Gefflaut, Thierry; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7980-7992</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of L-2,4-syn-4-alkylglutamic acid analogs I (R = Me, Et, Pr, Bu, i-Pr, i-Bu, pentyl, iso-pentyl, CH2Ph) were synthesized in high yields and high enantiomeric excess (> 99%) from their corresponding 4-substituted ketoglutaric acids dilithium salts II via enzymic transamination using aspartate aminotransferase (AAT) from pig heart or E. coli.  I were evaluated as potential ligands for the glutamate transporters EAAT1, EAAT2, and EAAT3 (excitatory amino acid transporter, subtypes 1-3) in the FLIPR membrane potential (FMP) assay.  The results showed a distinct change in the pharmacol. profile when the 4-Me group (an EAAT1 substrate and EAAT2,3 inhibitor) was extended to a 4-Et group, as this analog is an inhibitor at all three subtypes, EAAT1-3.  In addn., both large and bulky hydrophobic substituents in the 4-position of L-2,4-syn-glutamic acid are allowed by all three glutamate transporter subtypes EAAT1-3 while maintaining inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSrh51A-3q1rVg90H21EOLACvtfcHk0li5Xup8OJXwsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2htrfP&md5=5bad1a4908b9df5f7d5e8a6da9b35af7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm050597z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050597z%26sid%3Dliteratum%253Aachs%26aulast%3DAlaux%26aufirst%3DS.%26aulast%3DKusk%26aufirst%3DM.%26aulast%3DSagot%26aufirst%3DE.%26aulast%3DBolte%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DA.%2Ba%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DGefflaut%26aufirst%3DT.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DChemoenzymatic%2520Synthesis%2520of%2520a%2520Series%2520of%25204-Substituted%2520Glutamate%2520Analogues%2520and%2520Pharmacological%2520Characterization%2520at%2520Human%2520Glutamate%2520Transporters%2520Subtypes%25201%25E2%2580%25933%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7980%26epage%3D7992%26doi%3D10.1021%2Fjm050597z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahlke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span> </span><span class="NLM_article-title">Allosteric Modulation of an Excitatory Amino Acid Transporter: The Subtype-Selective Inhibitor UCPH-101 Exerts Sustained Inhibition of EAAT1 through an Intramonomeric Site in the Trimerization Domain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1068</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3396-12.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1523%2FJNEUROSCI.3396-12.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=23325245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVemsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1068-1087&author=B.+Abrahamsenauthor=N.+Schneiderauthor=M.+N.+Erichsenauthor=T.+H.+Huynhauthor=C.+Fahlkeauthor=L.+Bunchauthor=A.+A.+Jensen&title=Allosteric+Modulation+of+an+Excitatory+Amino+Acid+Transporter%3A+The+Subtype-Selective+Inhibitor+UCPH-101+Exerts+Sustained+Inhibition+of+EAAT1+through+an+Intramonomeric+Site+in+the+Trimerization+Domain&doi=10.1523%2FJNEUROSCI.3396-12.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of an excitatory amino acid transporter:the subtype-selective inhibitor UCPH-101 exerts sustained inhibition of EAAT1 through an intramonomeric site in the trimerization domain</span></div><div class="casAuthors">Abrahamsen, Bjarke; Schneider, Nicole; Erichsen, Mette N.; Huynh, Tri H. V.; Fahlke, Christoph; Bunch, Lennart; Jensen, Anders A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1068-1087</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In the present study, the mechanism of action and mol. basis for the activity of the first class of selective inhibitors of the human excitatory amino acid transporter subtype 1 (EAAT1) and its rodent ortholog GLAST are elucidated.  The previously reported specificity of UCPH-101 and UCPH-102 for EAAT1 over EAAT2 and EAAT3 is demonstrated to extend to the EAAT4 and EAAT5 subtypes as well.  Interestingly, brief exposure to UCPH-101 induces a long-lasting inactive state of EAAT1, whereas the inhibition exerted by closely related analogs is substantially more reversible in nature.  In agreement with this, the kinetic properties of UCPH-101 unblocking of the transporter are considerably slower than those of UCPH-102.  UCPH-101 exhibits noncompetitive inhibition of EAAT1, and its binding site in GLAST has been delineated in an elaborate mutagenesis study.  Substitutions of several residues in TM3, TM4c, and TM7a of GLAST have detrimental effects on the inhibitory potency and/or efficacy of UCPH-101 while not affecting the pharmacol. properties of (S)-glutamate or the competitive EAAT inhibitor TBOA significantly.  Hence, UCPH-101 is proposed to target a predominantly hydrophobic crevice in the "trimerization domain" of the GLAST monomer, and the inhibitor is demonstrated to inhibit the uptake through the monomer that it binds to exclusively and not to affect substrate translocation through the other monomers in the GLAST trimer.  The allosteric mode of UCPH-101 inhibition underlines the functional importance of the trimerization domain of the EAAT and demonstrates the feasibility of modulating transporter function through ligand binding to regions distant from its "transport domain.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqARUXvJR5bE7Vg90H21EOLACvtfcHk0ljdtaER87hKPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVemsLg%253D&md5=5e2b79367256a04008e6180cb9856d6f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3396-12.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3396-12.2013%26sid%3Dliteratum%253Aachs%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DSchneider%26aufirst%3DN.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%26aulast%3DFahlke%26aufirst%3DC.%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26atitle%3DAllosteric%2520Modulation%2520of%2520an%2520Excitatory%2520Amino%2520Acid%2520Transporter%253A%2520The%2520Subtype-Selective%2520Inhibitor%2520UCPH-101%2520Exerts%2520Sustained%2520Inhibition%2520of%2520EAAT1%2520through%2520an%2520Intramonomeric%2520Site%2520in%2520the%2520Trimerization%2520Domain%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D1068%26epage%3D1087%26doi%3D10.1523%2FJNEUROSCI.3396-12.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Discovery of the First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">912</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span><span class="refDoi"> DOI: 10.1021/jm8013458</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8013458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=912-915&author=A.+A.+Jensenauthor=M.+N.+Erichsenauthor=C.+W.+Nielsenauthor=T.+B.+Stensb%C3%B8lauthor=J.+Kehlerauthor=L.+Bunch&title=Discovery+of+the+First+Selective+Inhibitor+of+Excitatory+Amino+Acid+Transporter+Subtype+1&doi=10.1021%2Fjm8013458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1</span></div><div class="casAuthors">Jensen, Anders A.; Erichsen, Mette N.; Nielsen, Christina W.; Stensboel, Tine B.; Kehler, Jan; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">912-915</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of the first class of subtype-selective inhibitors of the human excitatory amino acid transporter subtype 1 (EAAT1) and its rat orthologue GLAST is reported.  An opening structure-activity relationship of 25 analogs is presented that addresses the influence of substitutions at the 4- and 7-positions of the parental skeleton 2-amino-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile.  The most potent analog 10 displays high nanomolar inhibitory activity at EAAT1 and a >400-fold selectivity over EAAT2 and EAAT3, making it a highly valuable pharmacol. tool.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVu7PAOshxerVg90H21EOLACvtfcHk0ljdtaER87hKPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSqs78%253D&md5=7036a6fe617a9908a36fda6a87400e2c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm8013458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8013458%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DNielsen%26aufirst%3DC.%2BW.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DKehler%26aufirst%3DJ.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520the%2520First%2520Selective%2520Inhibitor%2520of%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D912%26epage%3D915%26doi%3D10.1021%2Fjm8013458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastlund, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monrad, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekker-Jensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationship Study of First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1:2-Amino-4-(4-Methoxyphenyl)-7-(Naphthalen-1-Yl)-5-Oxo-5,6,7,8-Tetrahydro-4 H -Chromene-3-Carbonitrile (UCPH-101)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7180</span><span class="NLM_x">–</span> <span class="NLM_lpage">7191</span><span class="refDoi"> DOI: 10.1021/jm1009154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1009154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7180-7191&author=M.+N.+Erichsenauthor=T.+H.+V.+Huynhauthor=B.+Abrahamsenauthor=J.+F.+Bastlundauthor=C.+Bundgaardauthor=O.+Monradauthor=A.+Bekker-Jensenauthor=C.+W.+Nielsenauthor=K.+Frydenvangauthor=A.+A.+Jensenauthor=L.+Bunch&title=Structure%E2%80%93Activity+Relationship+Study+of+First+Selective+Inhibitor+of+Excitatory+Amino+Acid+Transporter+Subtype+1%3A2-Amino-4-%284-Methoxyphenyl%29-7-%28Naphthalen-1-Yl%29-5-Oxo-5%2C6%2C7%2C8-Tetrahydro-4+H+-Chromene-3-Carbonitrile+%28UCPH-101%29&doi=10.1021%2Fjm1009154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm1009154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1009154%26sid%3Dliteratum%253Aachs%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%2BV.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DBastlund%26aufirst%3DJ.%2BF.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DMonrad%26aufirst%3DO.%26aulast%3DBekker-Jensen%26aufirst%3DA.%26aulast%3DNielsen%26aufirst%3DC.%2BW.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationship%2520Study%2520of%2520First%2520Selective%2520Inhibitor%2520of%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%253A2-Amino-4-%25284-Methoxyphenyl%2529-7-%2528Naphthalen-1-Yl%2529-5-Oxo-5%252C6%252C7%252C8-Tetrahydro-4%2520H%2520-Chromene-3-Carbonitrile%2520%2528UCPH-101%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7180%26epage%3D7191%26doi%3D10.1021%2Fjm1009154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Haym, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T. H. V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, M. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erichsen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørn-Yoshimoto, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastlund, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Bioavailability Studies and in Vitro Profiling of the Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitor UCPH-102</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1002/cmdc.201500527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1002%2Fcmdc.201500527" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=403-419&author=I.+Haymauthor=T.+H.+V+Huynhauthor=S.+W.+Hansenauthor=M.+H.+F.+Pedersenauthor=J.+A.+Ruizauthor=M.+N.+Erichsenauthor=M.+Gyntherauthor=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=B.+Abrahamsenauthor=J.+F.+Bastlundauthor=C.+Bundgaardauthor=A.+L.+Eriksenauthor=A.+A.+Jensenauthor=L.+Bunch&title=Bioavailability+Studies+and+in+Vitro+Profiling+of+the+Selective+Excitatory+Amino+Acid+Transporter+Subtype+1+%28EAAT1%29+Inhibitor+UCPH-102&doi=10.1002%2Fcmdc.201500527"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500527%26sid%3Dliteratum%253Aachs%26aulast%3DHaym%26aufirst%3DI.%26aulast%3DHuynh%26aufirst%3DT.%2BH.%2BV%26aulast%3DHansen%26aufirst%3DS.%2BW.%26aulast%3DPedersen%26aufirst%3DM.%2BH.%2BF.%26aulast%3DRuiz%26aufirst%3DJ.%2BA.%26aulast%3DErichsen%26aufirst%3DM.%2BN.%26aulast%3DGynther%26aufirst%3DM.%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DBastlund%26aufirst%3DJ.%2BF.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DEriksen%26aufirst%3DA.%2BL.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DBioavailability%2520Studies%2520and%2520in%2520Vitro%2520Profiling%2520of%2520the%2520Selective%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%2520%2528EAAT1%2529%2520Inhibitor%2520UCPH-102%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D403%26epage%3D419%26doi%3D10.1002%2Fcmdc.201500527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hansen, S. W.; Erichsen, M. N.; Fu, B.; Bjørn-Yoshimoto, W. E.; Abrahamsen, B.; Hansen, J. C.; Jensen, A. A.; Bunch, L.</span><span> </span><span class="NLM_article-title">Identification of a New Class of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors Followed by a Structure–Activity Relationship Study</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01058</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&author=S.+W.+Hansen&author=M.+N.+Erichsen&author=B.+Fu&author=W.+E.+Bj%C3%B8rn-Yoshimoto&author=B.+Abrahamsen&author=J.+C.+Hansen&author=A.+A.+Jensen&author=L.+Bunch&title=Identification+of+a+New+Class+of+Selective+Excitatory+Amino+Acid+Transporter+Subtype+1+%28EAAT1%29+Inhibitors+Followed+by+a+Structure%E2%80%93Activity+Relationship+Study&doi=10.1021%2Facs.jmedchem.6b01058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01058%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DS.%2BW.%26atitle%3DIdentification%2520of%2520a%2520New%2520Class%2520of%2520Selective%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520Subtype%25201%2520%2528EAAT1%2529%2520Inhibitors%2520Followed%2520by%2520a%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26doi%3D10.1021%2Facs.jmedchem.6b01058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Esslinger, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerdes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awes, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mavencamp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhoderick, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlin, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, R. J.</span><span> </span><span class="NLM_article-title">The Substituted Aspartate Analogue L-Beta-Threo-Benzyl-Aspartate Preferentially Inhibits the Neuronal Excitatory Amino Acid Transporter EAAT3</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2Fj.neuropharm.2005.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=16183084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFehsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=850-861&author=C.+S.+Esslingerauthor=S.+Agarwalauthor=J.+Gerdesauthor=P.+A.+Wilsonauthor=E.+S.+Davisauthor=A.+N.+Awesauthor=E.+O%E2%80%99Brienauthor=T.+Mavencampauthor=H.+P.+Kochauthor=D.+J.+Poulsenauthor=J.+F.+Rhoderickauthor=A.+R.+Chamberlinauthor=M.+P.+Kavanaughauthor=R.+J.+Bridges&title=The+Substituted+Aspartate+Analogue+L-Beta-Threo-Benzyl-Aspartate+Preferentially+Inhibits+the+Neuronal+Excitatory+Amino+Acid+Transporter+EAAT3&doi=10.1016%2Fj.neuropharm.2005.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The substituted aspartate analogue L-β-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3</span></div><div class="casAuthors">Esslinger, C. Sean; Agarwal, Shailesh; Gerdes, John; Wilson, Paul A.; Davis, Erin S.; Awes, Alicia N.; O'Brien, Erin; Mavencamp, Teri; Koch, Hans P.; Poulsen, David J.; Rhoderick, Joseph F.; Chamberlin, A. Richard; Kavanaugh, Michael P.; Bridges, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">850-861</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The excitatory amino acid transporters (EAATs) play key roles in the regulation of CNS L-glutamate, esp. related to synthesis, signal termination, synaptic spillover, and excitotoxic protection.  Inhibitors available to delineate EAAT pharmacol. and function are essentially limited to those that non-selectively block all EAATs or those that exhibit a substantial preference for EAAT2.  Thus, it is difficult to selectively study the other subtypes, particularly EAAT1 and EAAT3.  Structure activity studies on a series of β-substituted aspartate analogs identify L-β-benzyl-aspartate (L-β-BA) as among the first blockers that potently and preferentially inhibits the neuronal EAAT3 subtype.  Kinetic anal. of D-[3H]aspartate uptake into C17.2 cells expressing the hEAATs demonstrate that L-β-threo-BA is the more potent diastereomer, acts competitively, and exhibits a 10-fold preference for EAAT3 compared to EAAT1 and EAAT2.  Electrophysiol. recordings of EAAT-mediated currents in Xenopus oocytes identify L-β-BA as a non-substrate inhibitor.  Analyzing L-β-threo-BA within the context of a novel EAAT2 pharmacophore model suggests: a highly conserved positioning of the electrostatic carboxyl and amino groups; nearby regions that accommodate select structural modifications (cyclopropyl rings, Me groups, oxygen atoms); and a unique region L-β-threo-BA occupied by the benzyl moieties of L-TBOA, L-β-threo-BA and related analogs.  It is plausible that the preference of L-β-threo-BA and L-TBOA for EAAT3 and EAAT2, resp., could reside in the latter two pharmacophore regions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4vqhxyJbFa7Vg90H21EOLACvtfcHk0li_KmYk_nvgcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFehsL7I&md5=5bf2793da482cf7bbf27e6a3b0d1bce8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DEsslinger%26aufirst%3DC.%2BS.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DGerdes%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DP.%2BA.%26aulast%3DDavis%26aufirst%3DE.%2BS.%26aulast%3DAwes%26aufirst%3DA.%2BN.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DE.%26aulast%3DMavencamp%26aufirst%3DT.%26aulast%3DKoch%26aufirst%3DH.%2BP.%26aulast%3DPoulsen%26aufirst%3DD.%2BJ.%26aulast%3DRhoderick%26aufirst%3DJ.%2BF.%26aulast%3DChamberlin%26aufirst%3DA.%2BR.%26aulast%3DKavanaugh%26aufirst%3DM.%2BP.%26aulast%3DBridges%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520Substituted%2520Aspartate%2520Analogue%2520L-Beta-Threo-Benzyl-Aspartate%2520Preferentially%2520Inhibits%2520the%2520Neuronal%2520Excitatory%2520Amino%2520Acid%2520Transporter%2520EAAT3%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D850%26epage%3D861%26doi%3D10.1016%2Fj.neuropharm.2005.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Bunch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span> </span><span class="NLM_article-title">Rational Design and Enantioselective Synthesis of (1R,4S,5R,6S)-3-azabicyclo[3.3.0]octane-4,6-Dicarboxylic Acid - a Novel Inhibitor at Human Glutamate Transporter Subtypes 1, 2, and 3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1021/jm0508336</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0508336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=172-178&author=L.+Bunchauthor=B.+Nielsenauthor=A.+a+Jensenauthor=H.+Br%C3%A4uner-Osborne&title=Rational+Design+and+Enantioselective+Synthesis+of+%281R%2C4S%2C5R%2C6S%29-3-azabicyclo%5B3.3.0%5Doctane-4%2C6-Dicarboxylic+Acid+-+a+Novel+Inhibitor+at+Human+Glutamate+Transporter+Subtypes+1%2C+2%2C+and+3&doi=10.1021%2Fjm0508336"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0508336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508336%26sid%3Dliteratum%253Aachs%26aulast%3DBunch%26aufirst%3DL.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DA.%2Ba%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26atitle%3DRational%2520Design%2520and%2520Enantioselective%2520Synthesis%2520of%2520%25281R%252C4S%252C5R%252C6S%2529-3-azabicyclo%255B3.3.0%255Doctane-4%252C6-Dicarboxylic%2520Acid%2520-%2520a%2520Novel%2520Inhibitor%2520at%2520Human%2520Glutamate%2520Transporter%2520Subtypes%25201%252C%25202%252C%2520and%25203%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D172%26epage%3D178%26doi%3D10.1021%2Fjm0508336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kanai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hediger, M. A.</span><span> </span><span class="NLM_article-title">Primary Structure and Functional Characterization of a High-Affinity Glutamate Transporter</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1038/360467a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1038%2F360467a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1280334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADyaK3sXltV2itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=1992&pages=467-471&author=Y.+Kanaiauthor=M.+A.+Hediger&title=Primary+Structure+and+Functional+Characterization+of+a+High-Affinity+Glutamate+Transporter&doi=10.1038%2F360467a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Primary structure and functional characterization of a high-affinity glutamate transporter</span></div><div class="casAuthors">Kanai, Yoshikatsu; Hediger, Matthias A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">6403</span>),
    <span class="NLM_cas:pages">467-71</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Glutamate transport across plasma membranes of neurons, glial cells and epithelial cells of the small intestine and kidney proceeds by high- and low-affinity transport systems.  High-affinity (Km 2-50 μM) transport systems have been described that are dependent on Na+ but not Cl- ions and have a preference for L-glutamate and D- and L-aspartate.  In neurons high-affinity glutamate transporters are essential for terminating the postsynaptic action of glutamate by rapidly removing released glutamate from the synaptic cleft.  The authors have isolated a cDNA encoding an electrogenic Na+- but not Cl--dependent high-affinity glutamate transporter (named EAAC1) from rabbit small intestine by expression in Xenopus oocytes.  The authors find EAAC1 transcripts in specific neuronal structures in the central nervous system as well as in the small intestine, kidney, liver, and heart.  The function and pharmacol. of the expressed protein are characteristic of the high-affinity glutamate transporter already identified in neuronal tissues.  The abnormal glutamate transport that is assocd. with certain neurodegenerative diseases and which occurs during ischemia and anoxia could be due to abnormalities in the function of this protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBZsP6SEUAH7Vg90H21EOLACvtfcHk0li_KmYk_nvgcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltV2itbY%253D&md5=bf04c9f2aa0e6e1d50d43a0778b8a13e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F360467a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F360467a0%26sid%3Dliteratum%253Aachs%26aulast%3DKanai%26aufirst%3DY.%26aulast%3DHediger%26aufirst%3DM.%2BA.%26atitle%3DPrimary%2520Structure%2520and%2520Functional%2520Characterization%2520of%2520a%2520High-Affinity%2520Glutamate%2520Transporter%26jtitle%3DNature%26date%3D1992%26volume%3D360%26spage%3D467%26epage%3D471%26doi%3D10.1038%2F360467a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Leuenberger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hediger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochner, M.</span><span> </span><span class="NLM_article-title">Concise Asymmetric Synthesis and Pharmacological Characterization of All Stereoisomers of Glutamate Transporter Inhibitor TFB-TBOA and Synthesis of EAAT Photoaffinity Probes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">539</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00311</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00311" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1aqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=534-539&author=M.+Leuenbergerauthor=A.+Ritlerauthor=A.+Simoninauthor=M.+A.+Hedigerauthor=M.+Lochner&title=Concise+Asymmetric+Synthesis+and+Pharmacological+Characterization+of+All+Stereoisomers+of+Glutamate+Transporter+Inhibitor+TFB-TBOA+and+Synthesis+of+EAAT+Photoaffinity+Probes&doi=10.1021%2Facschemneuro.5b00311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Concise Asymmetric Synthesis and Pharmacological Characterization of All Stereoisomers of Glutamate Transporter Inhibitor TFB-TBOA and Synthesis of EAAT Photoaffinity Probes</span></div><div class="casAuthors">Leuenberger, Michele; Ritler, Andreas; Simonin, Alexandre; Hediger, Matthias A.; Lochner, Martin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">534-539</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutamate is the major excitatory neurotransmitter in the mammalian brain.  Its rapid clearance after the release into the synaptic cleft is vital in order to avoid toxic effects and is ensured by several transmembrane transport proteins, so-called excitatory amino acid transporters (EAATs).  Impairment of glutamate removal has been linked to several neurodegenerative diseases and EAATs have therefore received increased attention as therapeutic targets.  O-Benzylated L-threo-β-hydroxyaspartate derivs. have been developed previously as highly potent inhibitors of EAATs with TFB-TBOA ((2S,3S)-2-amino-3-((3-(4-(trifluoromethyl)benzamido)benzyl)oxy)succinic acid) standing out as low-nanomolar inhibitor.  We report the stereoselective synthesis of all four stereoisomers of TFB-TBOA in less than a fifth of synthetic steps than the published route.  For the first time, the inhibitory activity and isoform selectivity of these TFB-TBOA enantio- and diastereomers were assessed on human glutamate transporters EAAT1-3.  Furthermore, we synthesized potent photoaffinity probes based on TFB-TBOA using our novel synthetic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9MiV2FJQk37Vg90H21EOLACvtfcHk0li_KmYk_nvgcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1aqsL4%253D&md5=1fa263356d6adc8a79bcafc26b463b7e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00311%26sid%3Dliteratum%253Aachs%26aulast%3DLeuenberger%26aufirst%3DM.%26aulast%3DRitler%26aufirst%3DA.%26aulast%3DSimonin%26aufirst%3DA.%26aulast%3DHediger%26aufirst%3DM.%2BA.%26aulast%3DLochner%26aufirst%3DM.%26atitle%3DConcise%2520Asymmetric%2520Synthesis%2520and%2520Pharmacological%2520Characterization%2520of%2520All%2520Stereoisomers%2520of%2520Glutamate%2520Transporter%2520Inhibitor%2520TFB-TBOA%2520and%2520Synthesis%2520of%2520EAAT%2520Photoaffinity%2520Probes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D534%26epage%3D539%26doi%3D10.1021%2Facschemneuro.5b00311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Shimamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yumoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeri, Y.</span><span> </span><span class="NLM_article-title">Characterization of Novel L-Threo- -Benzyloxyaspartate Derivatives, Potent Blockers of the Glutamate Transporters</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span><span class="refDoi"> DOI: 10.1124/mol.65.4.1008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1124%2Fmol.65.4.1008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=1008-1015&author=K.+Shimamotoauthor=R.+Sakaiauthor=K.+Takaokaauthor=N.+Yumotoauthor=T.+Nakajimaauthor=S.+G.+Amaraauthor=Y.+Shigeri&title=Characterization+of+Novel+L-Threo-+-Benzyloxyaspartate+Derivatives%2C+Potent+Blockers+of+the+Glutamate+Transporters&doi=10.1124%2Fmol.65.4.1008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fmol.65.4.1008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.65.4.1008%26sid%3Dliteratum%253Aachs%26aulast%3DShimamoto%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DR.%26aulast%3DTakaoka%26aufirst%3DK.%26aulast%3DYumoto%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DAmara%26aufirst%3DS.%2BG.%26aulast%3DShigeri%26aufirst%3DY.%26atitle%3DCharacterization%2520of%2520Novel%2520L-Threo-%2520-Benzyloxyaspartate%2520Derivatives%252C%2520Potent%2520Blockers%2520of%2520the%2520Glutamate%2520Transporters%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D65%26spage%3D1008%26epage%3D1015%26doi%3D10.1124%2Fmol.65.4.1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Shimamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeri, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda-Kamatani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yumoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span> </span><span class="NLM_article-title">Syntheses of Optically Pure β-Hydroxyaspartate Derivatives as Glutamate Transporter Blockers</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2407</span><span class="NLM_x">–</span> <span class="NLM_lpage">2410</span><span class="refDoi"> DOI: 10.1016/S0960-894X(00)00487-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2FS0960-894X%2800%2900487-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=11078189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVSlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2407-2410&author=K.+Shimamotoauthor=Y.+Shigeriauthor=Y.+Yasuda-Kamataniauthor=B.+Lebrunauthor=N.+Yumotoauthor=T.+Nakajima&title=Syntheses+of+Optically+Pure+%CE%B2-Hydroxyaspartate+Derivatives+as+Glutamate+Transporter+Blockers&doi=10.1016%2FS0960-894X%2800%2900487-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses of optically pure β-hydroxyaspartate derivatives as glutamate transporter blockers</span></div><div class="casAuthors">Shimamoto, Keiko; Shigeri, Yasushi; Yasuda-Kamatani, Yoshimi; Lebrun, Bruno; Yumoto, Noboru; Nakajima, Terumi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2407-2410</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">DL-threo-β-Benzyloxyaspartate (DL-TBOA) is a non-transportable blocker of the glutamate transporters that serves as an indispensable tool for the investigation of the physiol. roles of the transporters.  To examine the precise interaction between a blocker and the transporters, we synthesized the optically pure isomers (L- and D-TBOA) and its erythro-isomers.  L-TBOA is the most potent blocker for the human excitatory amino acid transporters (EAAT1-3), while D-TBOA revealed a difference in the pharmacophores between EAAT1 and EAAT3.  We also synthesized the substituent variants (Me or naphthylmethyl derivs.) of L-TBOA.  The results obtained here suggest that bulky substituents are crucial for non-transportable blockers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDvbv44N8TjbVg90H21EOLACvtfcHk0ljsfngso0L1Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVSlsbc%253D&md5=0278099dbaff566e6e480645d6b7815e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900487-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900487-X%26sid%3Dliteratum%253Aachs%26aulast%3DShimamoto%26aufirst%3DK.%26aulast%3DShigeri%26aufirst%3DY.%26aulast%3DYasuda-Kamatani%26aufirst%3DY.%26aulast%3DLebrun%26aufirst%3DB.%26aulast%3DYumoto%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DT.%26atitle%3DSyntheses%2520of%2520Optically%2520Pure%2520%25CE%25B2-Hydroxyaspartate%2520Derivatives%2520as%2520Glutamate%2520Transporter%2520Blockers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2407%26epage%3D2410%26doi%3D10.1016%2FS0960-894X%2800%2900487-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Mavencamp, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhoderick, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esslinger, C. S.</span><span> </span><span class="NLM_article-title">Synthesis and Preliminary Pharmacological Evaluation of Novel Derivatives of L-β-Threo-Benzylaspartate as Inhibitors of the Neuronal Glutamate Transporter EAAT3</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">7740</span><span class="NLM_x">–</span> <span class="NLM_lpage">7748</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1016%2Fj.bmc.2008.07.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=7740-7748&author=T.+L.+Mavencampauthor=J.+F.+Rhoderickauthor=R.+J.+Bridgesauthor=C.+S.+Esslinger&title=Synthesis+and+Preliminary+Pharmacological+Evaluation+of+Novel+Derivatives+of+L-%CE%B2-Threo-Benzylaspartate+as+Inhibitors+of+the+Neuronal+Glutamate+Transporter+EAAT3&doi=10.1016%2Fj.bmc.2008.07.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DMavencamp%26aufirst%3DT.%2BL.%26aulast%3DRhoderick%26aufirst%3DJ.%2BF.%26aulast%3DBridges%26aufirst%3DR.%2BJ.%26aulast%3DEsslinger%26aufirst%3DC.%2BS.%26atitle%3DSynthesis%2520and%2520Preliminary%2520Pharmacological%2520Evaluation%2520of%2520Novel%2520Derivatives%2520of%2520L-%25CE%25B2-Threo-Benzylaspartate%2520as%2520Inhibitors%2520of%2520the%2520Neuronal%2520Glutamate%2520Transporter%2520EAAT3%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D7740%26epage%3D7748%26doi%3D10.1016%2Fj.bmc.2008.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Meadows, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Wall, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokel, G. W.</span><span> </span><span class="NLM_article-title">Alkali Metal Cation - π Interactions Observed by Using a Lariat Ether Model System</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">3092</span><span class="NLM_x">–</span> <span class="NLM_lpage">3107</span><span class="refDoi"> DOI: 10.1021/ja003059e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja003059e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=3092-3107&author=E.+S.+Meadowsauthor=S.+L.+De+Wallauthor=L.+J.+Barbourauthor=G.+W.+Gokel&title=Alkali+Metal+Cation+-+%CF%80+Interactions+Observed+by+Using+a+Lariat+Ether+Model+System&doi=10.1021%2Fja003059e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja003059e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja003059e%26sid%3Dliteratum%253Aachs%26aulast%3DMeadows%26aufirst%3DE.%2BS.%26aulast%3DDe%2BWall%26aufirst%3DS.%2BL.%26aulast%3DBarbour%26aufirst%3DL.%2BJ.%26aulast%3DGokel%26aufirst%3DG.%2BW.%26atitle%3DAlkali%2520Metal%2520Cation%2520-%2520%25CF%2580%2520Interactions%2520Observed%2520by%2520Using%2520a%2520Lariat%2520Ether%2520Model%2520System%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D3092%26epage%3D3107%26doi%3D10.1021%2Fja003059e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, D. A.</span><span> </span><span class="NLM_article-title">From Ab Initio Quantum Mechanics to Molecular Neurobiology: A Cation-Pi Binding Site in the Nicotinic Receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">12088</span><span class="NLM_x">–</span> <span class="NLM_lpage">12093</span><span class="refDoi"> DOI: 10.1073/pnas.95.21.12088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1073%2Fpnas.95.21.12088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=9770444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADyaK1cXmsl2ktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12088-12093&author=W.+Zhongauthor=J.+P.+Gallivanauthor=Y.+Zhangauthor=L.+Liauthor=H.+A.+Lesterauthor=D.+A.+Dougherty&title=From+Ab+Initio+Quantum+Mechanics+to+Molecular+Neurobiology%3A+A+Cation-Pi+Binding+Site+in+the+Nicotinic+Receptor&doi=10.1073%2Fpnas.95.21.12088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">From ab initio quantum mechanics to molecular neurobiology: a cation-π binding site in the nicotinic receptor</span></div><div class="casAuthors">Zhong, Wenge; Gallivan, Justin P.; Zhang, Yinong; Li, Lintong; Lester, Henry A.; Dougherty, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12088-12093</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The nicotinic acetylcholine receptor is the prototype ligand-gated ion channel.  A no. of arom. amino acids have been identified as contributing to the agonist binding site, suggesting that cation-π interactions may be involved in binding the quaternary ammonium group of the agonist, acetylcholine.  Here we show a compelling correlation between: (i) ab initio quantum mech. predictions of cation-π binding abilities and (ii) EC50 values for acetylcholine at the receptor for a series of tryptophan derivs. that were incorporated into the receptor by using the in vivo nonsense-suppression method for unnatural amino acid incorporation.  Such a correlation is seen at one, and only one, of the arom. residues-tryptophan-149 of the α subunit.  This finding indicates that, on binding, the cationic, quaternary ammonium group of acetylcholine makes van der Waals contact with the indole side chain of α tryptophan-149, providing the most precise structural information to date on this receptor.  Consistent with this model, a tethered quaternary ammonium group emanating from position α149 produces a constitutively active receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonDdfCh77JjbVg90H21EOLACvtfcHk0ljsfngso0L1Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsl2ktL8%253D&md5=b120a73093e2243336924cd7d17867df</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.21.12088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.21.12088%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DGallivan%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLester%26aufirst%3DH.%2BA.%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DFrom%2520Ab%2520Initio%2520Quantum%2520Mechanics%2520to%2520Molecular%2520Neurobiology%253A%2520A%2520Cation-Pi%2520Binding%2520Site%2520in%2520the%2520Nicotinic%2520Receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D12088%26epage%3D12093%26doi%3D10.1073%2Fpnas.95.21.12088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">True, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gard, G. L.</span><span> </span><span class="NLM_article-title">Electronegativities from Core-Ionization Energies: Electronegativities of SF5 and CF3</span> <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">4437</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span><span class="refDoi"> DOI: 10.1021/ic0343298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic0343298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVChsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=4437-4441&author=J.+E.+Trueauthor=T.+D.+Thomasauthor=R.+W.+Winterauthor=G.+L.+Gard&title=Electronegativities+from+Core-Ionization+Energies%3A+Electronegativities+of+SF5+and+CF3&doi=10.1021%2Fic0343298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Electronegativities from Core-Ionization Energies: Electronegativities of SF5 and CF3</span></div><div class="casAuthors">True, Jan E.; Thomas, T. Darrah; Winter, Rolf W.; Gard, Gary L.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4437-4441</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Core-ionization energies have been measured for SF6 (S 2p), SF5SF5 (S 2p), SF5Br (S 2p and Br 3d), and SF5CF3 (S 2p and C 1s).  These results, together with others that establish correlations between core-ionization energies and Pauling electronegativities, make it possible to assign group electronegativities to SF5 and CF3.  This method gives electronegativities for these groups comparable to that of bromine, whereas anal. of the effect of these groups on acidity indicates electronegativities comparable to that of fluorine.  Other methods of estg. electronegativity fall between these extremes.  These disparities can be understood in part as reflecting the effects of polarizability of the substituent, which tends to lower both the core-ionization energy and the deprotonation energy, making the electronegativity appear to be less in one case and more in the other.  In addn., and possibly more important, the core-ionization energies presented here reflect the effect of the group on an adjacent atom, whereas the acidity reflects the effect on a remote atom.  It appears that fluorine has a large effect on an adjacent atom but a relatively small effect on a remote atom.  By contrast SF5 and CF3 have a relatively small effect on an adjacent atom, but this effect falls off only slowly with distance from the substituent. Thus, the effective electronegativities of CF3 and SF5 relative to those of the halogens depend on the site at which the mol. is probed as well as on the process that is under consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLSd9igLbkerVg90H21EOLACvtfcHk0liwhl9994zmNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVChsrY%253D&md5=db5801cf330faffd54ca770aeb236ea5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fic0343298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic0343298%26sid%3Dliteratum%253Aachs%26aulast%3DTrue%26aufirst%3DJ.%2BE.%26aulast%3DThomas%26aufirst%3DT.%2BD.%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DGard%26aufirst%3DG.%2BL.%26atitle%3DElectronegativities%2520from%2520Core-Ionization%2520Energies%253A%2520Electronegativities%2520of%2520SF5%2520and%2520CF3%26jtitle%3DInorg.%2520Chem.%26date%3D2003%26volume%3D42%26spage%3D4437%26epage%3D4441%26doi%3D10.1021%2Fic0343298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Assaf, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venskutonytė, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajhede, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrup, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickering, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frydenvang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gefflaut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunch, L.</span><span> </span><span class="NLM_article-title">Chemoenzymatic Synthesis of New 2,4-Syn-Functionalized (S)-Glutamate Analogues and Structure-Activity Relationship Studies at Ionotropic Glutamate Receptors and Excitatory Amino Acid Transporters</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1628</span><span class="refDoi"> DOI: 10.1021/jm301433m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301433m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Sktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1614-1628&author=Z.+Assafauthor=A.+P.+Larsenauthor=R.+Venskutonyt%C4%97author=L.+Hanauthor=B.+Abrahamsenauthor=B.+Nielsenauthor=M.+Gajhedeauthor=J.+S.+Kastrupauthor=A.+a+Jensenauthor=D.+S.+Pickeringauthor=K.+Frydenvangauthor=T.+Gefflautauthor=L.+Bunch&title=Chemoenzymatic+Synthesis+of+New+2%2C4-Syn-Functionalized+%28S%29-Glutamate+Analogues+and+Structure-Activity+Relationship+Studies+at+Ionotropic+Glutamate+Receptors+and+Excitatory+Amino+Acid+Transporters&doi=10.1021%2Fjm301433m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoenzymatic synthesis of new 2,4-syn-functionalized (S)-glutamate analogues and structure-activity relationship studies at ionotropic glutamate receptors and excitatory amino acid transporters</span></div><div class="casAuthors">Assaf, Zeinab; Larsen, Anja P.; Venskutonyte, Raminta; Han, Liwei; Abrahamsen, Bjarke; Nielsen, Birgitte; Gajhede, Michael; Kastrup, Jette S.; Jensen, Anders A.; Pickering, Darryl S.; Frydenvang, Karla; Gefflaut, Thierry; Bunch, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1614-1628</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the mammalian central nervous system, (S)-glutamate (Glu) is released from the presynaptic neuron where it activates a plethora of pre- and postsynaptic Glu receptors.  The fast acting ionotropic Glu receptors (iGluRs) are ligand gated ion channels and are believed to be involved in a vast no. of neurol. functions such as memory and learning, synaptic plasticity, and motor function.  The synthesis of 14 enantiopure 2,4-syn-Glu analogs, e.g. (I), (II), (III), is accessed by a short and efficient chemoenzymic approach starting from readily available cyclohexanone (IV).  Pharmacol. characterization at the iGluRs and EAAT1-3 subtypes revealed analog II as a selective GluK1 ligand with low nanomolar affinity.  Two X-ray crystal structures of the key analog II in the ligand-binding domain (LBD) of GluA2 and GluK3 were detd.  Partial domain closure was seen in the GluA2-LBD complex with II comparable to that induced by kainate.  In contrast, full domain closure was obsd. in the GluK3-LBD complex with II, similar to that of GluK3-LBD with glutamate bound.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNDU3_wI6ErbVg90H21EOLACvtfcHk0liwhl9994zmNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Sktbs%253D&md5=820d359e25bfc4d9505c20bc303cd67d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm301433m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301433m%26sid%3Dliteratum%253Aachs%26aulast%3DAssaf%26aufirst%3DZ.%26aulast%3DLarsen%26aufirst%3DA.%2BP.%26aulast%3DVenskutonyt%25C4%2597%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DB.%26aulast%3DGajhede%26aufirst%3DM.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26aulast%3DJensen%26aufirst%3DA.%2Ba%26aulast%3DPickering%26aufirst%3DD.%2BS.%26aulast%3DFrydenvang%26aufirst%3DK.%26aulast%3DGefflaut%26aufirst%3DT.%26aulast%3DBunch%26aufirst%3DL.%26atitle%3DChemoenzymatic%2520Synthesis%2520of%2520New%25202%252C4-Syn-Functionalized%2520%2528S%2529-Glutamate%2520Analogues%2520and%2520Structure-Activity%2520Relationship%2520Studies%2520at%2520Ionotropic%2520Glutamate%2520Receptors%2520and%2520Excitatory%2520Amino%2520Acid%2520Transporters%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1614%26epage%3D1628%26doi%3D10.1021%2Fjm301433m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Boudker, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yernool, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Coupling Substrate and Ion Binding to Extracellular Gate of a Sodium-Dependent Aspartate Transporter</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">445</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1038/nature05455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=10.1038%2Fnature05455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=17230192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;key=1%3ACAS%3A528%3ADC%252BD2sXos12ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=445&publication_year=2007&pages=387-393&author=O.+Boudkerauthor=R.+M.+Ryanauthor=D.+Yernoolauthor=K.+Shimamotoauthor=E.+Gouaux&title=Coupling+Substrate+and+Ion+Binding+to+Extracellular+Gate+of+a+Sodium-Dependent+Aspartate+Transporter&doi=10.1038%2Fnature05455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter</span></div><div class="casAuthors">Boudker, Olga; Ryan, Renae M.; Yernool, Dinesh; Shimamoto, Keiko; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">445</span>
        (<span class="NLM_cas:issue">7126</span>),
    <span class="NLM_cas:pages">387-393</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Secondary transporters are integral membrane proteins that catalyze the movement of substrate mols. across the lipid bilayer by coupling substrate transport to one or more ion gradients, thereby providing a mechanism for the concentrative uptake of substrates.  Here we describe crystallog. and thermodn. studies of GltPh, a sodium (Na+)-coupled aspartate transporter, defining sites for aspartate, two sodium ions and D,L-threo-β-benzyloxyaspartate, an inhibitor.  We further show that helical hairpin 2 is the extracellular gate that controls access of substrate and ions to the internal binding sites.  At least two sodium ions bind in close proximity to the substrate and these sodium-binding sites, together with the sodium-binding sites in another sodium-coupled transporter, LeuT, define an unwound α-helix as the central element of the ion-binding motif, a motif well suited to the binding of sodium and to participation in conformational changes that accompany ion binding and unbinding during the transport cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2WzQl5jvETrVg90H21EOLACvtfcHk0lj2Q0_LNE-XoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXos12ntQ%253D%253D&md5=f6ad5a2c7b561a8f38bd907db63640d2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature05455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05455%26sid%3Dliteratum%253Aachs%26aulast%3DBoudker%26aufirst%3DO.%26aulast%3DRyan%26aufirst%3DR.%2BM.%26aulast%3DYernool%26aufirst%3DD.%26aulast%3DShimamoto%26aufirst%3DK.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DCoupling%2520Substrate%2520and%2520Ion%2520Binding%2520to%2520Extracellular%2520Gate%2520of%2520a%2520Sodium-Dependent%2520Aspartate%2520Transporter%26jtitle%3DNature%26date%3D2007%26volume%3D445%26spage%3D387%26epage%3D393%26doi%3D10.1038%2Fnature05455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2nww" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2nww','PDB','2nww'); return false;">PDB: 2nww</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i59"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01066">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11212"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01066">10.1021/acs.jmedchem.6b01066</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Sequence alignment of EAAT1–3 with Glt<sub>Ph</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2nww">2nww</a>) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_001.pdf">PDF</a>)</p></li><li><p class="inline">3D coordinates of <a class="ref internalNav" href="#fig4">Figure 4</a> (PDB format) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_001.pdf">jm6b01066_si_001.pdf (196.53 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_002.pdb">jm6b01066_si_002.pdb (518.82 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01066/suppl_file/jm6b01066_si_003.csv">jm6b01066_si_003.csv (3.48 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01066&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-19%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01066" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01066" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994a3fcb3b3d5a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
